≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other spirochaetal diseases

DOID EFO Endpoint Browser PheWeb

AB1_OTHER_SPIROCHAETAL

Pinta: An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — A65-A69
  • Hospital discharge: ICD-9 — 104|08[7-7]
  • Hospital discharge: ICD-8 — 08[8-9]
  • Cause of death: ICD-10 — A65-A69
  • Cause of death: ICD-9 — 104|08[7-7]
  • Cause of death: ICD-8 — 08[8-9]

2 out of 7 registries used, show all original rules.

3918

4. Check minimum number of events

None

3918

5. Include endpoints

17106

6. Filter based on genotype QC (FinnGen only)

16508

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 16508 10369 6139
Unadjusted period prevalence (%) 3.36 3.68 2.81
Median age at first event (years) 63.29 62.29 64.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
17106
Matched controls
171059
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S12
ICPC
Insect bite/sting
7.5
307.7
4387
7518
J01CA04
ATC
amoxicillin; systemic
4.0
307.7
15557
122700
A69.2
ICD-10 Finland
Lyme disease
318137.9
307.7
16679
21
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
4.5
307.7
1084
2561
M01.2*A69.2
ICD-10 Finland
Arthritis in Lyme disease
116.8
272.8
139
12
S29
ICPC
Skin symptom/complaint other
1.7
178.6
3818
24224
G63.0*A69.2
ICD-10 Finland
Polyneuropathy (in) Lyme disease
355.0
175.7
177
5
S73
ICPC
Pediculosis/skin infestation other
11.8
173.3
176
150
S72
ICPC
Scabies/other acariasis
4.9
161.4
362
755
J01AA02
ATC
doxycycline; systemic
1.6
149.8
13183
115132
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
131.7
3818
25919
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
124.6
3699
25208
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
1217.7
124.1
121
*
TAB00
NOMESCO Finland
Lumbar puncture
2.3
107.1
831
3677
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
94.2
3218
22444
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
92.6
2276
14700
S13
ICPC
Animal/human bite
2.4
90.1
668
2896
A98
ICPC
Health maint/preventive medicine
2.8
86.7
16757
161486
M25.5
ICD-10 Finland
Pain in joint
1.4
84.4
5512
43352
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
84.3
674
3018
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
84.2
2941
20549
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.8
84.1
1340
7675
SPAT1262
SPAT
Handing over of treatment supplies
0.5
82.1
1056
18665
1048A
ICD-9 Finland
Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]
+∞
81.3
78
*
103
Kela drug reimbursment
Diabetes, insulin-treated
0.6
80.3
2068
30590
SPAT1152
SPAT
Removal of foreign body from under the skin
2.7
77.9
439
1672
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
77.4
4890
38117
Z2221
NOMESCO Finland
Medical doctor
1.4
72.6
4136
31607
S08
ICPC
Skin colour change
1.9
72.0
916
4880
S06
ICPC
Rash localized
1.9
71.1
933
5022
B88.0
ICD-10 Finland
Other acariasis
6.3
70.9
118
187
L57.0
ICD-10 Finland
Actinic keratosis
1.6
67.9
1563
9884
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
64.5
2047
29179
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
64.2
7981
68340
A10BA02
ATC
metformin; oral
0.7
59.4
2407
32824
N73
ICPC
Neurological infection other
18.4
57.7
46
25
205
Kela drug reimbursment
Chronic hypertension
0.7
54.8
1940
27194
SPAT1324
SPAT
Screening procedure
0.6
54.7
1301
19802
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.7
54.6
1923
26986
C03CA01
ATC
furosemide; systemic
0.7
52.1
2269
30669
M04AB01
ATC
probenecid; oral
10.6
49.6
54
51
T90
ICPC
Diabetes non-insulin dependent
0.7
49.4
2125
28824
G51.0
ICD-10 Finland
Bell palsy
2.2
49.2
421
1937
D22
ICD-10 Finland
Melanocytic naevi
1.7
49.0
864
5078
R83
ICPC
Respiratory infection other
1.3
48.8
3848
30624
M01AH05
ATC
etoricoxib; oral
1.3
47.0
10130
91366
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.3
46.6
3529
27891
D19
ICPC
Teeth/gum symptom/complaint
1.3
46.0
4818
39801
L548, A692,
ICD-10 Finland
+∞
45.8
44
*
S21
ICPC
Skin texture symptom/complaint
1.4
45.3
2327
17291
A68.9
ICD-10 Finland
Relapsing fever, unspecified
230.6
45.0
46
*
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
44.3
3948
31889
M79.6
ICD-10 Finland
Pain in limb
1.3
44.3
7001
60735
WX725
NOMESCO Finland
Noninvasive ventilation
0.4
44.1
213
5417
Z01.7
ICD-10 Finland
Laboratory examination
1.4
43.7
2557
19405
A10AE04
ATC
insulin glargine; parenteral
0.5
43.6
496
9201
Z71.8
ICD-10 Finland
Other specified counselling
1.3
42.2
5266
44351
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.7
41.7
2249
29505
WW200, ,
SPAT
1.3
40.8
4645
38650
H02
ICPC
Hearing complaint
1.4
40.4
2103
15643
WX720
NOMESCO Finland
Own respiration
0.4
39.9
173
4619
J01FA10
ATC
azithromycin; systemic
1.2
39.5
8985
80752
R06AX27
ATC
desloratadine; oral
1.3
39.1
4342
35977
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
36.5
5397
46162
H02AB07
ATC
prednisone; oral
1.4
36.2
1854
13735
D01AE16
ATC
amorolfine; topical
1.4
35.8
1611
11672
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
0.7
34.8
1265
17807
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
34.4
1061
7141
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
1.9
34.2
405
2104
R01AD09
ATC
mometasone; nasal
1.2
34.2
6953
61389
A97
ICPC
No disease
1.3
33.8
2952
23658
A23
ICPC
Risk factor NOS
1.4
33.8
1396
9954
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
33.6
723
4476
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.6
33.5
647
10410
GD1AA, ,
SPAT
1.3
33.4
2373
18482
A10AC01
ATC
insulin (human); parenteral
0.5
33.3
304
6061
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
32.9
3306
26961
WX704
NOMESCO Finland
Intubation
0.6
32.9
502
8579
SPAT1254
SPAT
Administration of medicine
0.7
32.7
993
14471
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
32.1
344
6514
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
32.0
813
5240
A10AB05
ATC
insulin aspart; parenteral
0.5
31.9
384
7018
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
31.7
1869
14143
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
31.3
705
10948
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.7
30.8
944
13743
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
30.7
1537
11328
L53.9
ICD-10 Finland
Erythematous condition, unspecified
2.4
30.4
202
836
D01BA02
ATC
terbinafine; oral
1.3
30.3
3642
30308
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
0.5
30.2
258
5262
J01DB01
ATC
cefalexin; oral
1.2
30.2
13323
126288
S82
ICPC
Naevus/mole
1.3
30.1
2061
15944
H93.1
ICD-10 Finland
Tinnitus
1.5
29.9
1016
6973
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
29.7
4082
34463
C01CA24
ATC
epinephrine; parenteral
1.5
29.7
855
5669
H10
ICD-10 Finland
Conjunctivitis
1.5
29.4
1019
7021
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
29.4
4243
49500
R01AD08
ATC
fluticasone; nasal
1.2
29.3
4170
35338
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
29.3
1521
11276
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.6
29.2
693
4395
SPAT1222
SPAT
Counselling/guidance promoting independent living
0.7
28.8
1046
14757
TPH07
NOMESCO Finland
Cathetrisation of artery
0.7
28.6
780
11636
DFF00
NOMESCO Finland
Pure tone audiometry
1.4
28.5
1415
10409
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
28.5
3678
30820
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
0.6
28.4
718
10884
EB1AA, ,
SPAT
1.5
28.1
910
6183
V18
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident
3.1
28.1
117
380
R05
ICD-10 Finland
Cough
1.3
28.1
3167
26126
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.7
28.1
1255
17085
D06BB10
ATC
imiquimod; topical
1.6
27.9
707
4556
Z51.5
ICD-10 Finland
Palliative care
0.6
27.4
479
7905
SPAT1263
SPAT
Sampling
0.8
27.3
4625
53203
A28
ICPC
Limited function/disability NOS
0.7
27.1
1296
17460
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.4
26.6
1248
9088
I50.0
ICD-10 Finland
Congestive heart failure
0.5
26.6
250
4936
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
26.3
6349
56518
130
Kela drug reimbursment
Malignant tumour
0.6
26.3
514
8256
L17
ICPC
Foot/toe symptom/complaint
1.2
26.0
4593
39699
J05AB11
ATC
valaciclovir; oral
1.3
26.0
2076
16391
HA1RA, ,
SPAT
1.6
25.9
672
4354
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.4
25.7
172
3831
W86
ICD-10 Finland
Exposure to other specified electric current
3.3
25.6
96
293
OAB50, ,
SPAT
0.6
25.6
540
8522
X58
ICD-10 Finland
Exposure to other specified factors
1.3
25.6
2065
16323
M01.2
ICD-10 Finland
Arthritis in Lyme disease
44.3
25.5
31
7
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
25.4
484
7824
R74
ICPC
Upper respiratory infection acute
1.2
25.2
4824
41986
M79.1
ICD-10 Finland
Myalgia
1.3
25.2
2128
16917
R51.80
ICD-10 Finland
Headache
1.3
25.2
2178
17367
R4110
NOMESCO Finland
Physiotherapy
1.2
25.2
3952
33734
H04.10
ICD-10 Finland
Dry eye syndrome
1.3
25.0
1742
13490
Z20.7
ICD-10 Finland
Contact with and exposure to pediculosis, acariasis and other infestations
4.7
24.9
57
122
B35.1
ICD-10 Finland
Tinea unguium
1.5
24.8
944
6621
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
24.8
1198
8768
S18
ICPC
Laceration/cut
1.2
24.4
7098
64084
SPAT1097
SPAT
Recording of ECG
0.7
24.3
1109
15067
R52.9
ICD-10 Finland
Pain, unspecified
1.3
24.2
1478
11225
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.2
24.0
4504
39092
F29
ICPC
Eye symptom/complaint other
1.3
23.9
1522
11628
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.6
23.8
393
6588
PH2AE, ,
SPAT
1.9
23.8
310
1665
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
23.6
1373
10348
A10BB12
ATC
glimepiride; oral
0.5
23.6
252
4774
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
23.4
3384
28612
B02
ICD-10 Finland
Zoster [herpes zoster]
1.6
23.4
599
3870
N05AX08
ATC
risperidone; systemic
0.6
23.2
425
6941
0879X
ICD-9 Finland
Relapsing fever, unspecified
+∞
22.9
22
*
A06AD11
ATC
lactulose; oral
0.7
22.9
974
13393
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
22.7
7358
66887
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
22.7
2824
23490
H81
ICPC
Excessive ear wax
1.3
22.7
2313
18808
M01AE02
ATC
naproxen; oral, rectal
1.2
22.6
8519
78372
A10BH01
ATC
sitagliptin; oral
0.7
22.6
614
9180
G04CA01
ATC
alfuzosin; oral
1.3
22.6
1345
10172
L08
ICPC
Shoulder symptom/complaint
1.2
22.5
3384
28711
M03BX02
ATC
tizanidine; oral
1.2
22.5
9701
90208
SDA03
NOMESCO Finland
Periodontal treatment
1.2
22.4
6207
55687
N02AA05
ATC
oxycodone; systemic
0.8
22.3
1490
19142
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
3.9
22.1
63
160
A69.9
ICD-10 Finland
Spirochaetal infection, unspecified
52.1
22.1
26
5
R51
ICD-10 Finland
Headache
1.5
21.7
750
5162
J20
ICD-10 Finland
Acute bronchitis
1.3
21.5
1443
11110
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
21.1
1274
9656
N05AA02
ATC
levomepromazine; systemic
0.4
21.0
140
3119
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
20.9
1323
10093
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
0.7
20.9
549
8267
Z71.9
ICD-10 Finland
Counselling, unspecified
1.4
20.9
1092
8091
UDC00
NOMESCO Finland
Ear microscopy
0.6
20.9
449
7060
L30
ICD-10 Finland
Other dermatitis
1.8
20.7
325
1850
K08.80
ICD-10 Finland
Toothache NOS
1.3
20.6
1246
9447
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
0.5
20.4
178
3603
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
20.3
1900
15275
F38
ICPC
Eye, Other laboratory test NEC
1.9
20.2
241
1260
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
20.1
2272
18680
SPAT1301
SPAT
No procedures
0.8
19.9
3177
37005
TPH04
NOMESCO Finland
Cathetrisation of vein
0.8
19.9
2128
25822
TQW99
NOMESCO Finland
Other minor procedure on skin
1.5
19.8
611
4110
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.6
19.7
449
2823
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.4
19.6
778
5499
G63.0
ICD-10 Finland
Polyneuropathy in infectious and parasitic diseases classified elsewhere
28.9
19.6
26
9
A10AE05
ATC
insulin detemir; parenteral
0.5
19.5
242
4381
H01.0
ICD-10 Finland
Blepharitis
1.4
19.4
932
6812
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
19.2
965
7106
Z01.2
ICD-10 Finland
Dental examination
1.2
19.0
7120
65137
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.3
18.9
1545
12206
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
18.9
6939
63367
R01AD58
ATC
fluticasone, combinations; nasal
1.2
18.8
3571
30905
L15
ICPC
Knee symptom/complaint
1.2
18.7
3701
32148
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
18.7
1197
9147
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
18.7
1330
10316
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.3
18.6
1137
8629
EB1SA, ,
SPAT
1.5
18.5
676
4704
I78.1
ICD-10 Finland
Naevus, non-neoplastic
1.8
18.5
290
1653
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.4
18.4
688
4812
M54
ICD-10 Finland
Dorsalgia
1.3
18.2
1683
13503
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
18.2
338
5499
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.4
18.2
797
5734
L01
ICPC
Neck symptom/complaint
1.2
17.9
2300
19157
SPAT1100
SPAT
Long-term monitoring of blood pressure
0.6
17.7
322
5267
F02.89*A69.2
ICD-10 Finland
Dementia in Lyme disease
+∞
17.7
17
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
17.7
3931
34467
SPAT1304
SPAT
Counselling and guidance related to ageing
0.6
17.7
337
5447
L08
ICD-10 Finland
Other local infections of skin and subcutaneous tissue
1.9
17.6
233
1261
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
17.6
378
5943
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
17.4
3284
28374
N05AH03
ATC
olanzapine; systemic
0.6
17.4
360
5712
L03
ICPC
Low back symptom/complaint
1.2
17.3
4247
37528
M67.4
ICD-10 Finland
Ganglion
1.4
17.3
913
6774
EBA15
NOMESCO Finland
Extraction of multiple teeth
0.5
17.3
167
3264
NG2AA
NOMESCO Finland
Patella X-ray examination
1.6
17.3
370
2294
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
17.2
14687
142472
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
0.6
17.1
389
6038
H92.0
ICD-10 Finland
Otalgia
1.4
17.0
835
6123
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
17.0
41
1463
SPAT1193
SPAT
Pap smear
0.7
17.0
607
8612
Z04.3
ICD-10 Finland
Examination and observation following other accident
1.8
17.0
249
1392
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
0.8
16.9
1391
17435
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
16.9
5282
47547
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.6
16.8
350
5541
A04AA02
ATC
granisetron; systemic, transdermal
0.6
16.7
421
6393
XX3DW
NOMESCO Finland
Time consuming IT work
0.7
16.6
835
11201
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.5
16.5
496
3322
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.4
16.4
777
5664
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
16.4
581
4021
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.5
16.3
574
3969
L13
ICPC
Hip symptom/complaint
1.2
16.3
2735
23371
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.5
16.2
177
3324
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
16.0
3650
32026
R42
ICD-10 Finland
Dizziness and giddiness
1.2
16.0
3096
26790
-31
ICPC
Medical examin/health eval partial
0.6
15.9
386
5909
A10BK03
ATC
empagliflozin; oral
0.7
15.9
806
10799
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.3
15.9
1169
9106
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
15.9
4703
42122
TK800
NOMESCO Finland
Hemodialysis
0.3
15.8
47
1498
T63.4
ICD-10 Finland
Toxic effect: Venom of other arthropods
2.1
15.7
153
747
R00.2
ICD-10 Finland
Palpitations
1.3
15.6
1070
8252
G01
ICD-10 Finland
Meningitis in bacterial diseases classified elsewhere
160.1
15.5
16
*
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.2
15.4
4273
38058
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.2
15.4
2708
23223
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
0.6
15.4
336
5263
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
15.4
1528
12356
SPAT1245
SPAT
Provision of support and information to patient’s family members
0.5
15.4
128
2626
L53.8
ICD-10 Finland
Other specified erythematous conditions
3.2
15.4
61
194
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
0.8
15.4
1436
17740
A10BB01
ATC
glibenclamide; oral
0.4
15.3
68
1785
G44.2
ICD-10 Finland
Tension-type headache
1.2
15.3
1846
15257
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.6
15.3
233
3979
ZX080
NOMESCO Finland
Image guided radiotherapy
0.4
15.2
57
1617
OAB95, ,
SPAT
1.3
15.2
998
7652
SPAT1148
SPAT
Treatment of chronic ulcer or burn
0.8
15.2
980
12681
SPAT1229
SPAT
Assessment of need for aid
0.7
15.1
446
6558
N17.9
ICD-10 Finland
Acute renal failure, unspecified
0.5
15.1
170
3161
CS494
NOMESCO Finland
Other visual field testing
1.6
15.0
317
1959
R06AX22
ATC
ebastine; oral
1.2
15.0
2326
19717
NH3AA, ,
SPAT
1.4
15.0
724
5299
J18.9
ICD-10 Finland
Pneumonia, unspecified
0.8
14.9
2343
27444
WX002
NOMESCO Finland
Sedation and analgesia
1.2
14.9
2468
21051
HARJA, ,
NOMESCO Finland
3.2
14.8
56
173
L54.8
ICD-10 Finland
Erythema in other diseases classified elsewhere
12.4
14.8
26
21
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.4
14.8
579
4084
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.3
14.8
1277
10152
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
0.5
14.8
157
2973
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
1.7
14.7
239
1379
OAA67, ,
SPAT
1.2
14.7
2238
18937
J01MA01
ATC
ofloxacin; systemic
1.3
14.6
916
6979
H48.1*A69.2
ICD-10 Finland
Retrobulbar neuritis in Lyme disease
+∞
14.6
14
*
M75
ICD-10 Finland
Shoulder lesions
1.4
14.6
568
4005
F45.8
ICD-10 Finland
Other somatoform disorders
1.3
14.6
838
6304
H02AB02
ATC
dexamethasone; systemic
0.8
14.5
980
12606
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.3
14.5
40
1323
HMAK, ,
NOMESCO Finland
0.8
14.5
925
11989
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
1.9
14.4
173
909
SPAT1360
SPAT
Extensive global examination
1.4
14.4
811
6082
A10AA02, ,
ATC
0.4
14.3
95
2111
A10BJ06
ATC
semaglutide; parenteral
0.6
14.3
338
5197
N30
ICD-10 Finland
Cystitis
1.3
14.2
1065
8318
WX780
NOMESCO Finland
Remote monitoring CPAP
0.6
14.2
260
4238
NG1BG, ,
SPAT
1.5
14.2
500
3461
H60
ICD-10 Finland
Otitis externa
1.4
14.1
667
4862
J01
ICD-10 Finland
Acute sinusitis
1.4
14.0
722
5337
L12
ICPC
Hand/finger symptom/complaint
1.2
14.0
2396
20484
SPAT1377
SPAT
Polysomnography
0.5
14.0
145
2764
M01AB05
ATC
diclofenac; systemic, rectal
1.1
13.9
10063
95373
A10BH05
ATC
linagliptin; oral
0.6
13.9
248
4068
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
0.3
13.9
50
1442
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
13.9
144
2743
R21
ICPC
Throat symptom/complaint
1.2
13.8
2827
24549
D01
ICPC
Abdominal pain/cramps general
1.2
13.8
1644
13563
WX110, ,
SPAT
1.4
13.7
709
5244
N18.8
ICD-10 Finland
Other chronic renal failure
0.4
13.7
55
1510
N17
ICPC
Vertigo/dizziness
1.2
13.7
1647
13600
SPAT1395
SPAT
Health check-up of persons outside student and working life
0.4
13.6
82
1890
G04CB01
ATC
finasteride; oral
1.3
13.6
980
7614
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
0.4
13.6
51
1442
WX723
NOMESCO Finland
CPAP therapy
0.6
13.4
257
4144
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.4
13.3
702
5209
A66.1
ICD-10 Finland
Multiple papillomata and wet crab yaws
18.2
13.3
20
11
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
0.4
13.3
78
1818
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.7
13.3
382
5643
L90.4
ICD-10 Finland
Acrodermatitis chronica atrophicans
11.4
13.3
24
21
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
13.2
4213
37833
A02BC04
ATC
rabeprazole; oral
1.3
13.2
1140
9064
H25.0
ICD-10 Finland
Senile incipient cataract
1.3
13.1
780
5896
R06AE07
ATC
cetirizine; oral
1.1
13.1
6412
59229
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
13.1
2681
23272
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
13.0
194
3331
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
13.0
938
11968
K30
ICD-10 Finland
Functional dyspepsia
1.2
13.0
1524
12553
I50.1
ICD-10 Finland
Left ventricular failure
0.6
12.8
187
3228
HA1AE, ,
SPAT
1.5
12.8
419
2859
S04
ICPC
Lump/swelling localized
1.2
12.8
1451
11905
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
0.6
12.8
231
3774
B01AB10
ATC
tinzaparin; parenteral
0.8
12.7
954
12110
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.2
12.7
1901
16042
R35
ICD-10 Finland
Polyuria
1.3
12.7
804
6134
J02AC02
ATC
itraconazole; systemic
1.2
12.7
2341
20134
A02BC05
ATC
esomeprazole; systemic
1.1
12.7
5827
53579
Z00.0
ICD-10 Finland
General medical examination
1.2
12.7
2540
22000
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
12.7
320
4853
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.5
12.7
434
2989
C03DA01
ATC
spironolactone; oral
0.8
12.6
935
11889
C09AA05
ATC
ramipril; oral
0.8
12.6
2300
26630
E66.01
ICD-10 Finland
Obesity due to excess calories
0.8
12.6
790
10266
XF400
NOMESCO Finland
ECG with 12 standard connections
1.2
12.6
1780
14939
M15
ICD-10 Finland
Polyarthrosis
1.4
12.6
631
4649
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.2
12.6
1701
14216
P72
ICPC
Schizophrenia
0.3
12.5
46
1313
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.4
12.5
57
1472
A10AB01
ATC
insulin (human); parenteral
0.5
12.5
129
2458
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.9
12.5
4757
52160
ZX070
NOMESCO Finland
Intensity modified radiotherapy
0.3
12.4
41
1233
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
12.4
1196
14741
M23
ICD-10 Finland
Internal derangement of knee
1.6
12.4
308
1982
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
1.8
12.4
177
985
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
1.6
12.4
259
1601
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
12.3
7713
72229
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.2
12.3
2504
21722
N05AD01
ATC
haloperidol; systemic
0.5
12.2
97
2018
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.2
12.2
1333
10895
R03BA02
ATC
budesonide; inhalant
1.2
12.2
2335
20149
J05AB01
ATC
aciclovir; systemic
1.2
12.1
2927
25729
A06AC51
ATC
ispaghula, combinations; oral
1.4
12.1
576
4207
EBA00
NOMESCO Finland
Extraction of tooth
0.9
12.1
4252
46889
H02AB04
ATC
methylprednisolone; systemic
1.2
12.0
1831
15473
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
12.0
6333
58666
N05AF03
ATC
chlorprothixene; systemic
0.5
12.0
95
1978
H61.2
ICD-10 Finland
Impacted cerumen
1.3
12.0
840
6499
H29
ICPC
Ear symptom/complaint other
1.2
12.0
1599
13339
J01MA06
ATC
norfloxacin; oral
1.2
12.0
1574
13112
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.5
11.9
414
2860
R22
ICD-10 Finland
Localized swelling, mass and lump of skin and subcutaneous tissue
1.5
11.9
309
2011
J37.0
ICD-10 Finland
Chronic laryngitis
1.5
11.9
399
2739
I10
ICD-10 Finland
Essential (primary) hypertension
0.9
11.9
7853
83391
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.2
11.8
1278
10429
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.2
11.8
1390
11447
NE1AA, ,
SPAT
1.6
11.7
232
1414
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
11.7
113
2201
A10AE06
ATC
insulin degludec; parenteral
0.6
11.7
174
2986
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.3
11.7
1189
9637
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.8
11.7
1406
16926
MAX99
NOMESCO Finland
Assistance to normal delivery
1.3
11.7
675
5084
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
0.2
11.7
8
499
A06AC01
ATC
ispaghula (psylla seeds); oral
1.1
11.7
3570
31925
M77.4
ICD-10 Finland
Metatarsalgia
1.3
11.6
788
6072
OAB43, ,
SPAT
1.1
11.6
4065
36685
R07.3
ICD-10 Finland
Other chest pain
1.2
11.6
1315
10790
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.3
11.5
1120
9035
SPAT1139
SPAT
Nutrition survey
0.5
11.5
140
2536
R01AD12
ATC
fluticasone furoate; nasal
1.1
11.5
4410
40040
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
5.7
11.5
21
37
H22.0*A69.2
ICD-10 Finland
Iridocyclitis in Lyme disease
120.1
11.4
12
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
11.4
975
7742
XF402
NOMESCO Finland
ECG with work load test
1.2
11.4
1238
10108
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.3
11.4
912
7183
Z24.1
ICD-10 Finland
Need for immunization against arthropod-borne viral encephalitis
2.4
11.4
76
319
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.6
11.4
175
2975
S59
ICPC
Skin, Other therap proced/minor surg NEC
1.6
11.4
262
1659
T36
ICD-10 Finland
Poisoning by systemic antibiotics
0.6
11.4
219
3521
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.2
11.3
2971
26270
C10AA01
ATC
simvastatin; oral
0.9
11.3
4434
48610
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.1
11.3
3596
32237
A10BD07
ATC
metformin and sitagliptin; systemic
0.6
11.3
222
3552
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
0.6
11.3
216
3478
J45
ICD-10 Finland
Asthma
1.2
11.3
1348
11123
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.4
11.2
443
3135
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
0.5
11.2
111
2142
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
1.5
11.2
332
2223
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.9
11.2
2363
27056
XQ855
NOMESCO Finland
Skin temperature measurement
2.8
11.2
55
199
LX2A3, ,
SPAT
0.5
11.1
132
2410
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
11.1
1065
8576
M01AX05
ATC
glucosamine; oral
1.2
11.1
2345
20389
N05AH02
ATC
clozapine; systemic
0.4
11.1
44
1207
XF640, ,
NOMESCO Finland
1.6
11.1
273
1757
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.2
11.1
1463
12195
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
0.8
11.0
1072
13198
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.2
11.0
1413
11743
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
0.7
11.0
268
4086
A49.9
ICD-10 Finland
Bacterial infection, unspecified
0.8
10.9
847
10710
R03BC03
ATC
nedocromil; inhalant
1.3
10.9
820
6407
R50.9
ICD-10 Finland
Fever, unspecified
1.2
10.9
1894
16193
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.1
10.9
6202
57616
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
10.9
2884
25509
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
2.6
10.9
61
236
SPAT1079
SPAT
Echocardiography
0.2
10.9
20
826
ZY010, ,
SPAT
1.7
10.8
181
1056
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
1.8
10.8
142
771
QBE99, ,
SPAT
2.0
10.8
115
582
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.3
10.8
855
6725
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
10.8
756
5856
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
0.5
10.7
90
1829
H02AB06
ATC
prednisolone; systemic
1.1
10.7
6808
63631
N05BA06
ATC
lorazepam; systemic, sublingual
0.7
10.6
277
4169
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
10.6
1741
20364
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
0.2
10.6
7
450
R52.2
ICD-10 Finland
Other chronic pain
1.4
10.5
450
3231
OAB47, ,
SPAT
0.7
10.5
319
4655
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
10.5
1298
10749
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.5
10.4
75
1611
A69.0
ICD-10 Finland
Necrotizing ulcerative stomatitis
110.1
10.4
11
*
K03.66
ICD-10 Finland
Tooth plaque
1.3
10.4
972
7805
J01AA04
ATC
lymecycline; systemic
1.2
10.4
1606
13590
TUPEI, ,
NOMESCO Finland
1.4
10.4
413
2930
L29
ICPC
Musculoskeletal sympt/complt other
1.2
10.3
1143
9356
B01AF01
ATC
rivaroxaban; oral
1.2
10.3
1551
13092
SPAT1279
SPAT
Preparation of immediate hospitalisation
0.2
10.3
8
462
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.4
10.2
376
2628
M19
ICD-10 Finland
Other arthrosis
1.5
10.2
268
1749
B35.3
ICD-10 Finland
Tinea pedis
1.3
10.2
561
4194
K59.0
ICD-10 Finland
Constipation
1.3
10.2
641
4887
D23
ICD-10 Finland
Other benign neoplasms of skin
1.5
10.2
279
1837
J02AC01
ATC
fluconazole; systemic
1.1
10.2
5663
52474
D07AD01
ATC
clobetasol; topical
1.2
10.2
2253
19645
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.6
10.2
219
3434
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.6
10.2
184
3001
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.2
10.2
1612
13670
R53
ICD-10 Finland
Malaise and fatigue
1.1
10.2
3278
29387
NG1AA, ,
SPAT
1.2
10.1
1044
8475
H91.1
ICD-10 Finland
Presbycusis
1.3
10.1
638
4869
-1, ,
NOMESCO Finland
0.9
10.1
3715
40954
A12BA01
ATC
potassium chloride; oral
0.6
10.1
137
2404
QCE99, ,
SPAT
2.9
10.1
46
160
A11
ICPC
Chest pain NOS
1.2
10.1
1071
8728
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.3
10.0
25
866
N05AC02
ATC
thioridazine; oral
0.4
10.0
55
1308
A10AB04
ATC
insulin lispro; parenteral
0.6
10.0
132
2333
QAE99, ,
SPAT
1.9
10.0
124
663
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.3
9.9
20
781
A41.9
ICD-10 Finland
Sepsis, unspecified
0.6
9.9
150
2555
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.3
9.9
818
6473
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.4
9.9
38
1054
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.3
9.8
708
5503
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.7
9.8
501
6699
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
2.0
9.8
105
534
QX3HE, ,
SPAT
1.5
9.8
284
1896
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
0.5
9.8
69
1490
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.3
9.8
765
6012
SPAT1131
SPAT
Colonoscopy
0.6
9.8
146
2495
R23
ICD-10 Finland
Other skin changes
1.8
9.7
148
843
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.3
9.7
667
5155
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.4
9.7
373
2632
Z37.0
ICD-10 Finland
Single live birth
1.3
9.7
730
5712
SPAT1216
SPAT
Assessment of functional ability
0.8
9.6
1272
15183
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.4
9.6
408
2927
K05.31
ICD-10 Finland
Periodontitis pronounced
0.8
9.6
980
12009
C09AA02
ATC
enalapril; systemic
0.8
9.6
1645
19181
K58
ICD-10 Finland
Irritable bowel syndrome
1.5
9.6
309
2108
J01FA09
ATC
clarithromycin; systemic
1.1
9.6
4301
39346
N04AA02
ATC
biperiden; systemic
0.4
9.6
57
1312
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.4
9.6
507
3773
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.4
9.6
386
2747
ZXH09, ,
SPAT
1.5
9.6
265
1753
SFB40
NOMESCO Finland
Filling of four surfaces reproduced outside mouth
2.1
9.5
87
418
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.4
9.5
453
3316
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
1.8
9.4
137
769
D06BB03
ATC
aciclovir; topical
1.3
9.4
538
4048
U07
ICPC
Urine symptom/complaint other
1.2
9.4
1057
8664
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.1
9.4
6700
62854
U02
ICPC
Urinary frequency/urgency
1.2
9.4
1964
17050
SPAT1305
SPAT
Counselling and guidance related to physical exercise
0.8
9.4
689
8768
L19
ICPC
Muscle symptom/complaint NOS
1.4
9.4
344
2406
A66.0
ICD-10 Finland
Initial lesions of yaws
+∞
9.4
9
*
H58.8*A69.2
ICD-10 Finland
Ophthalmopathy in Lyme disease
+∞
9.4
9
*
AN1
HP
Coronary angiography
0.8
9.4
726
9178
Z3226
NOMESCO Finland
Physiotherapist
1.2
9.4
2225
19508
H36.01
ICD-10 Finland
Diabetic maculopathy
0.3
9.4
24
816
Z25.1
ICD-10 Finland
Need for immunization against influenza
0.7
9.3
368
5124
J96.1
ICD-10 Finland
Chronic respiratory failure
0.4
9.3
55
1270
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.2
9.3
2403
21196
NH3EA
NOMESCO Finland
Feet X-ray examination with load
0.5
9.3
80
1611
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
1.7
9.3
179
1087
S01
ICPC
Pain/tenderness of skin
1.3
9.3
556
4214
L50
ICD-10 Finland
Urticaria
1.6
9.3
202
1265
S83
ICD-10 Finland
Dislocation, sprain and strain of joints and ligaments of knee
1.5
9.3
244
1596
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
0.7
9.3
485
6460
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
9.2
2021
17607
C09BA02
ATC
enalapril and diuretics; systemic
0.8
9.2
519
6843
N01
ICPC
Headache
1.2
9.2
1370
11549
N05AB03
ATC
perphenazine; systemic, rectal
0.6
9.2
168
2730
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
0.6
9.2
188
2976
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.3
9.2
848
6801
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
0.6
9.2
136
2329
H00.00
ICD-10 Finland
Hordeolum
1.3
9.1
548
4155
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
9.1
2468
21840
A91
ICPC
Abnormal result investigation NOS
1.3
9.1
634
4906
A11CC03
ATC
alfacalcidol; systemic
0.5
9.1
84
1651
DAX08
NOMESCO Finland
Fitting of hearing aid
1.3
9.1
617
4761
A10AA01, ,
ATC
0.5
9.1
94
1782
A26.0
ICD-10 Finland
Cutaneous erysipeloid
8.3
9.0
19
23
WX402
NOMESCO Finland
General anaesthesia
0.9
9.0
2487
27965
R053, ,
ICD-10 Finland
1.4
9.0
422
3082
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
0.5
9.0
81
1604
A10BK01
ATC
dapagliflozin; oral
0.8
9.0
622
7973
R01BA01
ATC
phenylpropanolamine; oral
1.3
9.0
608
4691
R12
ICD-10 Finland
Heartburn
1.2
9.0
1073
8856
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.5
8.9
95
1786
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.4
8.9
442
3256
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
8.9
13
618
L20
ICPC
Joint symptom/complaint NOS
1.4
8.9
472
3513
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.2
8.9
1164
9690
B03XA02
ATC
darbepoetin alfa; parenteral
0.5
8.9
69
1439
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
0.3
8.9
24
794
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.2
8.9
2376
21005
F20.10
ICD-10 Finland
Raise schizophrenia continuously
0.0
8.9
*
256
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.3
8.9
630
4890
S97
ICPC
Chronic ulcer skin
0.7
8.9
411
5576
A12AA04
ATC
calcium carbonate; oral
0.4
8.9
36
972
ZXE20
NOMESCO Finland
More than three and less than five hours
0.8
8.8
1112
13332
A10AD05
ATC
insulin aspart; parenteral
0.3
8.8
28
850
C07AB07
ATC
bisoprolol; oral
0.9
8.8
5751
61483
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.7
8.8
397
5404
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
0.4
8.8
54
1224
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.2
8.7
1371
11614
G04BD12
ATC
mirabegron; oral
1.2
8.7
1474
12569
Z49.1
ICD-10 Finland
Extracorporeal dialysis
0.3
8.7
27
829
SPAT1059
SPAT
Spirometry at the office
0.7
8.7
310
4385
R03DC03
ATC
montelukast; oral
1.2
8.6
2155
18958
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
1.5
8.6
228
1496
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
0.4
8.6
47
1115
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
2.0
8.5
93
477
DHB50
NOMESCO Finland
Turbinoplasty
1.5
8.5
283
1944
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
1.4
8.5
318
2233
NA3BG, ,
SPAT
1.3
8.5
495
3738
M54.5
ICD-10 Finland
Low back pain
1.1
8.5
5209
48415
N05AX12
ATC
aripiprazole; systemic
0.7
8.5
210
3187
SPAT1281
SPAT
Other administrative function
0.8
8.5
559
7211
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
1.5
8.5
268
1824
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
1.7
8.5
141
825
TPX10
NOMESCO Finland
Implantation of vascular injection port
0.6
8.4
150
2451
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
7.3
8.4
19
26
R07.0
ICD-10 Finland
Pain in throat
1.2
8.4
882
7179
R03AC03
ATC
terbutaline; inhalant
1.2
8.4
1691
14632
C09CA06
ATC
candesartan; oral
1.1
8.4
3273
29658
N06DX01
ATC
memantine; oral
0.7
8.4
348
4801
S80.0
ICD-10 Finland
Contusion of knee
1.2
8.4
941
7716
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.3
8.3
815
6581
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.6
8.3
189
2920
F20
ICD-10 Finland
Schizophrenia
0.2
8.3
7
380
EBA05, ,
SPAT
1.6
8.3
187
1182
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
0.5
8.3
59
1264
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
0.4
8.3
34
911
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.1
8.3
4562
42160
T89
ICPC
Diabetes insulin dependent
0.7
8.2
217
3250
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
0.7
8.2
234
3452
M01AG02
ATC
tolfenamic acid; oral, rectal
1.2
8.2
1878
16410
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
0.6
8.2
137
2273
C08CA01
ATC
amlodipine; oral
0.9
8.2
4390
47469
M54.2
ICD-10 Finland
Cervicalgia
1.2
8.2
997
8245
DM1QA, ,
SPAT
1.3
8.2
481
3640
R23.3
ICD-10 Finland
Spontaneous ecchymoses
1.5
8.2
241
1618
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.5
8.2
254
1724
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
1.3
8.2
575
4462
L03
ICD-10 Finland
Cellulitis
1.8
8.1
124
708
H66.9
ICD-10 Finland
Otitis media, unspecified
1.3
8.1
732
5856
AN2
HP
Balloon angioplasty, including several vessels
0.6
8.1
100
1798
WX872
NOMESCO Finland
Intensive care
0.7
8.1
308
4312
HAMTE, ,
NOMESCO Finland
0.2
8.1
10
529
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
8.1
2075
18286
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
1.6
8.1
172
1073
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
0.5
8.1
62
1295
S83.2
ICD-10 Finland
Tear of meniscus, current
1.2
8.1
828
6722
R06AE09
ATC
levocetirizine; oral
1.2
8.1
1793
15632
L60.9
ICD-10 Finland
Nail disorder, unspecified
1.6
8.1
199
1285
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.6
8.1
116
1999
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.2
8.1
896
7340
H3601, E113,
ICD-10 Finland
0.3
8.0
27
795
L89
ICD-10 Finland
Decubitus ulcer and pressure area
0.4
8.0
52
1154
Z75.2
ICD-10 Finland
Other waiting period for investigation and treatment
1.8
8.0
104
566
L50.9
ICD-10 Finland
Urticaria, unspecified
1.3
8.0
443
3323
SPAT1104
SPAT
Monitoring of emergency patient
0.7
8.0
432
5724
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
0.8
8.0
497
6458
K80
ICPC
Cardiac arrhythmia NOS
1.2
8.0
1067
8905
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.7
8.0
245
3561
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
1.6
8.0
162
1000
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
0.6
8.0
125
2104
PE1AT
NOMESCO Finland
Femoral artery PTA
0.3
8.0
21
700
R05
ICPC
Cough
1.1
8.0
3461
31553
C07AB02
ATC
metoprolol; systemic
0.9
8.0
1708
19567
C01DA14
ATC
isosorbide mononitrate; oral
0.8
7.9
1016
12164
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
0.5
7.9
67
1353
ZXC60
NOMESCO Finland
Application of heat
1.6
7.9
172
1079
L50.0
ICD-10 Finland
Allergic urticaria
1.4
7.9
298
2098
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
0.6
7.9
109
1896
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.4
7.9
330
2368
J01DC02
ATC
cefuroxime; systemic
1.3
7.9
618
4864
TNG10
NOMESCO Finland
Puncture of knee
1.7
7.8
135
798
KE1BG
NOMESCO Finland
MRI of prostate
1.9
7.8
97
520
RF210, ,
NOMESCO Finland
0.6
7.8
127
2119
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.3
7.8
708
5674
D07AC01
ATC
betamethasone; topical
1.1
7.8
5028
46821
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.2
7.8
1162
9804
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
1.5
7.8
212
1402
B35
ICD-10 Finland
Dermatophytosis
1.9
7.7
93
494
-1, ,
ICPC
0.7
7.7
205
3064
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
0.7
7.7
197
2968
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.5
7.7
82
1538
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.4
7.7
336
2428
I49.1
ICD-10 Finland
Atrial premature depolarization
1.3
7.7
433
3258
TUPAE, ,
NOMESCO Finland
3.9
7.7
22
57
D82
ICPC
Teeth/gum disease
1.1
7.7
5279
49300
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.6
7.7
167
2599
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
1.9
7.6
89
468
N02AA01
ATC
morphine; systemic, rectal
0.4
7.6
49
1090
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.2
7.6
858
7038
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
1.8
7.6
117
670
WX730
NOMESCO Finland
Conventional respirator
0.4
7.6
45
1034
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.3
7.6
629
4982
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
0.8
7.6
815
9932
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.2
7.6
934
7730
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
7.6
261
3716
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.3
7.6
456
3463
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.2
7.6
1032
8628
N05BA02
ATC
chlordiazepoxide; systemic
0.6
7.6
91
1646
ND1AA, ,
SPAT
1.4
7.6
330
2385
B01AA03
ATC
warfarin; systemic
0.9
7.6
1408
16312
R1100, ,
SPAT
0.4
7.5
43
1001
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.3
7.5
410
3069
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.3
7.5
510
3938
C01AA05
ATC
digoxin; systemic
0.7
7.5
360
4855
N02CC03
ATC
zolmitriptan; nasal, oral
1.3
7.5
613
4847
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.1
7.5
2173
19305
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
1.4
7.5
346
2523
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
0.2
7.5
9
395
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
0.2
7.5
14
567
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.2
7.5
843
6915
NHQ40
NOMESCO Finland
Amputation of toe
0.4
7.5
38
928
UJD10, ,
SPAT
1.4
7.5
304
2170
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.2
7.5
1156
9782
N05AF05
ATC
zuclopenthixol; systemic
0.3
7.5
17
613
R19.4
ICD-10 Finland
Change in bowel habit
1.4
7.4
339
2468
R95
ICPC
Chron obstructive pulmonary disease
0.6
7.4
141
2264
XX1XN
NOMESCO Finland
Other isotope examination
0.2
7.4
14
563
R49.03
ICD-10 Finland
Atrophic dysphonia
1.7
7.4
126
743
U09
ICD-10 Finland
Post COVID-19 condition
1.8
7.4
102
566
F10.20
ICD-10 Finland
Alcohol dependence currently independent
0.5
7.4
73
1400
WX290, ,
SPAT
1.4
7.4
377
2795
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
0.4
7.4
31
821
160
Kela drug reimbursment
exenatide
0.5
7.4
77
1451
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.2
7.4
814
6665
M20.2
ICD-10 Finland
Hallux rigidus
1.4
7.4
361
2660
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.2
7.4
1008
8434
WW500
NOMESCO Finland
Blood transfusion
0.7
7.4
224
3258
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
1.6
7.4
149
920
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
0.6
7.3
104
1795
UJH02
NOMESCO Finland
Anoscopy
1.3
7.3
459
3508
N05AH04
ATC
quetiapine; oral
0.9
7.3
1688
19241
SPAT1311
SPAT
Counselling and guidance related to occupational health
1.4
7.3
334
2433
NB2AT, ,
SPAT
1.8
7.3
96
525
K59.1
ICD-10 Finland
Functional diarrhoea
1.3
7.3
654
5231
DFF59
NOMESCO Finland
Other assessment of balance
1.7
7.3
113
649
C07FB02
ATC
metoprolol and felodipine; systemic
0.6
7.3
116
1944
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
1.4
7.3
340
2485
177
Kela drug reimbursment
Insulin glargine 300 U / ml
0.5
7.3
71
1365
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.3
7.3
654
5235
127
Kela drug reimbursment
Transplant complication
0.5
7.3
53
1123
F51.0
ICD-10 Finland
Nonorganic insomnia
1.1
7.3
2169
19315
ND2AA, ,
SPAT
1.3
7.2
649
5194
S72.0
ICD-10 Finland
Fracture of neck of femur
0.6
7.2
148
2334
XA402
NOMESCO Finland
ENMG
1.4
7.2
275
1942
XF610
NOMESCO Finland
Measurement of pulsvariation
3.4
7.2
25
74
PD3AT
NOMESCO Finland
Pelvic artery PTA
0.2
7.2
6
331
KAY20, ,
NOMESCO Finland
1.6
7.2
139
848
R01AD05
ATC
budesonide; nasal
1.2
7.2
862
7119
WX320
NOMESCO Finland
Spinalanesthesy
1.1
7.2
3204
29232
K40
ICD-10 Finland
Inguinal hernia
1.5
7.2
221
1499
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
0.8
7.2
1089
12835
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.2
7.2
1323
11368
E03
ICD-10 Finland
Other hypothyroidism
1.2
7.2
725
5882
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
0.7
7.2
249
3534
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.8
7.2
650
8060
XX9LA
NOMESCO Finland
Complementary kinetic X-ray examination without contrast
0.2
7.2
10
484
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
0.4
7.2
41
951
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
1.6
7.2
153
958
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
0.6
7.1
125
2044
R01AD59
ATC
mometasone, combinations; nasal
1.2
7.1
775
6337
EB4VA, ,
NOMESCO Finland
1.1
7.1
2303
20611
H57.1
ICD-10 Finland
Ocular pain
1.3
7.1
451
3453
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.4
7.1
357
2643
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
0.2
7.1
9
384
XQ800
NOMESCO Finland
Prick test
1.2
7.1
859
7105
WVA20, ,
SPAT
0.7
7.1
214
3114
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.2
7.0
1305
11218
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
0.2
7.0
8
361
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
0.6
7.0
86
1544
SPD00
NOMESCO Finland
Mucosa borne complete denture
0.3
7.0
23
683
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
0.2
7.0
13
527
OAB48, ,
SPAT
1.1
7.0
2018
17922
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
0.4
7.0
31
801
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.2
7.0
815
6712
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.2
7.0
1032
8697
H81.3
ICD-10 Finland
Other peripheral vertigo
1.4
7.0
311
2257
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
0.3
7.0
20
636
J01MA02
ATC
ciprofloxacin; systemic
1.1
7.0
5151
48214
RTGOM, ,
NOMESCO Finland
3.1
7.0
28
91
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
1.5
7.0
181
1185
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
0.2
7.0
7
339
R03BB04
ATC
tiotropium bromide; inhalant
0.8
7.0
753
9165
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
0.5
7.0
66
1280
N07BA03
ATC
varenicline; oral
0.7
7.0
330
4451
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
0.7
6.9
178
2674
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
0.2
6.9
6
321
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
0.4
6.9
26
723
J33.8
ICD-10 Finland
Other polyp of sinus
1.5
6.9
220
1503
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
1.7
6.9
108
623
NH1BG, ,
SPAT
1.5
6.9
187
1236
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
0.5
6.9
65
1262
WZC30
NOMESCO Finland
Teaching
0.9
6.9
1708
19371
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
0.3
6.9
15
553
F16
ICPC
Eyelid symptom/complaint
1.3
6.9
613
4903
M25.9
ICD-10 Finland
Joint disorder, unspecified
1.7
6.9
116
684
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
0.6
6.9
126
2036
E87.5
ICD-10 Finland
Hyperkalaemia
0.5
6.9
56
1140
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
1.3
6.9
438
3359
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.4
6.8
244
1704
G03DC05
ATC
[U] tibolone
1.3
6.8
491
3826
EB1CA, ,
SPAT
1.8
6.8
98
552
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
1.5
6.8
210
1426
H3603, E103,
ICD-10 Finland
0.3
6.8
18
596
G50.1
ICD-10 Finland
Atypical facial pain
1.5
6.8
200
1345
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
0.7
6.8
162
2470
L29
ICD-10 Finland
Pruritus
1.6
6.8
166
1073
DM1AI, ,
SPAT
1.8
6.8
87
473
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.2
6.8
1305
11251
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.3
6.8
446
3435
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
0.6
6.7
124
2002
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.2
6.7
898
7497
R56.8
ICD-10 Finland
Other and unspecified convulsions
0.7
6.7
300
4085
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.2
6.7
1684
14811
U01
ICPC
Dysuria/painful urination
1.2
6.7
957
8038
A03FA01
ATC
metoclopramide; systemic, rectal
0.9
6.7
2413
26723
H40.1
ICD-10 Finland
Primary open-angle glaucoma
2.5
6.7
40
161
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
1.4
6.7
229
1586
E0000UV, ,
ATC
1.1
6.7
5855
55201
H25.8
ICD-10 Finland
Other senile cataract
1.2
6.7
1119
9536
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.5
6.7
216
1481
N05CD07
ATC
temazepam; oral
0.8
6.7
861
10297
C02EA02, ,
ATC
0.7
6.7
165
2496
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
1.6
6.7
132
812
WYA20
NOMESCO Finland
Home visit
0.5
6.7
47
1006
TK810
NOMESCO Finland
Hemofiltration
0.2
6.7
9
368
KED22
NOMESCO Finland
Transurethral resection of prostate
1.3
6.6
427
3278
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
1.3
6.6
422
3235
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
1.6
6.6
159
1024
T82
ICPC
Obesity
0.7
6.6
298
4050
OAB72
NOMESCO Finland
Weight control and weight loss guidance
0.3
6.6
20
617
N05AA01
ATC
chlorpromazine; systemic, rectal
0.4
6.6
33
808
J01FA06
ATC
roxithromycin; oral
1.1
6.6
5338
50147
E86
ICD-10 Finland
Volume depletion
0.6
6.6
88
1541
K05.1
ICD-10 Finland
Chronic gingivitis
1.2
6.6
798
6600
B35.4
ICD-10 Finland
Tinea corporis
1.6
6.6
154
986
KAY40, ,
NOMESCO Finland
1.5
6.6
208
1420
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.9
6.6
3247
35328
H3603, E113,
ICD-10 Finland
0.2
6.6
10
457
S15
ICPC
Foreign body in skin
1.2
6.6
766
6311
H00.1
ICD-10 Finland
Chalazion
1.3
6.6
440
3397
E66.8
ICD-10 Finland
Other obesity
0.8
6.6
421
5441
R52.0
ICD-10 Finland
Acute pain
1.3
6.6
355
2659
H91.9
ICD-10 Finland
Hearing loss, unspecified
1.3
6.6
564
4494
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.1
6.6
2195
19684
H25
ICD-10 Finland
Senile cataract
1.7
6.6
114
678
Z10.0
ICD-10 Finland
Occupational health examination
1.2
6.6
1047
8888
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
1.6
6.6
149
948
L02
ICPC
Back symptom/complaint
1.2
6.5
1294
11182
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.3
6.5
421
3233
M19.8
ICD-10 Finland
Other specified arthrosis
1.3
6.5
470
3663
SFA20
NOMESCO Finland
Two-surface restoration
1.1
6.5
8764
84116
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
0.4
6.5
26
702
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
0.5
6.5
69
1291
XX2RW, ,
NOMESCO Finland
0.5
6.5
53
1079
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.2
6.5
804
6663
N07BB01
ATC
disulfiram; oral
0.7
6.5
253
3519
E66.9
ICD-10 Finland
Obesity, unspecified
0.7
6.5
217
3098
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.2
6.5
939
7901
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
0.4
6.5
30
758
Z04
ICD-10 Finland
Examination and observation for other reasons
1.5
6.5
169
1109
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.3
6.5
373
2820
XQ855, ,
SPAT
0.4
6.5
39
884
NH1AA, ,
SPAT
1.3
6.5
360
2709
V03AE01
ATC
polystyrene sulfonate; oral
0.4
6.5
29
742
NB1DG, ,
SPAT
1.6
6.4
129
796
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
0.2
6.4
11
467
WX702
NOMESCO Finland
Supraglottic ventilation device
0.8
6.4
434
5572
Z50.0
ICD-10 Finland
Cardiac rehabilitation
0.3
6.4
18
577
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
6.4
11076
107398
J02
ICD-10 Finland
Acute pharyngitis
1.3
6.4
368
2784
G01AA10
ATC
clindamycin; vaginal
1.1
6.4
1796
15929
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
1.3
6.3
538
4281
A10BJ02
ATC
liraglutide; parenteral
0.7
6.3
171
2540
R4120
NOMESCO Finland
Occupational therapy
1.2
6.3
743
6130
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.6
6.3
86
1495
D06BX02
ATC
ingenol mebutate; topical
1.7
6.3
114
686
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.5
6.3
71
1302
A10AD01
ATC
insulin (human); parenteral
0.4
6.3
39
874
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
0.7
6.3
146
2235
N76.0
ICD-10 Finland
Acute vaginitis
1.2
6.3
678
5544
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
0.5
6.3
73
1326
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
0.8
6.3
455
5786
1048X
ICD-9 Finland
Other spirochaetal infection, Other specified spirochaetal infections[INFECTIO SPIROCHAETALES ALIA DEFINITA]
+∞
6.2
6
*
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.3
6.2
365
2768
P70
ICPC
Dementia
0.5
6.2
66
1232
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.3
6.2
468
3671
I84
ICD-10 Finland
Hemorrhoids
1.4
6.2
276
2006
N64.4
ICD-10 Finland
Mastodynia
1.3
6.2
380
2900
SPAT1255
SPAT
Intravenous administration of medicine
0.8
6.2
476
6011
E66.00
ICD-10 Finland
Metabolic syndrome
0.8
6.2
420
5384
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
0.5
6.2
69
1268
L71
ICD-10 Finland
Rosacea
1.4
6.2
299
2204
D11
ICPC
Diarrhoea
1.2
6.2
1467
12860
SPAT1053
SPAT
Memory test
0.8
6.1
1045
12195
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
6.1
1502
13190
SPAT1240
SPAT
Therapeutic discussion
0.8
6.1
848
10073
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
1.3
6.1
401
3090
C09CA01
ATC
losartan; oral
0.9
6.1
2795
30542
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
2.2
6.1
49
226
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.7
6.1
202
2884
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
0.4
6.1
23
634
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
0.6
6.1
130
2024
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.2
6.1
1119
9618
R41.3
ICD-10 Finland
Other amnesia
1.4
6.1
287
2108
R51.81
ICD-10 Finland
Facial pain NOS
1.4
6.1
262
1896
ITSEH, ,
NOMESCO Finland
0.2
6.0
6
294
H53
ICD-10 Finland
Visual disturbances
1.7
6.0
102
603
XFE00
NOMESCO Finland
Epicardial ultrasonography
0.6
6.0
83
1438
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
0.3
6.0
21
602
M01AC06
ATC
meloxicam; systemic, rectal
1.1
6.0
4948
46477
XQ899
NOMESCO Finland
Other assessment of skin
2.1
6.0
54
260
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
0.2
6.0
5
272
K07.60
ICD-10 Finland
Snapping jaw
1.2
6.0
580
4687
M02.8
ICD-10 Finland
Other reactive arthropathies
2.1
6.0
55
267
D07AB02
ATC
hydrocortisone butyrate; topical
1.1
6.0
3881
36060

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7.5e-01
1.7e+00
4.9e+00
—
4.5e+00
2.5e+00
1.5e+00
cases:4.29%
controls:2.07%
cases:2.74%
controls:0.52%
cases:5.48%
controls:0.04%
—
—
cases:3.73%
controls:0.04%
cases:5.08%
controls:0.46%
cases:7.07%
controls:1.63%
732
3532
16317
166956
467
883
16582
169637
935
75
16113
170445
—
629
70
16228
168724
756
689
14135
150492
740
1608
9729
97167
amoxicillin; oral, parenteral
J01CA04 [21602823]
2.7e-01
4.0e-01
1.6e+00
8.8e+00
3.4e+00
4.6e-01
5.2e-01
cases:26.75%
controls:21.81%
cases:9.44%
controls:6.53%
cases:3.20%
controls:0.68%
cases:57.97%
controls:0.02%
cases:16.74%
controls:0.68%
cases:9.84%
controls:6.43%
cases:29.29%
controls:19.79%
4560
37182
12489
133306
1610
11130
15439
159390
546
1159
16502
169361
9882
34
7166
170486
2822
1145
14035
167649
1466
9721
13425
141460
3066
19545
7403
79230
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7.5e-01
1.6e+00
4.7e+00
—
4.4e+00
2.3e+00
1.5e+00
cases:3.95%
controls:1.91%
cases:2.31%
controls:0.48%
cases:4.48%
controls:0.04%
—
—
cases:3.08%
controls:0.04%
cases:4.28%
controls:0.43%
cases:6.29%
controls:1.51%
674
3251
16375
167237
394
826
16655
169694
763
76
16285
170444
—
519
64
16338
168730
638
648
14253
150533
658
1489
9811
97286
Infectious Disease
44 [38004484]
-1.3e-01
2.3e-01
1.4e+00
7.1e+00
3.3e+00
2.0e+00
7.5e-01
cases:2.35%
controls:2.67%
cases:1.13%
controls:0.90%
cases:0.59%
controls:0.15%
cases:4.62%
controls:0.00%
cases:3.99%
controls:0.15%
cases:5.76%
controls:0.79%
cases:4.38%
controls:2.11%
401
4546
16648
165942
192
1535
16857
168985
100
253
16948
170267
787
7
16261
170513
673
255
16184
168539
858
1189
14033
149992
459
2085
10010
96690
Insect bite/sting
S12 [2002000977]
1.1e+00
1.5e+00
4.9e+00
—
3.6e+00
1.6e+00
1.6e+00
cases:3.41%
controls:1.13%
cases:1.43%
controls:0.32%
cases:3.92%
controls:0.03%
—
—
cases:1.35%
controls:0.04%
cases:1.61%
controls:0.33%
cases:6.28%
controls:1.31%
581
1935
16468
168553
244
538
16805
169982
668
54
16380
170466
—
228
66
16629
168728
240
497
14651
150684
657
1293
9812
97482
doxycycline; oral, parenteral
J01AA02 [21602800]
2.2e-01
3.5e-01
1.3e+00
6.9e+00
3.2e+00
6.8e-01
4.4e-01
cases:18.98%
controls:15.84%
cases:6.22%
controls:4.47%
cases:1.74%
controls:0.47%
cases:16.45%
controls:0.02%
cases:10.23%
controls:0.46%
cases:8.31%
controls:4.40%
cases:18.86%
controls:13.00%
3236
27013
13813
143475
1060
7622
15989
162898
297
800
16751
169720
2804
35
14244
170485
1724
783
15133
168011
1238
6656
13653
144525
1974
12839
8495
85936
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]
-1.8e-02
1.0e+00
3.9e+00
1.0e+50
5.1e+00
1.9e+00
9.9e-01
cases:0.29%
controls:0.29%
cases:0.18%
controls:0.06%
cases:0.27%
controls:0.01%
cases:0.53%
controls:0.00%
cases:0.58%
controls:0.00%
cases:0.32%
controls:0.05%
cases:0.51%
controls:0.19%
49
499
17000
169989
31
109
17018
170411
46
9
17002
170511
91
0
16957
170520
98
6
16759
168788
47
71
14844
151110
53
187
10416
98588
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
-3.6e-02
9.4e-01
3.8e+00
1.0e+50
5.0e+00
1.9e+00
1.2e+00
cases:0.32%
controls:0.33%
cases:0.18%
controls:0.07%
cases:0.24%
controls:0.01%
cases:0.65%
controls:0.00%
cases:0.59%
controls:0.00%
cases:0.35%
controls:0.05%
cases:0.71%
controls:0.22%
54
560
16995
169928
30
117
17019
170403
41
9
17007
170511
111
0
16937
170520
100
7
16757
168787
52
83
14839
151098
74
214
10395
98561
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
W57 [45756308]
1.2e+00
1.4e+00
5.0e+00
—
2.7e+00
1.4e+00
1.1e+00
cases:1.27%
controls:0.39%
cases:0.55%
controls:0.14%
cases:1.58%
controls:0.01%
—
—
cases:0.31%
controls:0.02%
cases:0.62%
controls:0.15%
cases:1.53%
controls:0.51%
216
658
16833
169830
94
241
16955
170279
269
19
16779
170501
—
53
36
16804
168758
93
231
14798
150950
160
499
10309
98276
Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
49615-8 [3030429]
7.5e-01
1.7e+00
—
1.0e+50
5.1e+00
3.0e+00
2.1e+00
cases:0.18%
controls:0.08%
cases:0.13%
controls:0.02%
—
—
cases:0.59%
controls:0.00%
cases:0.47%
controls:0.00%
cases:0.37%
controls:0.02%
cases:0.44%
controls:0.06%
30
142
17019
170346
23
41
17026
170479
—
101
0
16947
170520
79
5
16778
168789
55
27
14836
151154
46
56
10423
98719
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
-4.5e-02
8.0e-01
3.4e+00
1.0e+50
5.0e+00
1.8e+00
1.1e+00
cases:0.31%
controls:0.32%
cases:0.16%
controls:0.07%
cases:0.16%
controls:0.01%
cases:0.60%
controls:0.00%
cases:0.52%
controls:0.00%
cases:0.31%
controls:0.05%
cases:0.62%
controls:0.21%
52
544
16997
169944
27
122
17022
170398
28
9
17020
170511
103
0
16945
170520
88
6
16769
168788
46
79
14845
151102
65
203
10404
98572
Skin symptom/complaint other
S29 [2002000993]
2.6e-01
5.1e-01
2.4e+00
6.2e+00
1.8e+00
4.1e-01
4.5e-01
cases:4.79%
controls:3.75%
cases:2.24%
controls:1.36%
cases:1.67%
controls:0.15%
cases:2.83%
controls:0.01%
cases:0.98%
controls:0.16%
cases:2.15%
controls:1.43%
cases:7.50%
controls:4.91%
817
6390
16232
164098
382
2318
16667
168202
285
258
16763
170262
482
10
16566
170510
165
273
16692
168521
320
2168
14571
149013
785
4851
9684
93924
encephalitis, tick borne, inactivated, whole virus
J07BA01 [21601331]
1.0e+00
1.1e+00
1.5e+00
2.8e+00
2.0e+00
1.7e+00
1.5e+00
cases:6.91%
controls:2.56%
cases:2.89%
controls:0.95%
cases:0.53%
controls:0.12%
cases:0.18%
controls:0.01%
cases:0.86%
controls:0.11%
cases:4.78%
controls:0.95%
cases:10.95%
controls:2.76%
1178
4368
15871
166120
492
1614
16557
168906
90
205
16958
170315
30
18
17018
170502
145
191
16712
168603
712
1441
14179
149740
1146
2723
9323
96052
Bell palsy
G51.0 [45571815]
1.2e-01
1.3e+00
3.8e+00
—
3.4e+00
2.1e+00
8.4e-01
cases:0.29%
controls:0.25%
cases:0.31%
controls:0.09%
cases:0.82%
controls:0.02%
—
—
cases:0.57%
controls:0.02%
cases:0.62%
controls:0.08%
cases:0.53%
controls:0.23%
49
434
17000
170054
53
147
16996
170373
139
30
16909
170490
—
96
32
16761
168762
93
115
14798
151066
55
224
10414
98551
Appearance of Cerebral spinal fluid
10333-3 [3023410]
6.7e-02
7.1e-01
3.9e+00
1.0e+50
4.4e+00
1.3e+00
7.9e-01
cases:0.33%
controls:0.31%
cases:0.18%
controls:0.09%
cases:0.21%
controls:0.00%
cases:0.31%
controls:0.00%
cases:0.40%
controls:0.00%
cases:0.20%
controls:0.06%
cases:0.49%
controls:0.22%
57
533
16992
169955
30
147
17019
170373
36
7
17012
170513
52
0
16996
170520
68
8
16789
168786
30
84
14861
151097
51
220
10418
98555
Lumbar puncture
TAB00 [2001300538]
1.7e-02
1.0e+00
3.7e+00
—
3.5e+00
1.8e+00
1.0e+00
cases:0.54%
controls:0.53%
cases:0.29%
controls:0.10%
cases:0.44%
controls:0.01%
—
—
cases:0.39%
controls:0.01%
cases:0.54%
controls:0.09%
cases:0.95%
controls:0.35%
92
905
16957
169583
50
177
16999
170343
75
18
16973
170502
—
66
20
16791
168774
81
131
14810
151050
99
343
10370
98432
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 [40759883]
-8.9e-02
8.2e-01
3.2e+00
1.0e+50
4.4e+00
1.6e+00
1.1e+00
cases:0.23%
controls:0.25%
cases:0.12%
controls:0.05%
cases:0.08%
controls:0.00%
cases:0.39%
controls:0.00%
cases:0.24%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.40%
controls:0.14%
39
426
17010
170062
21
93
17028
170427
14
6
17034
170514
67
0
16981
170520
40
5
16817
168789
26
56
14865
151125
42
139
10427
98636
Skin texture symptom/complaint
S21 [2002000986]
1.6e-01
2.7e-01
1.8e+00
5.6e+00
1.3e+00
3.3e-01
3.4e-01
cases:3.27%
controls:2.80%
cases:1.34%
controls:1.03%
cases:0.70%
controls:0.12%
cases:1.07%
controls:0.00%
cases:0.40%
controls:0.11%
cases:1.47%
controls:1.07%
cases:5.11%
controls:3.68%
557
4781
16492
165707
229
1755
16820
168765
120
198
16928
170322
182
7
16866
170513
67
191
16790
168603
219
1611
14672
149570
535
3634
9934
95141
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
7.7e-02
6.2e-01
3.3e+00
1.0e+50
4.4e+00
1.1e+00
8.6e-01
cases:0.36%
controls:0.33%
cases:0.19%
controls:0.10%
cases:0.23%
controls:0.01%
cases:0.57%
controls:0.00%
cases:0.50%
controls:0.01%
cases:0.24%
controls:0.08%
cases:0.68%
controls:0.29%
61
565
16988
169923
32
173
17017
170347
39
14
17009
170506
98
0
16950
170520
84
10
16773
168784
36
126
14855
151055
71
285
10398
98490
Dermatitis, unspecified
L30.9 [45572271]
2.5e-01
6.3e-01
2.4e+00
3.6e+00
1.5e+00
7.0e-01
4.7e-01
cases:4.76%
controls:3.75%
cases:2.70%
controls:1.46%
cases:1.99%
controls:0.18%
cases:0.36%
controls:0.01%
cases:0.80%
controls:0.17%
cases:2.94%
controls:1.49%
cases:7.19%
controls:4.63%
812
6386
16237
164102
461
2482
16588
168038
340
305
16708
170215
61
16
16987
170504
135
295
16722
168499
438
2249
14453
148932
753
4574
9716
94201
Scabies/other acariasis
S72 [2002001036]
3.0e-01
1.1e+00
3.2e+00
1.0e+50
3.6e+00
6.9e-01
1.3e+00
cases:0.14%
controls:0.10%
cases:0.13%
controls:0.04%
cases:0.16%
controls:0.01%
cases:0.74%
controls:0.00%
cases:0.18%
controls:0.00%
cases:0.09%
controls:0.04%
cases:0.52%
controls:0.14%
24
177
17025
170311
22
70
17027
170450
28
11
17020
170509
126
0
16922
170520
30
8
16827
168786
13
66
14878
151115
54
140
10415
98635
Skin Pathology biopsy report
65754-4 [40768443]
1.7e-01
4.0e-01
2.0e+00
3.8e+00
1.5e+00
8.9e-01
6.3e-01
cases:1.63%
controls:1.37%
cases:0.57%
controls:0.38%
cases:0.21%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.87%
controls:0.36%
cases:2.26%
controls:1.22%
278
2344
16771
168144
97
653
16952
169867
35
49
17013
170471
22
5
17026
170515
28
64
16829
168730
129
542
14762
150639
237
1206
10232
97569
Erythematous condition, unspecified
L53.9 [45577042]
4.9e-01
1.0e+00
3.8e+00
1.0e+50
2.7e+00
1.4e+00
5.3e-01
cases:0.18%
controls:0.11%
cases:0.12%
controls:0.04%
cases:0.26%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.05%
controls:0.00%
cases:0.18%
controls:0.04%
cases:0.27%
controls:0.16%
31
190
17018
170298
20
73
17029
170447
45
10
17003
170510
12
0
17036
170520
9
6
16848
168788
27
66
14864
151115
28
156
10441
98619
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
69923-1 [42868414]
5.6e-01
1.5e+00
4.4e+00
1.0e+50
—
1.9e+00
1.2e+00
cases:0.18%
controls:0.10%
cases:0.11%
controls:0.03%
cases:0.23%
controls:0.00%
cases:0.49%
controls:0.00%
—
—
cases:0.21%
controls:0.03%
cases:0.34%
controls:0.11%
30
172
17019
170316
19
44
17030
170476
40
5
17008
170515
84
0
16964
170520
—
32
50
14859
151131
36
104
10433
98671
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
-7.5e-02
5.2e-01
2.9e+00
1.0e+50
3.9e+00
8.6e-01
5.6e-01
cases:0.65%
controls:0.70%
cases:0.30%
controls:0.18%
cases:0.28%
controls:0.02%
cases:0.73%
controls:0.00%
cases:0.72%
controls:0.01%
cases:0.40%
controls:0.17%
cases:1.05%
controls:0.60%
111
1196
16938
169292
51
303
16998
170217
48
26
17000
170494
125
0
16923
170520
122
25
16735
168769
59
255
14832
150926
110
593
10359
98182
Fever, unspecified
R50.9 [45582716]
1.6e-01
2.3e-01
2.0e+00
4.1e+00
1.7e+00
4.5e-01
3.4e-01
cases:2.42%
controls:2.07%
cases:0.90%
controls:0.72%
cases:0.60%
controls:0.08%
cases:0.35%
controls:0.01%
cases:0.43%
controls:0.08%
cases:1.13%
controls:0.72%
cases:2.98%
controls:2.15%
412
3524
16637
166964
154
1229
16895
169291
102
144
16946
170376
60
10
16988
170510
72
134
16785
168660
168
1092
14723
150089
312
2120
10157
96655
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
-1.2e-01
5.0e-01
2.9e+00
1.0e+50
4.1e+00
9.0e-01
5.6e-01
cases:0.59%
controls:0.66%
cases:0.27%
controls:0.16%
cases:0.29%
controls:0.02%
cases:0.73%
controls:0.00%
cases:0.66%
controls:0.01%
cases:0.37%
controls:0.15%
cases:0.96%
controls:0.55%
100
1130
16949
169358
46
280
17003
170240
49
26
16999
170494
124
0
16924
170520
112
18
16745
168776
55
228
14836
150953
101
548
10368
98227
Rash and other nonspecific skin eruption
R21 [45553721]
3.4e-01
1.1e+00
3.4e+00
1.0e+50
2.3e+00
8.0e-01
4.9e-01
cases:0.79%
controls:0.56%
cases:0.49%
controls:0.17%
cases:0.42%
controls:0.01%
cases:0.04%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.42%
controls:0.19%
cases:1.06%
controls:0.65%
134
955
16915
169533
84
291
16965
170229
72
24
16976
170496
7
0
17041
170520
24
23
16833
168771
62
283
14829
150898
111
646
10358
98129
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
-9.2e-02
4.5e-01
2.8e+00
1.0e+50
4.0e+00
9.8e-01
6.3e-01
cases:0.73%
controls:0.80%
cases:0.32%
controls:0.21%
cases:0.32%
controls:0.02%
cases:0.82%
controls:0.00%
cases:0.81%
controls:0.02%
cases:0.49%
controls:0.18%
cases:1.26%
controls:0.67%
124
1359
16925
169129
55
351
16994
170169
55
34
16993
170486
140
0
16908
170520
136
26
16721
168768
73
278
14818
150903
132
666
10337
98109
Observation for other suspected diseases and conditions
Z03.8 [45585798]
1.2e+00
1.4e+00
2.6e+00
—
—
1.7e+00
1.4e+00
cases:0.87%
controls:0.27%
cases:0.20%
controls:0.05%
cases:0.04%
controls:0.00%
—
—
—
—
cases:0.23%
controls:0.04%
cases:0.52%
controls:0.12%
148
466
16901
170022
34
86
17015
170434
7
5
17041
170515
—
—
34
66
14857
151115
54
122
10415
98653
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 [3035999]
-1.5e-01
6.4e-01
2.5e+00
1.0e+50
3.8e+00
9.7e-01
8.0e-01
cases:0.21%
controls:0.24%
cases:0.09%
controls:0.05%
cases:0.08%
controls:0.01%
cases:0.43%
controls:0.00%
cases:0.26%
controls:0.01%
cases:0.15%
controls:0.06%
cases:0.44%
controls:0.20%
35
407
17014
170081
16
84
17033
170436
14
11
17034
170509
74
0
16974
170520
43
10
16814
168784
22
85
14869
151096
46
195
10423
98580
Headache
R51.80 [2000503603]
1.5e-01
3.6e-01
1.7e+00
3.4e+00
1.6e+00
5.3e-01
3.8e-01
cases:2.94%
controls:2.54%
cases:1.09%
controls:0.76%
cases:0.37%
controls:0.07%
cases:0.11%
controls:0.00%
cases:0.42%
controls:0.08%
cases:1.26%
controls:0.75%
cases:3.51%
controls:2.43%
502
4335
16547
166153
185
1300
16864
169220
63
119
16985
170401
18
6
17030
170514
70
140
16787
168654
188
1129
14703
150052
367
2404
10102
96371
Removal of foreign body from under the skin
SPAT1152 [2001700253]
9.5e-01
9.7e-01
3.2e+00
1.0e+50
—
1.4e+00
1.3e+00
cases:0.72%
controls:0.28%
cases:0.15%
controls:0.06%
cases:0.17%
controls:0.01%
cases:0.09%
controls:0.00%
—
—
cases:0.18%
controls:0.04%
cases:0.81%
controls:0.21%
122
475
16927
170013
26
99
17023
170421
29
12
17019
170508
16
0
17032
170520
—
27
67
14864
151114
85
211
10384
98564
Animal/human bite
S13 [2002000978]
4.9e-01
6.9e-01
2.9e+00
—
1.9e+00
8.0e-01
8.3e-01
cases:0.68%
controls:0.42%
cases:0.26%
controls:0.13%
cases:0.24%
controls:0.01%
—
—
cases:0.11%
controls:0.02%
cases:0.29%
controls:0.13%
cases:1.10%
controls:0.48%
116
715
16933
169773
44
222
17005
170298
41
22
17007
170498
—
19
29
16838
168765
43
197
14848
150984
115
477
10354
98298
Encephalitis, myelitis and encephalomyelitis, unspecified
G04.9 [45562073]
6.0e-01
—
3.0e+00
1.0e+50
2.7e+00
1.9e+00
1.3e+00
cases:0.05%
controls:0.03%
—
—
cases:0.06%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.05%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.11%
controls:0.03%
8
44
17041
170444
—
10
5
17038
170515
11
0
17037
170520
9
6
16848
168788
13
20
14878
151161
11
29
10458
98746
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
-1.8e-01
3.1e-01
2.7e+00
1.0e+50
3.9e+00
8.2e-01
3.4e-01
cases:0.60%
controls:0.72%
cases:0.26%
controls:0.19%
cases:0.28%
controls:0.02%
cases:0.49%
controls:0.00%
cases:0.63%
controls:0.01%
cases:0.38%
controls:0.17%
cases:0.85%
controls:0.61%
102
1224
16947
169264
44
322
17005
170198
48
31
17000
170489
83
0
16965
170520
106
22
16751
168772
57
256
14834
150925
89
602
10380
98173
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
-1.9e-01
3.1e-01
2.8e+00
1.0e+50
3.8e+00
8.4e-01
2.9e-01
cases:0.60%
controls:0.72%
cases:0.25%
controls:0.19%
cases:0.28%
controls:0.02%
cases:0.48%
controls:0.00%
cases:0.57%
controls:0.01%
cases:0.38%
controls:0.17%
cases:0.80%
controls:0.60%
102
1226
16947
169262
43
317
17006
170203
47
29
17001
170491
82
0
16966
170520
96
22
16761
168772
57
251
14834
150930
84
593
10385
98182
Other and unspecified skin changes
R23.8 [45573020]
2.9e-01
4.6e-01
1.6e+00
3.2e+00
7.7e-01
4.6e-01
5.0e-01
cases:5.38%
controls:4.09%
cases:2.75%
controls:1.75%
cases:0.93%
controls:0.19%
cases:0.22%
controls:0.01%
cases:0.47%
controls:0.22%
cases:2.81%
controls:1.79%
cases:9.63%
controls:6.09%
917
6970
16132
163518
468
2977
16581
167543
159
327
16889
170193
38
15
17010
170505
79
366
16778
168428
419
2704
14472
148477
1008
6018
9461
92757
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
3.1e-01
4.0e-01
1.1e+00
3.5e+00
8.3e-01
5.0e-01
6.4e-01
cases:4.83%
controls:3.60%
cases:1.72%
controls:1.16%
cases:0.40%
controls:0.13%
cases:0.25%
controls:0.01%
cases:0.28%
controls:0.12%
cases:1.79%
controls:1.09%
cases:6.43%
controls:3.49%
824
6145
16225
164343
293
1973
16756
168547
69
226
16979
170294
43
13
17005
170507
47
206
16810
168588
267
1652
14624
149529
673
3451
9796
95324
Case Management Agency
251B00000X [38004193]
1.1e-01
3.5e-01
3.4e-01
5.4e+00
3.2e-01
4.0e-01
2.7e-01
cases:88.68%
controls:87.51%
cases:87.24%
controls:82.88%
cases:45.84%
controls:37.55%
cases:85.33%
controls:2.51%
cases:45.43%
controls:37.58%
cases:88.30%
controls:83.50%
cases:94.29%
controls:92.64%
15119
149202
1930
21286
14874
141327
2175
29193
7814
64024
9234
106496
14547
4278
2501
166242
7658
63438
9199
105356
13149
126239
1742
24942
9871
91504
598
7271
Observation for suspected nervous system disorder
Z03.3 [45609903]
2.6e-02
6.6e-01
2.4e+00
—
2.4e+00
1.0e+00
6.0e-01
cases:0.68%
controls:0.66%
cases:0.31%
controls:0.16%
cases:0.16%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.46%
controls:0.17%
cases:1.19%
controls:0.66%
116
1130
16933
169358
53
274
16996
170246
28
25
17020
170495
—
18
17
16839
168777
69
258
14822
150923
125
654
10344
98121
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.5e-01
2.6e-01
4.8e-01
4.3e+00
8.7e-01
5.4e-01
4.1e-01
cases:10.04%
controls:8.76%
cases:4.81%
controls:3.74%
cases:1.03%
controls:0.64%
cases:1.93%
controls:0.03%
cases:1.54%
controls:0.65%
cases:6.20%
controls:3.70%
cases:12.23%
controls:8.45%
1712
14933
15337
155555
820
6381
16229
164139
176
1096
16872
169424
329
47
16719
170473
259
1094
16598
167700
923
5592
13968
145589
1280
8345
9189
90430
Emergency Room Visit
ER [9203]
4.2e-02
9.4e-02
7.8e-01
5.0e+00
7.2e-01
1.6e-01
2.4e-01
cases:32.72%
controls:31.80%
cases:9.57%
controls:8.78%
cases:2.35%
controls:1.09%
cases:4.39%
controls:0.03%
cases:2.05%
controls:1.01%
cases:9.70%
controls:8.39%
cases:29.34%
controls:24.64%
5578
54211
11471
116277
1631
14979
15418
155541
401
1860
16647
168660
748
54
16300
170466
346
1710
16511
167084
1445
12681
13446
138500
3072
24334
7397
74441
fusidic acid; ointment
D06AX01 [21602062]
2.4e-01
2.6e-01
8.7e-01
4.2e+00
7.3e-01
3.8e-01
2.9e-01
cases:6.50%
controls:5.18%
cases:1.92%
controls:1.49%
cases:0.37%
controls:0.16%
cases:0.27%
controls:0.00%
cases:0.28%
controls:0.14%
cases:2.18%
controls:1.50%
cases:6.79%
controls:5.19%
1109
8826
15940
161662
327
2535
16722
167985
63
265
16985
170255
46
7
17002
170513
48
232
16809
168562
324
2274
14567
148907
711
5124
9758
93651
fusidic acid
D09AA02 [21602265]
2.4e-01
2.6e-01
8.7e-01
4.2e+00
7.3e-01
3.8e-01
2.9e-01
cases:6.50%
controls:5.18%
cases:1.92%
controls:1.49%
cases:0.37%
controls:0.16%
cases:0.27%
controls:0.00%
cases:0.28%
controls:0.14%
cases:2.18%
controls:1.50%
cases:6.79%
controls:5.19%
1109
8826
15940
161662
327
2535
16722
167985
63
265
16985
170255
46
7
17002
170513
48
232
16809
168562
324
2274
14567
148907
711
5124
9758
93651
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
-1.2e-01
5.2e-02
8.6e-01
4.3e+00
1.2e+00
2.6e-01
2.8e-01
cases:2.39%
controls:2.69%
cases:1.17%
controls:1.11%
cases:0.39%
controls:0.16%
cases:0.43%
controls:0.01%
cases:0.49%
controls:0.15%
cases:1.30%
controls:1.00%
cases:3.22%
controls:2.46%
408
4579
16641
165909
199
1891
16850
168629
66
281
16982
170239
74
10
16974
170510
83
251
16774
168543
193
1516
14698
149665
337
2433
10132
96342
Neurology
13 [38004458]
-1.2e-01
1.1e-01
8.2e-01
4.3e+00
1.0e+00
5.2e-01
3.2e-01
cases:10.51%
controls:11.70%
cases:5.57%
controls:5.02%
cases:2.13%
controls:0.95%
cases:2.34%
controls:0.03%
cases:2.54%
controls:0.95%
cases:7.79%
controls:4.80%
cases:14.78%
controls:11.16%
1791
19952
15258
150536
950
8556
16099
161964
363
1619
16685
168901
399
54
16649
170466
429
1604
16428
167190
1160
7255
13731
143926
1547
11020
8922
87755
Skin colour change
S08 [2002000973]
4.1e-01
5.7e-01
2.9e+00
—
1.8e+00
5.7e-01
6.1e-01
cases:1.09%
controls:0.73%
cases:0.36%
controls:0.20%
cases:0.38%
controls:0.02%
—
—
cases:0.15%
controls:0.02%
cases:0.36%
controls:0.21%
cases:1.46%
controls:0.80%
186
1239
16863
169249
61
347
16988
170173
64
36
16984
170484
—
25
42
16832
168752
54
311
14837
150870
153
786
10316
97989
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 [3010521]
4.3e-01
4.5e-01
2.3e+00
1.0e+50
3.0e+00
6.1e-01
5.1e-01
cases:1.17%
controls:0.76%
cases:0.23%
controls:0.15%
cases:0.11%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.20%
controls:0.01%
cases:0.28%
controls:0.15%
cases:0.88%
controls:0.53%
200
1301
16849
169187
40
256
17009
170264
19
20
17029
170500
18
0
17030
170520
34
17
16823
168777
42
231
14849
150950
92
522
10377
98253
Rash localized
S06 [2002000971]
1.4e-01
4.9e-01
3.4e+00
—
2.4e+00
4.1e-01
5.1e-01
cases:0.86%
controls:0.74%
cases:0.32%
controls:0.20%
cases:0.64%
controls:0.02%
—
—
cases:0.22%
controls:0.02%
cases:0.29%
controls:0.19%
cases:1.27%
controls:0.77%
146
1265
16903
169223
55
336
16994
170184
109
37
16939
170483
—
37
34
16820
168760
43
291
14848
150890
133
757
10336
98018
Pharmacy visit
OMOP4822462 [581458]
4.0e-01
1.8e-01
2.8e-02
4.6e+00
3.0e-01
3.6e-01
8.4e-01
cases:97.97%
controls:97.02%
cases:92.46%
controls:91.09%
cases:56.57%
controls:55.87%
cases:76.19%
controls:3.15%
cases:62.88%
controls:55.60%
cases:93.74%
controls:91.25%
cases:98.81%
controls:97.28%
16703
165400
346
5088
15764
155323
1285
15197
9644
95267
7404
75253
12989
5369
4059
165151
10600
93842
6257
74952
13959
137955
932
13226
10344
96089
125
2686
Fever
A03 [2002000144]
5.2e-02
1.8e-01
1.3e+00
4.4e+00
8.1e-01
1.5e-01
1.8e-01
cases:3.07%
controls:2.92%
cases:0.99%
controls:0.83%
cases:0.26%
controls:0.08%
cases:0.23%
controls:0.00%
cases:0.20%
controls:0.09%
cases:0.90%
controls:0.78%
cases:3.29%
controls:2.75%
523
4971
16526
165517
168
1411
16881
169109
45
128
17003
170392
40
5
17008
170515
33
147
16824
168647
134
1174
14757
150007
344
2716
10125
96059
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
-9.1e-02
8.6e-01
3.1e+00
1.0e+50
—
1.5e+00
9.6e-01
cases:0.25%
controls:0.27%
cases:0.13%
controls:0.06%
cases:0.11%
controls:0.00%
cases:0.39%
controls:0.00%
—
—
cases:0.19%
controls:0.04%
cases:0.42%
controls:0.16%
42
460
17007
170028
23
97
17026
170423
18
8
17030
170512
66
0
16982
170520
—
29
65
14862
151116
44
159
10425
98616
Internal Medicine
11 [38004456]
-1.1e-02
7.2e-02
4.5e-01
4.4e+00
1.1e+00
2.8e-01
2.4e-01
cases:19.87%
controls:20.04%
cases:7.45%
controls:6.97%
cases:1.71%
controls:1.09%
cases:3.50%
controls:0.05%
cases:3.11%
controls:1.05%
cases:8.66%
controls:6.68%
cases:20.71%
controls:17.01%
3387
34168
13662
136320
1271
11892
15778
158628
291
1859
16757
168661
597
79
16451
170441
525
1775
16332
167019
1290
10101
13601
141080
2168
16799
8301
81976
Other dermatitis
L30 [45591633]
3.7e-01
7.1e-01
2.8e+00
1.0e+50
2.3e+00
4.8e-01
6.4e-01
cases:0.43%
controls:0.30%
cases:0.19%
controls:0.09%
cases:0.25%
controls:0.02%
cases:0.04%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.17%
controls:0.11%
cases:0.56%
controls:0.30%
74
510
16975
169978
32
158
17017
170362
42
26
17006
170494
6
0
17042
170520
14
14
16843
168780
26
164
14865
151017
59
295
10410
98480
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
4.2e-02
2.3e-01
1.4e+00
2.9e+00
1.1e+00
4.2e-01
3.1e-01
cases:6.81%
controls:6.55%
cases:2.32%
controls:1.85%
cases:0.68%
controls:0.17%
cases:0.10%
controls:0.01%
cases:0.52%
controls:0.18%
cases:2.58%
controls:1.71%
cases:7.94%
controls:5.93%
1161
11163
15888
159325
396
3151
16653
167369
116
282
16932
170238
17
9
17031
170511
88
298
16769
168496
384
2587
14507
148594
831
5854
9638
92921
Reactive arthropathy, unspecified
M02.9 [45591683]
-2.3e-02
4.1e-01
1.9e+00
—
2.1e+00
1.4e+00
1.0e+00
cases:0.13%
controls:0.13%
cases:0.07%
controls:0.05%
cases:0.04%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.15%
controls:0.04%
cases:0.24%
controls:0.09%
22
225
17027
170263
12
80
17037
170440
7
11
17041
170509
—
9
11
16848
168783
22
55
14869
151126
25
84
10444
98691
Bilateral foot X-ray examination
NH3DA [2001308279]
5.6e-01
1.9e+00
—
—
—
2.2e+00
1.7e+00
cases:0.30%
controls:0.17%
cases:0.12%
controls:0.02%
—
—
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.33%
controls:0.06%
51
292
16998
170196
20
31
17029
170489
—
—
—
22
24
14869
151157
35
59
10434
98716
Nitrate [Presence] in Urine
32030-9 [3006462]
1.1e+00
1.5e+00
—
—
—
1.9e+00
1.8e+00
cases:0.41%
controls:0.13%
cases:0.20%
controls:0.05%
—
—
—
—
—
—
cases:0.23%
controls:0.03%
cases:0.75%
controls:0.12%
70
226
16979
170262
34
78
17015
170442
—
—
—
34
51
14857
151130
79
122
10390
98653
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
69926-4 [42868417]
4.9e-01
1.1e+00
3.8e+00
1.0e+50
—
1.6e+00
9.0e-01
cases:0.08%
controls:0.05%
cases:0.06%
controls:0.02%
cases:0.13%
controls:0.00%
cases:0.29%
controls:0.00%
—
—
cases:0.13%
controls:0.03%
cases:0.18%
controls:0.07%
14
86
17035
170402
11
35
17038
170485
22
5
17026
170515
49
0
16999
170520
—
19
38
14872
151143
19
73
10450
98702
fluconazole; oral, parenteral
J02AC01 [21603080]
1.6e-01
9.4e-02
5.0e-01
3.9e+00
1.5e+00
3.8e-01
3.1e-01
cases:6.66%
controls:5.74%
cases:1.82%
controls:1.66%
cases:0.31%
controls:0.19%
cases:0.42%
controls:0.01%
cases:0.92%
controls:0.20%
cases:2.28%
controls:1.57%
cases:5.83%
controls:4.36%
1136
9791
15913
160697
310
2827
16739
167693
52
317
16996
170203
71
14
16977
170506
155
340
16702
168454
339
2379
14552
148802
610
4306
9859
94469
Paraesthesia of skin
R20.2 [45568120]
2.5e-01
7.7e-01
2.0e+00
—
1.6e+00
9.6e-01
7.3e-01
cases:1.28%
controls:1.00%
cases:0.63%
controls:0.29%
cases:0.29%
controls:0.04%
—
—
cases:0.17%
controls:0.04%
cases:0.78%
controls:0.30%
cases:1.83%
controls:0.90%
219
1709
16830
168779
108
501
16941
170019
50
67
16998
170453
—
29
61
16828
168733
116
453
14775
150728
192
885
10277
97890
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
-9.1e-02
8.7e-01
2.9e+00
1.0e+50
—
1.5e+00
9.9e-01
cases:0.24%
controls:0.26%
cases:0.13%
controls:0.06%
cases:0.08%
controls:0.00%
cases:0.38%
controls:0.00%
—
—
cases:0.19%
controls:0.04%
cases:0.42%
controls:0.16%
41
449
17008
170039
23
96
17026
170424
14
8
17034
170512
64
0
16984
170520
—
29
63
14862
151118
44
155
10425
98620
Pain in joint
M25.5 [45586941]
2.0e-01
3.4e-01
9.1e-01
3.0e+00
7.9e-01
5.4e-01
4.9e-01
cases:9.03%
controls:7.51%
cases:3.82%
controls:2.75%
cases:0.82%
controls:0.33%
cases:0.24%
controls:0.01%
cases:0.75%
controls:0.34%
cases:4.52%
controls:2.68%
cases:12.27%
controls:7.92%
1539
12801
15510
157687
652
4683
16397
165837
140
564
16908
169956
41
21
17007
170499
126
573
16731
168221
673
4050
14218
147131
1285
7826
9184
90949
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
3.1e-02
2.7e-01
1.5e+00
2.6e+00
1.0e+00
4.4e-01
3.6e-01
cases:6.10%
controls:5.92%
cases:2.18%
controls:1.68%
cases:0.66%
controls:0.15%
cases:0.08%
controls:0.01%
cases:0.45%
controls:0.16%
cases:2.46%
controls:1.60%
cases:7.72%
controls:5.52%
1040
10101
16009
160387
372
2860
16677
167660
112
251
16936
170269
14
10
17034
170510
76
277
16781
168517
366
2419
14525
148762
808
5450
9661
93325
Office Visit
OMOP4822458 [581477]
-5.7e-02
2.1e-01
6.7e-01
3.6e+00
8.9e-01
4.1e-01
3.9e-01
cases:7.17%
controls:7.56%
cases:1.91%
controls:1.55%
cases:0.43%
controls:0.22%
cases:0.36%
controls:0.01%
cases:0.48%
controls:0.20%
cases:2.02%
controls:1.35%
cases:6.43%
controls:4.46%
1222
12885
15827
157603
326
2641
16723
167879
74
381
16974
170139
61
16
16987
170504
81
334
16776
168460
301
2035
14590
149146
673
4404
9796
94371
Actinic keratosis
L57.0 [45591640]
4.5e-01
4.8e-01
6.0e-01
3.6e+00
3.4e-01
4.3e-01
5.9e-01
cases:3.06%
controls:1.97%
cases:1.60%
controls:1.00%
cases:0.23%
controls:0.13%
cases:0.13%
controls:0.00%
cases:0.20%
controls:0.14%
cases:1.60%
controls:1.04%
cases:4.81%
controls:2.72%
522
3358
16527
167130
272
1698
16777
168822
40
220
17008
170300
22
6
17026
170514
33
236
16824
168558
238
1573
14653
149608
504
2690
9965
96085
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
-1.6e-01
1.7e-01
2.3e+00
—
3.2e+00
7.4e-01
6.3e-01
cases:0.24%
controls:0.28%
cases:0.09%
controls:0.07%
cases:0.06%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
cases:0.15%
controls:0.07%
cases:0.42%
controls:0.22%
41
482
17008
170006
15
127
17034
170393
10
10
17038
170510
—
20
8
16837
168786
22
107
14869
151074
44
222
10425
98553
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7970-7 [3018387]
4.6e-01
4.1e-01
2.4e+00
1.0e+50
2.7e+00
1.6e-01
5.3e-01
cases:0.72%
controls:0.45%
cases:0.16%
controls:0.11%
cases:0.06%
controls:0.01%
cases:0.05%
controls:0.00%
cases:0.07%
controls:0.00%
cases:0.15%
controls:0.13%
cases:0.64%
controls:0.38%
122
774
16927
169714
28
186
17021
170334
11
10
17037
170510
8
0
17040
170520
12
8
16845
168786
22
191
14869
150990
67
374
10402
98401
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
2.5e-02
-1.7e-01
1.1e+00
3.3e+00
1.1e+00
3.7e-01
2.4e-01
cases:3.17%
controls:3.09%
cases:0.82%
controls:0.97%
cases:0.27%
controls:0.09%
cases:0.09%
controls:0.00%
cases:0.28%
controls:0.10%
cases:1.19%
controls:0.82%
cases:2.89%
controls:2.30%
540
5270
16509
165218
140
1658
16909
168862
46
154
17002
170366
16
6
17032
170514
48
162
16809
168632
177
1242
14714
149939
303
2270
10166
96505
Diplopia
H53.2 [45576792]
2.5e-01
6.8e-01
2.1e+00
—
2.3e+00
9.1e-01
3.5e-01
cases:0.42%
controls:0.33%
cases:0.20%
controls:0.10%
cases:0.11%
controls:0.01%
—
—
cases:0.09%
controls:0.01%
cases:0.20%
controls:0.08%
cases:0.50%
controls:0.35%
72
561
16977
169927
34
173
17015
170347
18
22
17030
170498
—
16
16
16841
168778
30
123
14861
151058
52
347
10417
98428
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
-4.4e-01
-5.7e-02
2.5e+00
1.0e+50
3.5e+00
2.8e-01
1.7e-01
cases:0.18%
controls:0.28%
cases:0.07%
controls:0.07%
cases:0.08%
controls:0.01%
cases:0.28%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.09%
controls:0.07%
cases:0.30%
controls:0.25%
31
482
17018
170006
12
127
17037
170393
14
12
17034
170508
48
0
17000
170520
35
11
16822
168783
14
107
14877
151074
31
248
10438
98527
Other acariasis
B88.0 [45537777]
1.4e+00
1.6e+00
—
1.0e+50
2.3e+00
1.7e+00
1.2e+00
cases:0.12%
controls:0.03%
cases:0.05%
controls:0.01%
—
—
cases:0.04%
controls:0.00%
cases:0.03%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.13%
controls:0.04%
20
48
17029
170440
8
16
17041
170504
—
6
0
17042
170520
5
5
16852
168789
11
21
14880
151160
14
41
10455
98734
Bilateral hand X-ray examination
ND2DA [2001307619]
4.9e-01
1.9e+00
—
—
—
2.2e+00
1.8e+00
cases:0.24%
controls:0.15%
cases:0.11%
controls:0.02%
—
—
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.34%
controls:0.06%
41
251
17008
170237
19
28
17030
170492
—
—
—
23
27
14868
151154
36
56
10433
98719
Pediculosis/skin infestation other
S73 [2002001037]
1.4e+00
—
—
1.0e+50
—
2.1e+00
2.3e+00
cases:0.12%
controls:0.03%
—
—
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.07%
controls:0.01%
cases:0.23%
controls:0.02%
20
47
17029
170441
—
—
69
0
16979
170520
—
10
13
14881
151168
24
22
10445
98753
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
74917-6 [44816808]
3.6e-01
1.4e+00
—
1.0e+50
—
2.6e+00
1.7e+00
cases:0.13%
controls:0.09%
cases:0.11%
controls:0.03%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.32%
controls:0.02%
cases:0.44%
controls:0.08%
22
154
17027
170334
19
47
17030
170473
—
105
0
16943
170520
—
48
35
14843
151146
46
77
10423
98698
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
-1.7e-01
8.0e-02
2.1e+00
—
3.0e+00
7.0e-01
6.7e-01
cases:0.22%
controls:0.26%
cases:0.08%
controls:0.07%
cases:0.05%
controls:0.01%
—
—
cases:0.08%
controls:0.00%
cases:0.14%
controls:0.07%
cases:0.41%
controls:0.21%
37
438
17012
170050
13
120
17036
170400
8
10
17040
170510
—
14
7
16843
168787
21
106
14870
151075
43
207
10426
98568
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
5.5e-01
7.0e-01
1.6e+00
—
1.2e+00
7.8e-01
8.9e-01
cases:2.49%
controls:1.45%
cases:0.77%
controls:0.38%
cases:0.18%
controls:0.04%
—
—
cases:0.10%
controls:0.03%
cases:0.72%
controls:0.33%
cases:2.46%
controls:1.02%
425
2475
16624
168013
131
652
16918
169868
30
61
17018
170459
—
17
50
16840
168744
107
498
14784
150683
258
1012
10211
97763
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.7e-02
-1.3e-01
9.9e-01
3.3e+00
9.2e-01
2.2e-01
3.2e-01
cases:6.41%
controls:6.31%
cases:1.79%
controls:2.03%
cases:0.51%
controls:0.19%
cases:0.11%
controls:0.00%
cases:0.51%
controls:0.20%
cases:2.12%
controls:1.71%
cases:6.46%
controls:4.75%
1093
10755
15956
159733
305
3458
16744
167062
87
326
16961
170194
19
7
17029
170513
86
345
16771
168449
316
2585
14575
148596
676
4696
9793
94079
Inpatient Hospital
21 [8717]
-9.6e-02
-1.1e-01
1.2e-01
4.7e+00
9.9e-01
1.2e-01
1.6e-01
cases:21.95%
controls:23.64%
cases:5.46%
controls:6.03%
cases:0.92%
controls:0.82%
cases:2.76%
controls:0.03%
cases:2.12%
controls:0.80%
cases:6.14%
controls:5.49%
cases:17.83%
controls:15.58%
3742
40295
13307
130193
931
10283
16118
160237
157
1393
16891
169127
471
45
16577
170475
357
1342
16500
167452
914
8304
13977
142877
1867
15387
8602
83388
hydrocortisone
S02BA01 [21605166]
1.8e-02
1.4e-01
1.1e+00
3.8e+00
7.7e-01
2.1e-03
8.1e-02
cases:7.03%
controls:6.91%
cases:2.74%
controls:2.40%
cases:0.82%
controls:0.26%
cases:0.53%
controls:0.01%
cases:0.57%
controls:0.26%
cases:2.40%
controls:2.39%
cases:7.57%
controls:7.03%
1199
11786
15850
158702
467
4086
16582
166434
139
448
16909
170072
91
20
16957
170500
96
446
16761
168348
357
3617
14534
147564
793
6942
9676
91833
Urine protein measurement
57378007 [4211845]
1.0e+00
1.4e+00
—
—
—
1.6e+00
1.6e+00
cases:0.42%
controls:0.15%
cases:0.21%
controls:0.05%
—
—
—
—
—
—
cases:0.23%
controls:0.04%
cases:0.76%
controls:0.15%
71
257
16978
170231
35
86
17014
170434
—
—
—
34
67
14857
151114
80
148
10389
98627
combinations of corticosteroids
D07XB30 [21602188]
1.8e-01
2.2e-01
9.5e-01
3.3e+00
5.0e-01
2.2e-01
2.9e-01
cases:14.86%
controls:12.74%
cases:5.76%
controls:4.68%
cases:1.47%
controls:0.57%
cases:0.79%
controls:0.03%
cases:0.90%
controls:0.55%
cases:5.63%
controls:4.59%
cases:16.34%
controls:12.79%
2534
21716
14515
148772
982
7981
16067
162539
250
972
16798
169548
134
48
16914
170472
152
929
16705
167865
839
6937
14052
144244
1711
12637
8758
86138
combinations of corticosteroids
D07AB30 [21602118]
1.8e-01
2.2e-01
9.5e-01
3.3e+00
5.0e-01
2.2e-01
2.9e-01
cases:14.86%
controls:12.74%
cases:5.76%
controls:4.68%
cases:1.47%
controls:0.57%
cases:0.79%
controls:0.03%
cases:0.90%
controls:0.55%
cases:5.63%
controls:4.59%
cases:16.34%
controls:12.79%
2534
21716
14515
148772
982
7981
16067
162539
250
972
16798
169548
134
48
16914
170472
152
929
16705
167865
839
6937
14052
144244
1711
12637
8758
86138
hydrocortisone buteprate
D07AB11 [21602115]
2.2e-02
1.4e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.4e-02
cases:8.22%
controls:8.06%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.67%
controls:8.03%
1402
13745
15647
156743
537
4709
16512
165811
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4193
14471
146988
908
7930
9561
90845
hydrocortisone
A07EA02 [21600654]
2.1e-02
1.3e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.5e-02
cases:8.24%
controls:8.08%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.69%
controls:8.04%
1404
13770
15645
156718
537
4714
16512
165806
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4195
14471
146986
910
7940
9559
90835
hydrocortisone
D07AA02 [21602102]
2.2e-02
1.4e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.4e-02
cases:8.22%
controls:8.06%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.67%
controls:8.03%
1402
13745
15647
156743
537
4709
16512
165811
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4193
14471
146988
908
7930
9561
90845
hydrocortisone butyrate
D07AB02 [21602106]
2.2e-02
1.4e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.4e-02
cases:8.22%
controls:8.06%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.67%
controls:8.03%
1402
13745
15647
156743
537
4709
16512
165811
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4193
14471
146988
908
7930
9561
90845
hydrocortisone
C05AA01 [21601608]
2.1e-02
1.3e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.5e-02
cases:8.24%
controls:8.08%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.69%
controls:8.04%
1404
13770
15645
156718
537
4714
16512
165806
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4195
14471
146986
910
7940
9559
90835
hydrocortisone aceponate
D07AC16 [21602135]
2.2e-02
1.4e-01
1.0e+00
3.9e+00
7.3e-01
1.7e-02
8.4e-02
cases:8.22%
controls:8.06%
cases:3.15%
controls:2.76%
cases:0.87%
controls:0.31%
cases:0.57%
controls:0.01%
cases:0.64%
controls:0.31%
cases:2.82%
controls:2.77%
cases:8.67%
controls:8.03%
1402
13745
15647
156743
537
4709
16512
165811
148
521
16900
169999
97
20
16951
170500
108
523
16749
168271
420
4193
14471
146988
908
7930
9561
90845
Disorder of skin and subcutaneous tissue, unspecified
L98.9 [45562566]
-1.2e-05
1.1e+00
2.4e+00
—
2.0e+00
1.3e+00
8.8e-01
cases:0.11%
controls:0.11%
cases:0.09%
controls:0.03%
cases:0.06%
controls:0.01%
—
—
cases:0.03%
controls:0.00%
cases:0.13%
controls:0.04%
cases:0.25%
controls:0.10%
19
190
17030
170298
15
50
17034
170470
10
9
17038
170511
—
5
7
16852
168787
19
54
14872
151127
26
102
10443
98673
Outpatient Hospital
22 [8756]
-5.0e-02
-1.1e-01
2.7e-01
4.2e+00
8.2e-01
2.6e-01
3.0e-01
cases:19.00%
controls:19.78%
cases:3.85%
controls:4.30%
cases:0.70%
controls:0.54%
cases:1.18%
controls:0.02%
cases:1.12%
controls:0.49%
cases:4.69%
controls:3.68%
cases:14.97%
controls:11.51%
3239
33724
13810
136764
657
7328
16392
163192
120
919
16928
169601
202
32
16846
170488
188
833
16669
167961
699
5557
14192
145624
1567
11371
8902
87404
Supplier / Service Provider
OMOP5117446 [33004]
-1.8e-01
-3.2e-01
-2.6e-01
9.4e-01
1.7e+00
1.8e+00
2.4e+00
cases:26.91%
controls:30.69%
cases:5.44%
controls:7.36%
cases:0.52%
controls:0.68%
cases:0.06%
controls:0.02%
cases:0.52%
controls:0.09%
cases:5.18%
controls:0.85%
cases:18.81%
controls:2.00%
4588
52330
12461
118158
928
12547
16121
157973
89
1152
16959
169368
10
39
17038
170481
87
153
16770
168641
772
1291
14119
149890
1969
1978
8500
96797
Local infection of skin and subcutaneous tissue, unspecified
L08.9 [45577027]
1.9e-01
5.0e-01
2.5e+00
—
1.6e+00
6.4e-01
7.5e-01
cases:0.50%
controls:0.42%
cases:0.25%
controls:0.15%
cases:0.19%
controls:0.02%
—
—
cases:0.05%
controls:0.01%
cases:0.23%
controls:0.12%
cases:0.96%
controls:0.46%
86
709
16963
169779
42
255
17007
170265
32
26
17016
170494
—
9
18
16848
168776
34
183
14857
150998
101
453
10368
98322
Outpatient Visit
OP [9202]
2.1e-01
3.1e-01
1.2e-01
2.9e+00
5.8e-01
6.3e-01
6.3e-01
cases:88.39%
controls:86.00%
cases:68.98%
controls:61.99%
cases:12.25%
controls:10.98%
cases:7.99%
controls:0.48%
cases:17.99%
controls:10.94%
cases:73.35%
controls:59.49%
cases:90.96%
controls:84.27%
15069
146617
1980
23871
11760
105697
5289
64823
2089
18720
14959
151800
1362
813
15686
169707
3033
18459
13824
150335
10922
89932
3969
61249
9523
83241
946
15534
Scheduled procedure
ZXD10 [2001311387]
2.9e-01
1.7e-01
7.4e-03
2.6e+00
8.4e-01
7.7e-01
8.4e-01
cases:7.04%
controls:5.35%
cases:1.17%
controls:0.98%
cases:0.08%
controls:0.08%
cases:0.05%
controls:0.00%
cases:0.18%
controls:0.08%
cases:1.54%
controls:0.72%
cases:5.08%
controls:2.25%
1200
9117
15849
161371
199
1679
16850
168841
14
139
17034
170381
8
6
17040
170514
31
134
16826
168660
229
1089
14662
150092
532
2227
9937
96548
Allergic urticaria
L50.0 [45581945]
2.3e-01
5.9e-01
2.1e+00
—
3.3e+00
2.2e-01
3.4e-01
cases:0.30%
controls:0.24%
cases:0.12%
controls:0.07%
cases:0.05%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.08%
controls:0.06%
cases:0.31%
controls:0.22%
51
404
16998
170084
21
117
17028
170403
8
10
17040
170510
—
36
14
16821
168780
12
98
14879
151083
32
216
10437
98559
Person consulting for explanation of investigation findings
Z71.2 [45552100]
3.0e-01
3.9e-01
6.1e-01
2.4e+00
8.2e-01
4.1e-01
3.9e-01
cases:8.85%
controls:6.71%
cases:4.35%
controls:3.00%
cases:0.70%
controls:0.39%
cases:0.12%
controls:0.01%
cases:0.84%
controls:0.37%
cases:4.48%
controls:3.02%
cases:12.65%
controls:8.94%
1509
11442
15540
159046
742
5108
16307
165412
120
657
16928
169863
20
18
17028
170502
142
628
16715
168166
667
4560
14224
146621
1324
8831
9145
89944
Hantavirus puumala IgG Ab [Titer] in Serum
22308-1 [3012447]
3.5e-01
6.3e-01
2.5e+00
—
2.8e+00
4.9e-01
5.0e-01
cases:0.46%
controls:0.33%
cases:0.13%
controls:0.07%
cases:0.09%
controls:0.01%
—
—
cases:0.08%
controls:0.00%
cases:0.11%
controls:0.07%
cases:0.39%
controls:0.24%
79
555
16970
169933
23
123
17026
170397
15
12
17033
170508
—
13
8
16844
168786
17
106
14874
151075
41
235
10428
98540
desonide
D07AB08 [21602112]
1.2e-01
6.0e-02
9.3e-01
3.1e+00
1.0e+00
2.5e-01
2.7e-01
cases:2.35%
controls:2.10%
cases:0.72%
controls:0.67%
cases:0.18%
controls:0.07%
cases:0.10%
controls:0.00%
cases:0.19%
controls:0.07%
cases:0.84%
controls:0.65%
cases:2.50%
controls:1.93%
401
3579
16648
166909
122
1150
16927
169370
31
123
17017
170397
17
8
17031
170512
32
118
16825
168676
125
988
14766
150193
262
1904
10207
96871
General health counselling
SPAT1312 [2001700413]
-1.1e-01
-3.5e-03
4.2e-01
4.9e+00
3.0e-01
9.2e-02
7.4e-02
cases:8.48%
controls:9.35%
cases:2.43%
controls:2.44%
cases:0.43%
controls:0.29%
cases:0.89%
controls:0.01%
cases:0.35%
controls:0.26%
cases:2.60%
controls:2.38%
cases:7.87%
controls:7.35%
1446
15945
15603
154543
415
4165
16634
166355
74
486
16974
170034
151
11
16897
170509
59
436
16798
168358
387
3591
14504
147590
824
7258
9645
91517
Rheumatology
66 [38004491]
1.2e-01
2.5e-01
3.9e-01
2.9e+00
5.4e-01
5.2e-01
5.2e-01
cases:5.75%
controls:5.15%
cases:3.75%
controls:2.94%
cases:0.85%
controls:0.58%
cases:0.43%
controls:0.02%
cases:0.98%
controls:0.57%
cases:4.57%
controls:2.77%
cases:7.17%
controls:4.41%
981
8772
16068
161716
639
5008
16410
165512
145
989
16903
169531
74
41
16974
170479
165
967
16692
167827
681
4194
14210
146987
751
4355
9718
94420
Urticaria
L50 [45543371]
2.4e-01
5.6e-01
1.6e+00
—
2.9e+00
5.2e-01
6.6e-01
cases:0.25%
controls:0.20%
cases:0.13%
controls:0.07%
cases:0.05%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.13%
controls:0.08%
cases:0.40%
controls:0.21%
43
339
17006
170149
22
126
17027
170394
8
16
17040
170504
—
20
11
16837
168783
20
121
14871
151060
42
205
10427
98570
General Practice
1 [38004446]
-1.1e-01
-2.3e-01
1.6e-01
4.6e+00
9.3e-01
-7.1e-02
2.4e-03
cases:13.27%
controls:14.54%
cases:4.20%
controls:5.25%
cases:0.85%
controls:0.72%
cases:2.52%
controls:0.03%
cases:1.82%
controls:0.73%
cases:5.14%
controls:5.49%
cases:16.15%
controls:16.12%
2262
24790
14787
145698
716
8955
16333
161565
145
1232
16903
169288
429
45
16619
170475
306
1228
16551
167566
765
8304
14126
142877
1691
15923
8778
82852
Seborrhoeic keratosis
L82 [45548208]
4.1e-01
5.1e-01
5.0e-01
3.1e+00
4.0e-01
5.5e-01
4.8e-01
cases:5.75%
controls:3.89%
cases:2.40%
controls:1.46%
cases:0.23%
controls:0.14%
cases:0.13%
controls:0.01%
cases:0.23%
controls:0.15%
cases:2.52%
controls:1.46%
cases:8.02%
controls:5.12%
980
6628
16069
163860
409
2490
16640
168030
40
242
17008
170278
23
10
17025
170510
38
256
16819
168538
375
2213
14516
148968
840
5062
9629
93713
Sixth [abducent] nerve palsy
H49.2 [45557451]
-1.2e-05
9.8e-01
2.8e+00
—
2.3e+00
8.1e-01
—
cases:0.07%
controls:0.07%
cases:0.08%
controls:0.03%
cases:0.05%
controls:0.00%
—
—
cases:0.04%
controls:0.00%
cases:0.05%
controls:0.02%
—
—
12
120
17037
170368
13
49
17036
170471
8
5
17040
170515
—
6
6
16851
168788
8
36
14883
151145
—
pH of Specimen
17433-4 [3019225]
2.5e-01
3.7e-01
6.4e-01
2.4e+00
4.3e-01
5.8e-01
8.1e-01
cases:4.54%
controls:3.57%
cases:2.07%
controls:1.44%
cases:0.40%
controls:0.21%
cases:0.06%
controls:0.01%
cases:0.31%
controls:0.20%
cases:2.41%
controls:1.36%
cases:7.23%
controls:3.36%
774
6082
16275
164406
353
2449
16696
168071
68
359
16980
170161
11
10
17037
170510
53
344
16804
168450
359
2061
14532
149120
757
3316
9712
95459
Intravenous
ZX120 [2001311495]
-1.9e-01
4.0e-02
1.4e-01
3.7e+00
1.3e+00
1.5e-01
1.7e-01
cases:1.16%
controls:1.40%
cases:0.46%
controls:0.44%
cases:0.13%
controls:0.11%
cases:0.15%
controls:0.00%
cases:0.40%
controls:0.11%
cases:0.51%
controls:0.44%
cases:1.22%
controls:1.03%
198
2382
16851
168106
78
750
16971
169770
22
191
17026
170329
25
6
17023
170514
68
183
16789
168611
76
666
14815
150515
128
1017
10341
97758
Emergency Medicine
93 [38004510]
-3.7e-02
-5.5e-02
3.5e-01
4.2e+00
3.7e-01
5.1e-04
1.4e-01
cases:25.36%
controls:26.06%
cases:11.56%
controls:12.14%
cases:2.29%
controls:1.63%
cases:4.19%
controls:0.07%
cases:2.30%
controls:1.60%
cases:12.12%
controls:12.12%
cases:33.80%
controls:30.77%
4324
44431
12725
126057
1971
20695
15078
149825
391
2772
16657
167748
714
114
16334
170406
388
2702
16469
166092
1805
18317
13086
132864
3539
30389
6930
68386
Varicella zoster virus IgG Ab [Units/volume] in Serum
8047-3 [3022575]
-5.8e-01
4.4e-01
2.3e+00
1.0e+50
2.7e+00
8.8e-01
5.8e-01
cases:0.08%
controls:0.15%
cases:0.08%
controls:0.05%
cases:0.04%
controls:0.00%
cases:0.06%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.09%
controls:0.04%
cases:0.24%
controls:0.13%
14
249
17035
170239
13
84
17036
170436
6
6
17042
170514
10
0
17038
170520
13
9
16844
168785
14
59
14877
151122
25
132
10444
98643
Dizziness and giddiness
R42 [45568132]
2.4e-02
2.6e-01
6.7e-01
2.5e+00
9.2e-01
3.2e-01
2.6e-01
cases:4.23%
controls:4.13%
cases:1.78%
controls:1.38%
cases:0.34%
controls:0.17%
cases:0.12%
controls:0.01%
cases:0.37%
controls:0.15%
cases:1.91%
controls:1.40%
cases:6.00%
controls:4.71%
721
7044
16328
163444
303
2357
16746
168163
58
296
16990
170224
20
16
17028
170504
62
247
16795
168547
285
2114
14606
149067
628
4651
9841
94124
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5253-0 [3027545]
4.0e-01
3.1e-01
1.9e+00
1.0e+50
2.2e+00
5.1e-01
4.4e-01
cases:1.24%
controls:0.83%
cases:0.28%
controls:0.21%
cases:0.11%
controls:0.02%
cases:0.07%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.32%
controls:0.19%
cases:1.08%
controls:0.70%
212
1422
16837
169066
48
351
17001
170169
18
26
17030
170494
12
0
17036
170520
21
24
16836
168770
47
286
14844
150895
113
687
10356
98088
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70058-3 [42868544]
1.4e-01
2.9e-01
2.6e+00
—
2.3e+00
3.5e-01
2.4e-01
cases:0.57%
controls:0.49%
cases:0.15%
controls:0.11%
cases:0.14%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.16%
controls:0.11%
cases:0.51%
controls:0.40%
97
842
16952
169646
25
187
17024
170333
24
17
17024
170503
—
17
17
16840
168777
24
171
14867
151010
53
393
10416
98382
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 [3012220]
-1.5e-01
-1.7e-01
2.4e+00
1.0e+50
2.5e+00
6.3e-01
3.5e-01
cases:0.36%
controls:0.42%
cases:0.09%
controls:0.11%
cases:0.07%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.17%
controls:0.09%
cases:0.43%
controls:0.30%
61
711
16988
169777
16
189
17033
170331
12
11
17036
170509
16
0
17032
170520
28
22
16829
168772
26
140
14865
151041
45
301
10424
98474
Myalgia
M79.1 [45587062]
2.2e-01
4.0e-01
9.1e-01
1.9e+00
7.5e-01
3.6e-01
3.9e-01
cases:3.45%
controls:2.78%
cases:1.39%
controls:0.93%
cases:0.33%
controls:0.13%
cases:0.06%
controls:0.01%
cases:0.26%
controls:0.12%
cases:1.35%
controls:0.95%
cases:4.16%
controls:2.86%
589
4737
16460
165751
237
1593
16812
168927
56
225
16992
170295
10
15
17038
170505
44
209
16813
168585
201
1431
14690
149750
435
2821
10034
95954
azithromycin; oral, parenteral
J01FA10 [21602978]
2.6e-01
2.0e-01
-2.6e-01
3.7e+00
5.8e-01
1.9e-01
3.1e-01
cases:7.76%
controls:6.09%
cases:1.84%
controls:1.52%
cases:0.13%
controls:0.17%
cases:0.29%
controls:0.01%
cases:0.30%
controls:0.17%
cases:1.65%
controls:1.37%
cases:5.89%
controls:4.40%
1323
10383
15726
160105
314
2584
16735
167936
22
285
17026
170235
50
12
16998
170508
50
281
16807
168513
245
2064
14646
149117
617
4349
9852
94426
Headache
R51 [45558474]
4.2e-01
5.9e-01
1.5e+00
—
1.2e+00
7.5e-01
4.1e-01
cases:1.10%
controls:0.72%
cases:0.40%
controls:0.22%
cases:0.12%
controls:0.03%
—
—
cases:0.12%
controls:0.04%
cases:0.44%
controls:0.21%
cases:1.03%
controls:0.69%
187
1232
16862
169256
68
377
16981
170143
20
44
17028
170476
—
20
61
16837
168733
66
318
14825
150863
108
680
10361
98095
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-1.9e-01
-3.2e-01
7.0e-01
3.9e+00
7.6e-01
4.6e-02
7.2e-02
cases:3.82%
controls:4.59%
cases:1.09%
controls:1.50%
cases:0.30%
controls:0.15%
cases:0.18%
controls:0.00%
cases:0.30%
controls:0.14%
cases:1.34%
controls:1.28%
cases:4.77%
controls:4.45%
651
7820
16398
162668
186
2553
16863
167967
51
253
16997
170267
30
6
17018
170514
50
235
16807
168559
199
1931
14692
149250
499
4394
9970
94381
Medical doctor
Z2221 [2001311556]
4.3e-01
7.2e-01
1.1e+00
—
9.5e-01
8.4e-01
8.4e-01
cases:5.81%
controls:3.84%
cases:1.71%
controls:0.84%
cases:0.34%
controls:0.12%
—
—
cases:0.30%
controls:0.12%
cases:1.75%
controls:0.76%
cases:3.95%
controls:1.74%
990
6550
16059
163938
291
1436
16758
169084
58
199
16990
170321
—
51
197
16806
168597
261
1155
14630
150026
414
1723
10055
97052
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
1.5e-01
2.6e-01
7.5e-01
3.5e+00
3.0e-01
1.3e-01
2.1e-01
cases:5.41%
controls:4.71%
cases:2.20%
controls:1.70%
cases:0.43%
controls:0.20%
cases:0.25%
controls:0.01%
cases:0.26%
controls:0.19%
cases:1.88%
controls:1.66%
cases:5.72%
controls:4.67%
923
8033
16126
162455
375
2901
16674
167619
73
347
16975
170173
42
13
17006
170507
44
327
16813
168467
280
2504
14611
148677
599
4613
9870
94162
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-9.6e-03
1.2e-01
7.4e-01
2.8e+00
6.2e-01
2.2e-01
2.9e-01
cases:33.01%
controls:33.22%
cases:16.56%
controls:14.97%
cases:4.12%
controls:2.01%
cases:1.15%
controls:0.07%
cases:3.49%
controls:1.90%
cases:17.47%
controls:14.49%
cases:41.92%
controls:35.12%
5628
56640
11421
113848
2823
25522
14226
144998
702
3427
16346
167093
196
116
16852
170404
589
3211
16268
165583
2601
21910
12290
129271
4389
34694
6080
64081
Otolaryngology
4 [38004449]
1.1e-01
1.4e-01
4.9e-01
2.9e+00
5.4e-01
3.0e-01
3.2e-01
cases:14.44%
controls:13.09%
cases:5.41%
controls:4.76%
cases:1.21%
controls:0.74%
cases:0.54%
controls:0.03%
cases:1.26%
controls:0.74%
cases:6.08%
controls:4.57%
cases:16.22%
controls:12.32%
2462
22319
14587
148169
923
8109
16126
162411
207
1270
16841
169250
92
50
16956
170470
212
1244
16645
167550
906
6912
13985
144269
1698
12174
8771
86601
Telehealth
OMOP5556618 [722455]
1.0e-01
2.1e-01
4.2e-01
3.0e+00
5.9e-01
2.8e-01
2.6e-01
cases:34.73%
controls:32.40%
cases:11.85%
controls:9.83%
cases:2.54%
controls:1.68%
cases:1.49%
controls:0.08%
cases:2.90%
controls:1.63%
cases:11.89%
controls:9.26%
cases:26.51%
controls:21.82%
5921
55236
11128
115252
2020
16766
15029
153754
433
2863
16615
167657
254
134
16794
170386
489
2748
16368
166046
1771
13997
13120
137184
2775
21553
7694
77222
hydrocortisone and antiseptics
D07BA04 [21602146]
6.2e-02
1.1e-01
1.0e+00
3.8e+00
5.3e-01
9.6e-02
5.5e-02
cases:2.42%
controls:2.28%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.23%
412
3879
16637
166609
135
1205
16914
169315
37
134
17011
170386
26
6
17022
170514
22
130
16835
168664
113
1043
14778
150138
246
2199
10223
96576
hydrocortisone
D07XA01 [21602180]
6.2e-02
1.1e-01
1.0e+00
3.8e+00
5.3e-01
9.6e-02
5.5e-02
cases:2.42%
controls:2.28%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.23%
412
3879
16637
166609
135
1205
16914
169315
37
134
17011
170386
26
6
17022
170514
22
130
16835
168664
113
1043
14778
150138
246
2199
10223
96576
chlorhexidine
S02AA09 [21605155]
6.5e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.8e-02
5.9e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.22%
412
3866
16637
166622
134
1203
16915
169317
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1041
14778
150140
246
2190
10223
96585
chlorhexidine
D09AA12 [21602275]
6.5e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.8e-02
5.9e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.22%
412
3866
16637
166622
134
1203
16915
169317
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1041
14778
150140
246
2190
10223
96585
triamcinolone and antiseptics
D07BB03 [21602150]
6.2e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.3e-02
7.4e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.39%
controls:2.22%
412
3877
16637
166611
134
1205
16915
169315
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1046
14778
150135
250
2195
10219
96580
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
6.5e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.8e-02
5.9e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.22%
412
3866
16637
166622
134
1203
16915
169317
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1041
14778
150140
246
2190
10223
96585
chlorhexidine, combinations
D08AC52 [21602208]
6.5e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.8e-02
5.9e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.22%
412
3866
16637
166622
134
1203
16915
169317
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1041
14778
150140
246
2190
10223
96585
chlorhexidine
S03AA04 [21605193]
6.5e-02
1.1e-01
1.0e+00
3.7e+00
5.3e-01
9.8e-02
5.9e-02
cases:2.42%
controls:2.27%
cases:0.79%
controls:0.71%
cases:0.22%
controls:0.08%
cases:0.15%
controls:0.00%
cases:0.13%
controls:0.08%
cases:0.76%
controls:0.69%
cases:2.35%
controls:2.22%
412
3866
16637
166622
134
1203
16915
169317
37
132
17011
170388
25
6
17023
170514
22
130
16835
168664
113
1041
14778
150140
246
2190
10223
96585
Cutaneous abscess, furuncle and carbuncle
L02 [45538561]
4.4e-01
6.4e-01
1.6e+00
—
1.6e+00
5.4e-01
5.4e-01
cases:0.86%
controls:0.56%
cases:0.29%
controls:0.16%
cases:0.08%
controls:0.02%
—
—
cases:0.06%
controls:0.01%
cases:0.26%
controls:0.15%
cases:0.87%
controls:0.51%
147
952
16902
169536
50
265
16999
170255
13
27
17035
170493
—
10
21
16847
168773
39
231
14852
150950
91
502
10378
98273
Contact with and exposure to pediculosis, acariasis and other infestations
Z20.7 [45609915]
8.4e-01
2.6e+00
1.0e+50
—
—
2.2e+00
1.3e+00
cases:0.04%
controls:0.02%
cases:0.05%
controls:0.00%
cases:0.07%
controls:0.00%
—
—
—
—
cases:0.05%
controls:0.01%
cases:0.08%
controls:0.02%
6
26
17043
170462
9
7
17040
170513
12
0
17036
170520
—
—
7
8
14884
151173
8
20
10461
98755
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
1.7e-01
5.6e-01
1.4e+00
—
1.4e+00
7.0e-01
6.5e-01
cases:0.99%
controls:0.84%
cases:0.36%
controls:0.21%
cases:0.08%
controls:0.02%
—
—
cases:0.07%
controls:0.02%
cases:0.38%
controls:0.19%
cases:1.35%
controls:0.71%
169
1428
16880
169060
62
353
16987
170167
13
31
17035
170489
—
12
30
16845
168764
57
288
14834
150893
141
702
10328
98073
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
4.3e-01
6.0e-01
1.2e+00
1.8e+00
1.1e+00
7.7e-01
6.2e-01
cases:3.68%
controls:2.41%
cases:1.36%
controls:0.75%
cases:0.26%
controls:0.08%
cases:0.03%
controls:0.00%
cases:0.24%
controls:0.08%
cases:1.55%
controls:0.72%
cases:4.52%
controls:2.47%
627
4113
16422
166375
232
1277
16817
169243
44
134
17004
170386
5
8
17043
170512
40
135
16817
168659
231
1093
14660
150088
473
2443
9996
96332
valaciclovir; oral
J05AB11 [21603137]
2.5e-01
3.6e-01
6.7e-01
2.0e+00
5.7e-01
4.5e-01
3.3e-01
cases:3.41%
controls:2.68%
cases:1.59%
controls:1.11%
cases:0.40%
controls:0.21%
cases:0.06%
controls:0.01%
cases:0.33%
controls:0.19%
cases:1.75%
controls:1.13%
cases:3.74%
controls:2.71%
582
4566
16467
165922
271
1900
16778
168620
69
355
16979
170165
10
13
17038
170507
56
316
16801
168478
261
1708
14630
149473
392
2681
10077
96094
Tissue Pathology biopsy report
66121-5 [40768804]
2.0e-01
3.0e-01
2.0e-01
2.6e+00
5.0e-01
4.8e-01
5.4e-01
cases:18.26%
controls:15.42%
cases:5.90%
controls:4.45%
cases:0.57%
controls:0.47%
cases:0.15%
controls:0.01%
cases:0.66%
controls:0.40%
cases:6.09%
controls:3.85%
cases:19.42%
controls:12.32%
3113
26291
13936
144197
1006
7596
16043
162924
97
794
16951
169726
25
18
17023
170502
111
679
16746
168115
907
5820
13984
145361
2033
12174
8436
86601
Malaise and fatigue
R53 [45553741]
6.9e-02
1.1e-01
5.9e-01
2.9e+00
6.4e-01
3.0e-01
1.8e-01
cases:5.06%
controls:4.73%
cases:2.15%
controls:1.93%
cases:0.39%
controls:0.21%
cases:0.16%
controls:0.01%
cases:0.42%
controls:0.22%
cases:2.67%
controls:2.00%
cases:7.52%
controls:6.35%
862
8070
16187
162418
366
3291
16683
167229
66
365
16982
170155
28
15
17020
170505
70
369
16787
168425
398
3022
14493
148159
787
6271
9682
92504
Zoster [herpes zoster]
B02 [45552205]
3.1e-01
5.8e-01
1.6e+00
—
1.2e+00
5.4e-01
4.4e-01
cases:0.84%
controls:0.62%
cases:0.35%
controls:0.20%
cases:0.07%
controls:0.01%
—
—
cases:0.08%
controls:0.02%
cases:0.38%
controls:0.22%
cases:1.17%
controls:0.76%
144
1060
16905
169428
60
337
16989
170183
12
25
17036
170495
—
13
39
16844
168755
57
337
14834
150844
123
751
10346
98024
Examination and observation for other specified reasons
Z04.8 [45552063]
2.8e-01
2.9e-01
8.3e-01
2.1e+00
5.9e-01
5.7e-01
5.0e-01
cases:2.89%
controls:2.21%
cases:0.87%
controls:0.65%
cases:0.15%
controls:0.07%
cases:0.04%
controls:0.00%
cases:0.12%
controls:0.07%
cases:1.11%
controls:0.64%
cases:3.52%
controls:2.16%
493
3760
16556
166728
148
1105
16901
169415
26
113
17022
170407
6
7
17042
170513
21
117
16836
168677
166
960
14725
150221
368
2137
10101
96638
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
8.7e-02
4.1e-01
1.8e+00
—
1.5e+00
6.8e-01
6.2e-01
cases:0.94%
controls:0.86%
cases:0.36%
controls:0.24%
cases:0.16%
controls:0.03%
—
—
cases:0.14%
controls:0.03%
cases:0.46%
controls:0.23%
cases:1.36%
controls:0.74%
160
1468
16889
169020
62
414
16987
170106
28
47
17020
170473
—
23
50
16834
168744
69
355
14822
150826
142
726
10327
98049
Counselling related to known health issue
SPAT1310 [2001700411]
-1.0e-01
-8.8e-02
6.1e-01
4.1e+00
1.3e-01
9.1e-02
8.6e-02
cases:8.16%
controls:8.94%
cases:2.22%
controls:2.42%
cases:0.51%
controls:0.28%
cases:0.73%
controls:0.01%
cases:0.30%
controls:0.26%
cases:2.54%
controls:2.32%
cases:7.64%
controls:7.06%
1391
15244
15658
155244
378
4119
16671
166401
87
475
16961
170045
124
21
16924
170499
50
439
16807
168355
378
3513
14513
147668
800
6970
9669
91805
Consultation of another employee
SPAT1260 [2001700361]
-2.0e-01
-2.6e-01
5.2e-01
4.8e+00
1.0e-01
-1.3e-01
-5.0e-02
cases:3.51%
controls:4.28%
cases:0.88%
controls:1.14%
cases:0.19%
controls:0.12%
cases:0.63%
controls:0.01%
cases:0.14%
controls:0.12%
cases:0.95%
controls:1.08%
cases:3.40%
controls:3.57%
599
7289
16450
163199
150
1937
16899
168583
33
197
17015
170323
108
9
16940
170511
23
208
16834
168586
142
1632
14749
149549
356
3524
10113
95251
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
-9.4e-02
-1.6e-02
8.3e-01
3.1e+00
5.6e-01
5.1e-02
1.5e-01
cases:9.20%
controls:10.01%
cases:3.41%
controls:3.46%
cases:0.87%
controls:0.38%
cases:0.27%
controls:0.01%
cases:0.72%
controls:0.41%
cases:3.58%
controls:3.41%
cases:12.54%
controls:10.99%
1568
17068
15481
153420
581
5902
16468
164618
149
652
16899
169868
46
20
17002
170500
122
699
16735
168095
533
5149
14358
146032
1313
10853
9156
87922
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
-5.6e-02
6.9e-02
1.9e+00
—
1.6e+00
5.8e-01
4.2e-01
cases:1.13%
controls:1.20%
cases:0.30%
controls:0.28%
cases:0.17%
controls:0.03%
—
—
cases:0.14%
controls:0.03%
cases:0.44%
controls:0.25%
cases:1.35%
controls:0.89%
193
2039
16856
168449
51
476
16998
170044
29
43
17019
170477
—
23
46
16834
168748
65
371
14826
150810
141
876
10328
97899
Erysipelas
A46 [45561706]
-2.2e-01
-1.2e-01
1.2e+00
3.6e+00
3.2e-01
-8.7e-02
-3.6e-02
cases:1.97%
controls:2.45%
cases:0.77%
controls:0.87%
cases:0.35%
controls:0.11%
cases:0.21%
controls:0.01%
cases:0.16%
controls:0.12%
cases:0.83%
controls:0.91%
cases:2.79%
controls:2.89%
336
4174
16713
166314
132
1488
16917
169032
60
187
16988
170333
35
10
17013
170510
27
196
16830
168598
124
1372
14767
149809
292
2854
10177
95921
Streptococcus sp identified in Specimen by Organism specific culture
38353-9 [3053028]
8.8e-01
1.8e+00
—
—
—
1.7e+00
9.5e-01
cases:0.26%
controls:0.11%
cases:0.06%
controls:0.01%
—
—
—
—
—
—
cases:0.07%
controls:0.01%
cases:0.14%
controls:0.06%
44
182
17005
170306
10
16
17039
170504
—
—
—
10
18
14881
151163
15
55
10454
98720
Other specified counselling
Z71.8 [45581061]
3.8e-02
1.6e-01
4.6e-01
2.7e+00
6.3e-01
2.4e-01
2.7e-01
cases:8.18%
controls:7.90%
cases:4.63%
controls:3.98%
cases:0.89%
controls:0.56%
cases:0.26%
controls:0.02%
cases:1.02%
controls:0.55%
cases:5.17%
controls:4.12%
cases:14.34%
controls:11.37%
1394
13466
15655
157022
790
6793
16259
163727
151
957
16897
169563
44
31
17004
170489
172
924
16685
167870
770
6226
14121
144955
1501
11233
8968
87542
hydrocortisone; local oral
A01AC03 [21600036]
1.4e-01
1.2e-01
1.0e+00
3.3e+00
4.6e-01
2.2e-01
1.3e-01
cases:1.67%
controls:1.46%
cases:0.54%
controls:0.48%
cases:0.15%
controls:0.05%
cases:0.10%
controls:0.00%
cases:0.09%
controls:0.06%
cases:0.56%
controls:0.45%
cases:1.61%
controls:1.43%
285
2494
16764
167994
92
818
16957
169702
25
88
17023
170432
17
6
17031
170514
15
95
16842
168699
83
674
14808
150507
169
1408
10300
97367
Joint symptom/complaint NOS
L20 [2002000644]
-1.1e-01
3.5e-01
1.7e+00
1.0e+50
1.4e+00
7.5e-01
5.0e-01
cases:0.48%
controls:0.54%
cases:0.21%
controls:0.15%
cases:0.11%
controls:0.02%
cases:0.04%
controls:0.00%
cases:0.08%
controls:0.02%
cases:0.34%
controls:0.16%
cases:0.92%
controls:0.56%
82
918
16967
169570
36
253
17013
170267
19
34
17029
170486
7
0
17041
170520
14
34
16843
168760
51
245
14840
150936
96
553
10373
98222
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
-3.1e-02
1.3e-01
1.3e+00
1.0e+50
1.7e+00
7.8e-01
5.9e-01
cases:1.27%
controls:1.31%
cases:0.47%
controls:0.41%
cases:0.12%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.19%
controls:0.04%
cases:0.75%
controls:0.34%
cases:1.88%
controls:1.05%
217
2238
16832
168250
80
703
16969
169817
21
56
17027
170464
44
0
17004
170520
32
60
16825
168734
111
519
14780
150662
197
1036
10272
97739
desloratadine; oral
R06AX27 [21603526]
2.1e-01
2.1e-01
3.5e-01
2.7e+00
3.2e-01
2.3e-01
2.9e-01
cases:8.57%
controls:7.03%
cases:4.54%
controls:3.73%
cases:0.92%
controls:0.65%
cases:0.39%
controls:0.03%
cases:0.87%
controls:0.63%
cases:4.62%
controls:3.69%
cases:8.42%
controls:6.41%
1461
11984
15588
158504
774
6356
16275
164164
157
1111
16891
169409
66
43
16982
170477
146
1069
16711
167725
688
5586
14203
145595
882
6333
9587
92442
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 [3008733]
2.9e-02
5.3e-01
3.5e+00
1.0e+50
—
1.0e+00
8.0e-01
cases:0.16%
controls:0.16%
cases:0.05%
controls:0.03%
cases:0.10%
controls:0.00%
cases:0.25%
controls:0.00%
—
—
cases:0.08%
controls:0.03%
cases:0.25%
controls:0.11%
28
272
17021
170216
9
53
17040
170467
17
5
17031
170515
43
0
17005
170520
—
12
43
14879
151138
26
110
10443
98665
HLA-B27 [Presence]
4821-5 [3008898]
1.2e-01
2.9e-01
1.4e+00
—
1.6e+00
7.5e-01
5.7e-01
cases:1.21%
controls:1.08%
cases:0.35%
controls:0.26%
cases:0.10%
controls:0.02%
—
—
cases:0.09%
controls:0.02%
cases:0.43%
controls:0.20%
cases:1.25%
controls:0.71%
207
1842
16842
168646
59
442
16990
170078
17
41
17031
170479
—
15
31
16842
168763
64
307
14827
150874
131
700
10338
98075
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
7.5e-02
-3.9e-02
4.2e-01
2.9e+00
5.1e-01
1.2e-01
4.2e-01
cases:10.04%
controls:9.39%
cases:3.69%
controls:3.83%
cases:0.77%
controls:0.50%
cases:0.29%
controls:0.02%
cases:0.81%
controls:0.49%
cases:3.87%
controls:3.46%
cases:12.76%
controls:8.76%
1712
16003
15337
154485
629
6530
16420
163990
131
860
16917
169660
49
26
16999
170494
136
819
16721
167975
577
5229
14314
145952
1336
8656
9133
90119
Differential panel, method unspecified - Blood
69738-3 [42870588]
-5.0e-02
3.7e-02
4.6e-01
2.6e+00
5.9e-01
2.6e-01
4.0e-01
cases:12.83%
controls:13.41%
cases:7.08%
controls:6.84%
cases:2.05%
controls:1.30%
cases:0.66%
controls:0.05%
cases:2.29%
controls:1.29%
cases:8.35%
controls:6.57%
cases:18.31%
controls:13.03%
2188
22856
14861
147632
1207
11668
15842
158852
350
2216
16698
168304
113
86
16935
170434
386
2173
16471
166621
1244
9940
13647
141241
1917
12874
8552
85901
Thorax X-ray examination
GD1AA [2001303617]
-8.5e-03
-7.1e-02
2.5e-01
3.7e+00
2.8e-01
1.8e-01
3.3e-01
cases:11.98%
controls:12.07%
cases:3.99%
controls:4.27%
cases:0.64%
controls:0.50%
cases:0.56%
controls:0.01%
cases:0.62%
controls:0.47%
cases:4.84%
controls:4.07%
cases:15.61%
controls:11.72%
2042
20573
15007
149915
680
7282
16369
163238
109
850
16939
169670
96
23
16952
170497
104
791
16753
168003
721
6149
14170
145032
1634
11574
8835
87201
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
2.5e-01
2.8e-01
9.6e-03
2.3e+00
6.4e-01
4.4e-01
2.8e-01
cases:6.63%
controls:5.22%
cases:2.31%
controls:1.75%
cases:0.25%
controls:0.25%
cases:0.14%
controls:0.01%
cases:0.44%
controls:0.23%
cases:2.50%
controls:1.63%
cases:5.76%
controls:4.44%
1131
8905
15918
161583
394
2989
16655
167531
43
426
17005
170094
24
23
17024
170497
74
391
16783
168403
372
2460
14519
148721
603
4381
9866
94394
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
53019-6 [3041423]
7.1e-02
9.3e-01
9.2e-01
—
1.6e+00
9.7e-01
7.0e-01
cases:0.32%
controls:0.30%
cases:0.23%
controls:0.09%
cases:0.03%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.25%
controls:0.09%
cases:0.53%
controls:0.27%
54
503
16995
169985
40
158
17009
170362
5
20
17043
170500
—
8
16
16849
168778
37
142
14854
151039
56
264
10413
98511
mometasone
D07AC13 [21602132]
7.7e-02
2.2e-01
4.6e-01
3.5e+00
3.3e-01
3.2e-01
2.1e-01
cases:5.10%
controls:4.74%
cases:1.95%
controls:1.57%
cases:0.30%
controls:0.19%
cases:0.24%
controls:0.01%
cases:0.28%
controls:0.20%
cases:2.05%
controls:1.50%
cases:5.01%
controls:4.09%
870
8083
16179
162405
333
2673
16716
167847
51
323
16997
170197
41
13
17007
170507
48
345
16809
168449
306
2270
14585
148911
524
4037
9945
94738
Respiratory, Other diagnostic procedure
R43 [2002000912]
9.0e-01
—
—
—
—
2.0e+00
1.3e+00
cases:0.14%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.05%
controls:0.01%
cases:0.13%
controls:0.04%
24
98
17025
170390
—
—
—
—
8
11
14883
151170
14
36
10455
98739
Cough
R05 [45606792]
2.5e-01
4.0e-01
2.4e-01
2.8e+00
-2.7e-02
3.9e-01
3.7e-01
cases:5.31%
controls:4.20%
cases:2.08%
controls:1.41%
cases:0.20%
controls:0.16%
cases:0.05%
controls:0.00%
cases:0.14%
controls:0.15%
cases:1.97%
controls:1.34%
cases:6.29%
controls:4.42%
906
7165
16143
163323
355
2396
16694
168124
34
267
17014
170253
8
5
17040
170515
24
247
16833
168547
293
2031
14598
149150
659
4369
9810
94406
One hour or less
ZXE00 [2001311394]
-4.0e-02
-2.5e-01
8.3e-02
3.4e+00
5.0e-01
3.4e-01
4.1e-01
cases:6.08%
controls:6.31%
cases:0.99%
controls:1.26%
cases:0.11%
controls:0.10%
cases:0.09%
controls:0.00%
cases:0.20%
controls:0.12%
cases:1.30%
controls:0.93%
cases:4.43%
controls:2.98%
1036
10757
16013
159731
168
2151
16881
168369
19
175
17029
170345
15
5
17033
170515
33
201
16824
168593
194
1412
14697
149769
464
2943
10005
95832
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
-1.7e-01
5.3e-01
1.4e+00
1.0e+50
1.4e+00
7.2e-01
3.0e-01
cases:0.89%
controls:1.05%
cases:0.52%
controls:0.30%
cases:0.18%
controls:0.04%
cases:0.05%
controls:0.00%
cases:0.17%
controls:0.04%
cases:0.60%
controls:0.29%
cases:1.28%
controls:0.95%
151
1790
16898
168698
88
518
16961
170002
31
74
17017
170446
9
0
17039
170520
28
66
16829
168728
89
443
14802
150738
134
936
10335
97839
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53017-0 [3041067]
5.4e-02
8.5e-01
9.6e-01
—
1.5e+00
9.6e-01
7.8e-01
cases:0.37%
controls:0.35%
cases:0.25%
controls:0.11%
cases:0.04%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.28%
controls:0.11%
cases:0.71%
controls:0.32%
63
597
16986
169891
42
180
17007
170340
6
23
17042
170497
—
10
22
16847
168772
42
164
14849
151017
74
321
10395
98454
betamethasone
D07AC01 [21602120]
-3.8e-02
8.1e-03
4.8e-01
3.4e+00
2.5e-01
7.3e-02
1.5e-01
cases:8.22%
controls:8.51%
cases:3.41%
controls:3.38%
cases:0.69%
controls:0.43%
cases:0.40%
controls:0.01%
cases:0.59%
controls:0.46%
cases:3.62%
controls:3.37%
cases:9.95%
controls:8.68%
1401
14502
15648
155986
581
5766
16468
164754
118
731
16930
169789
69
23
16979
170497
99
775
16758
168019
539
5099
14352
146082
1042
8575
9427
90200
betamethasone
S02BA07 [21605169]
-3.8e-02
8.1e-03
4.8e-01
3.4e+00
2.5e-01
7.3e-02
1.5e-01
cases:8.22%
controls:8.51%
cases:3.41%
controls:3.38%
cases:0.69%
controls:0.43%
cases:0.40%
controls:0.01%
cases:0.59%
controls:0.46%
cases:3.62%
controls:3.37%
cases:9.95%
controls:8.68%
1401
14502
15648
155986
581
5766
16468
164754
118
731
16930
169789
69
23
16979
170497
99
775
16758
168019
539
5099
14352
146082
1042
8575
9427
90200
betamethasone
A07EA04 [21600656]
-3.8e-02
8.1e-03
4.8e-01
3.4e+00
2.5e-01
7.3e-02
1.5e-01
cases:8.22%
controls:8.51%
cases:3.41%
controls:3.38%
cases:0.69%
controls:0.43%
cases:0.40%
controls:0.01%
cases:0.59%
controls:0.46%
cases:3.62%
controls:3.37%
cases:9.95%
controls:8.68%
1401
14502
15648
155986
581
5766
16468
164754
118
731
16930
169789
69
23
16979
170497
99
775
16758
168019
539
5099
14352
146082
1042
8575
9427
90200
betamethasone
C05AA05 [21601610]
-3.8e-02
8.1e-03
4.8e-01
3.4e+00
2.5e-01
7.3e-02
1.5e-01
cases:8.22%
controls:8.51%
cases:3.41%
controls:3.38%
cases:0.69%
controls:0.43%
cases:0.40%
controls:0.01%
cases:0.59%
controls:0.46%
cases:3.62%
controls:3.37%
cases:9.95%
controls:8.68%
1401
14502
15648
155986
581
5766
16468
164754
118
731
16930
169789
69
23
16979
170497
99
775
16758
168019
539
5099
14352
146082
1042
8575
9427
90200
Pain in limb
M79.6 [45587063]
1.3e-01
2.1e-01
5.1e-01
2.2e+00
4.6e-01
2.2e-01
2.8e-01
cases:12.39%
controls:11.09%
cases:5.70%
controls:4.66%
cases:1.04%
controls:0.63%
cases:0.21%
controls:0.02%
cases:0.92%
controls:0.58%
cases:5.91%
controls:4.80%
cases:17.92%
controls:14.13%
2113
18905
14936
151583
971
7950
16078
162570
178
1072
16870
169448
36
39
17012
170481
155
986
16702
167808
880
7255
14011
143926
1876
13953
8593
84822
Multiple sclerosis
109 [2001600109]
-1.9e-01
—
—
—
—
2.1e+00
1.9e+00
cases:0.05%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.05%
controls:0.01%
cases:0.11%
controls:0.02%
8
97
17041
170391
—
—
—
—
8
10
14883
151171
12
17
10457
98758
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
1.1e-01
4.9e-01
1.0e+00
—
1.2e+00
6.7e-01
5.7e-01
cases:1.07%
controls:0.96%
cases:0.49%
controls:0.30%
cases:0.10%
controls:0.04%
—
—
cases:0.12%
controls:0.03%
cases:0.60%
controls:0.31%
cases:1.63%
controls:0.93%
183
1644
16866
168844
83
508
16966
170012
17
61
17031
170459
—
20
59
16837
168735
90
471
14801
150710
171
920
10298
97855
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
1.1e-01
5.0e-01
1.0e+00
—
1.2e+00
6.8e-01
5.6e-01
cases:1.08%
controls:0.97%
cases:0.49%
controls:0.30%
cases:0.10%
controls:0.04%
—
—
cases:0.12%
controls:0.03%
cases:0.61%
controls:0.31%
cases:1.62%
controls:0.94%
184
1647
16865
168841
83
506
16966
170014
17
62
17031
170458
—
20
59
16837
168735
91
469
14800
150712
170
924
10299
97851
Physiotherapy
R4110 [2001310233]
1.5e-01
4.0e-02
6.7e-03
3.1e+00
1.1e-01
2.8e-01
4.4e-01
cases:7.61%
controls:6.64%
cases:2.22%
controls:2.14%
cases:0.28%
controls:0.27%
cases:0.19%
controls:0.01%
cases:0.30%
controls:0.27%
cases:2.47%
controls:1.88%
cases:7.81%
controls:5.15%
1298
11327
15751
159161
379
3644
16670
166876
47
467
17001
170053
33
15
17015
170505
50
450
16807
168344
368
2841
14523
148340
818
5091
9651
93684
Pure hypercholesterolaemia
E78.0 [45542771]
2.7e-01
3.7e-01
3.2e-01
2.5e+00
3.1e-01
3.8e-01
3.9e-01
cases:7.03%
controls:5.48%
cases:3.58%
controls:2.50%
cases:0.39%
controls:0.29%
cases:0.13%
controls:0.01%
cases:0.41%
controls:0.30%
cases:3.57%
controls:2.46%
cases:9.71%
controls:6.78%
1199
9348
15850
161140
611
4257
16438
166263
67
487
16981
170033
23
18
17025
170502
69
506
16788
168288
531
3721
14360
147460
1017
6698
9452
92077
Viral infection, unspecified
B34.9 [45605229]
5.7e-02
3.4e-01
1.8e+00
—
2.1e+00
4.6e-01
4.4e-01
cases:0.30%
controls:0.28%
cases:0.12%
controls:0.09%
cases:0.06%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.15%
controls:0.10%
cases:0.39%
controls:0.25%
51
482
16998
170006
21
150
17028
170370
10
16
17038
170504
—
10
12
16847
168782
23
148
14868
151033
41
250
10428
98525
Allergy, unspecified
T78.4 [45580373]
5.2e-01
7.2e-01
1.6e+00
—
2.1e+00
2.9e-01
5.6e-01
cases:0.83%
controls:0.49%
cases:0.26%
controls:0.13%
cases:0.04%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.14%
controls:0.11%
cases:0.68%
controls:0.39%
141
838
16908
169650
45
220
17004
170300
7
14
17041
170506
—
17
20
16840
168774
21
159
14870
151022
71
385
10398
98390
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
7.3e-02
5.2e-01
1.2e+00
—
1.1e+00
6.0e-01
4.4e-01
cases:1.60%
controls:1.49%
cases:0.76%
controls:0.45%
cases:0.17%
controls:0.05%
—
—
cases:0.17%
controls:0.05%
cases:0.79%
controls:0.43%
cases:1.93%
controls:1.25%
273
2541
16776
167947
129
768
16920
169752
29
90
17019
170430
—
28
89
16829
168705
117
655
14774
150526
202
1236
10267
97539
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-3.5e-02
-2.6e-02
4.2e-01
2.4e+00
5.9e-01
1.8e-01
2.6e-01
cases:18.49%
controls:19.02%
cases:9.84%
controls:10.07%
cases:2.83%
controls:1.88%
cases:0.83%
controls:0.07%
cases:3.27%
controls:1.84%
cases:11.33%
controls:9.64%
cases:24.30%
controls:19.81%
3152
32424
13897
138064
1677
17165
15372
153355
482
3205
16566
167315
142
126
16906
170394
551
3101
16306
165693
1687
14575
13204
136606
2544
19572
7925
79203
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-3.9e-02
-2.4e-02
4.2e-01
2.4e+00
5.9e-01
1.8e-01
2.6e-01
cases:18.37%
controls:18.97%
cases:9.84%
controls:10.06%
cases:2.83%
controls:1.87%
cases:0.82%
controls:0.07%
cases:3.27%
controls:1.83%
cases:11.35%
controls:9.63%
cases:24.28%
controls:19.79%
3132
32339
13917
138149
1678
17156
15371
153364
482
3197
16566
167323
140
126
16908
170394
551
3092
16306
165702
1690
14556
13201
136625
2542
19544
7927
79231
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11054-4 [3002109]
3.6e-01
3.3e-01
1.8e-01
2.7e+00
3.0e-01
2.6e-01
2.0e-01
cases:5.32%
controls:3.77%
cases:2.50%
controls:1.81%
cases:0.24%
controls:0.20%
cases:0.05%
controls:0.00%
cases:0.28%
controls:0.21%
cases:2.50%
controls:1.93%
cases:5.61%
controls:4.65%
907
6432
16142
164056
426
3094
16623
167426
41
341
17007
170179
9
6
17039
170514
48
355
16809
168439
372
2916
14519
148265
587
4596
9882
94179
Varicella zoster virus Ab [Titer] in Serum
21594-7 [3014148]
-2.0e-01
-2.0e-01
2.1e+00
1.0e+50
1.7e+00
6.1e-01
3.2e-01
cases:0.33%
controls:0.40%
cases:0.09%
controls:0.11%
cases:0.05%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.16%
controls:0.09%
cases:0.39%
controls:0.28%
56
683
16993
169805
15
183
17034
170337
9
11
17039
170509
10
0
17038
170520
12
21
16845
168773
24
132
14867
151049
41
281
10428
98494
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
9.4e-04
9.0e-03
3.8e-01
2.8e+00
4.1e-01
8.8e-02
1.9e-01
cases:51.62%
controls:51.59%
cases:30.07%
controls:29.88%
cases:8.12%
controls:5.70%
cases:4.70%
controls:0.31%
cases:8.03%
controls:5.48%
cases:31.29%
controls:29.42%
cases:62.15%
controls:57.47%
8800
87959
8249
82529
5127
50958
11922
119562
1385
9714
15663
160806
802
526
16246
169994
1354
9255
15503
159539
4659
44473
10232
106708
6506
56765
3963
42010
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
1.1e-01
4.6e-01
9.8e-01
—
1.2e+00
6.3e-01
5.5e-01
cases:1.16%
controls:1.04%
cases:0.49%
controls:0.31%
cases:0.10%
controls:0.04%
—
—
cases:0.12%
controls:0.03%
cases:0.62%
controls:0.33%
cases:1.70%
controls:0.99%
198
1768
16851
168720
83
527
16966
169993
17
64
17031
170456
—
20
59
16837
168735
92
499
14799
150682
178
977
10291
97798
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-1.5e-02
-1.8e-02
3.9e-01
2.4e+00
5.7e-01
1.8e-01
2.6e-01
cases:18.83%
controls:19.07%
cases:10.03%
controls:10.20%
cases:2.82%
controls:1.92%
cases:0.84%
controls:0.08%
cases:3.24%
controls:1.85%
cases:11.52%
controls:9.81%
cases:24.63%
controls:20.10%
3211
32507
13838
137981
1710
17387
15339
153133
480
3270
16568
167250
143
128
16905
170392
546
3127
16311
165667
1716
14824
13175
136357
2578
19852
7891
78923
epinephrine
S01EA01 [21603673]
5.0e-01
3.2e-01
8.3e-01
—
1.2e+00
5.0e-01
4.7e-01
cases:2.04%
controls:1.25%
cases:0.78%
controls:0.57%
cases:0.13%
controls:0.06%
—
—
cases:0.20%
controls:0.06%
cases:0.89%
controls:0.54%
cases:1.81%
controls:1.13%
347
2125
16702
168363
133
966
16916
169554
22
96
17026
170424
—
33
100
16824
168694
133
821
14758
150360
189
1118
10280
97657
epinephrine; parenteral
C01CA24 [21600303]
5.0e-01
3.2e-01
8.3e-01
—
1.2e+00
5.0e-01
4.7e-01
cases:2.04%
controls:1.25%
cases:0.78%
controls:0.57%
cases:0.13%
controls:0.06%
—
—
cases:0.20%
controls:0.06%
cases:0.89%
controls:0.54%
cases:1.81%
controls:1.13%
347
2125
16702
168363
133
966
16916
169554
22
96
17026
170424
—
33
100
16824
168694
133
822
14758
150359
189
1118
10280
97657
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
-2.4e-02
3.7e-01
1.2e+00
—
1.0e+00
5.6e-01
6.7e-01
cases:1.57%
controls:1.61%
cases:0.65%
controls:0.45%
cases:0.16%
controls:0.05%
—
—
cases:0.12%
controls:0.05%
cases:0.71%
controls:0.41%
cases:2.59%
controls:1.34%
268
2744
16781
167744
111
772
16938
169748
27
81
17021
170439
—
21
76
16836
168718
106
619
14785
150562
271
1324
10198
97451
Basophils/Leukocytes in Blood
30180-4 [3022096]
-3.8e-02
-2.8e-02
4.2e-01
2.4e+00
5.8e-01
1.8e-01
2.6e-01
cases:18.32%
controls:18.90%
cases:9.82%
controls:10.07%
cases:2.84%
controls:1.89%
cases:0.82%
controls:0.08%
cases:3.24%
controls:1.84%
cases:11.33%
controls:9.68%
cases:24.29%
controls:19.86%
3124
32227
13925
138261
1675
17179
15374
153341
484
3217
16564
167303
140
130
16908
170390
546
3110
16311
165684
1687
14627
13204
136554
2543
19620
7926
79155
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
-4.4e-02
1.8e-01
1.5e+00
—
1.5e+00
4.4e-01
3.6e-01
cases:1.26%
controls:1.31%
cases:0.46%
controls:0.39%
cases:0.19%
controls:0.04%
—
—
cases:0.18%
controls:0.04%
cases:0.55%
controls:0.35%
cases:1.67%
controls:1.17%
214
2236
16835
168252
79
663
16970
169857
33
76
17015
170444
—
31
67
16826
168727
82
536
14809
150645
175
1160
10294
97615
Body height measure
50373000 [4177340]
-2.8e-01
-5.3e-01
-4.3e-01
1.1e+00
4.6e+00
1.0e+50
1.0e+50
cases:21.17%
controls:26.28%
cases:3.56%
controls:5.87%
cases:0.33%
controls:0.51%
cases:0.05%
controls:0.02%
cases:0.36%
controls:0.00%
cases:3.48%
controls:0.00%
cases:13.30%
controls:0.00%
3609
44799
13440
125689
607
10018
16442
160502
57
877
16991
169643
8
27
17040
170493
60
6
16797
168788
518
0
14373
151181
1392
0
9077
98775
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-3.9e-02
-4.2e-02
4.0e-01
2.4e+00
5.7e-01
1.6e-01
2.4e-01
cases:18.85%
controls:19.45%
cases:9.94%
controls:10.32%
cases:2.84%
controls:1.92%
cases:0.86%
controls:0.08%
cases:3.28%
controls:1.88%
cases:11.44%
controls:9.93%
cases:24.60%
controls:20.47%
3213
33166
13836
137322
1694
17601
15355
152919
485
3279
16563
167241
147
130
16901
170390
553
3181
16304
165613
1704
15014
13187
136167
2575
20217
7894
78558
Intravenous administration of medicine
SPAT1255 [2001700356]
-4.7e-01
-6.0e-01
1.8e-01
2.2e+00
2.6e+00
-2.0e-01
-5.2e-01
cases:0.63%
controls:1.01%
cases:0.16%
controls:0.30%
cases:0.05%
controls:0.04%
cases:0.04%
controls:0.00%
cases:0.49%
controls:0.04%
cases:0.24%
controls:0.29%
cases:0.59%
controls:1.00%
108
1720
16941
168768
28
509
17021
170011
9
75
17039
170445
7
8
17041
170512
82
60
16775
168734
35
433
14856
150748
62
983
10407
97792
Body mass index
60621009 [4245997]
-2.8e-01
-5.3e-01
-4.4e-01
1.1e+00
4.6e+00
1.0e+50
1.0e+50
cases:21.00%
controls:26.10%
cases:3.51%
controls:5.83%
cases:0.33%
controls:0.51%
cases:0.05%
controls:0.02%
cases:0.36%
controls:0.00%
cases:3.45%
controls:0.00%
cases:13.21%
controls:0.00%
3581
44505
13468
125983
598
9949
16451
160571
56
868
16992
169652
8
26
17040
170494
60
6
16797
168788
514
0
14377
151181
1383
0
9086
98775
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
89640-7 [1175715]
5.2e-01
4.6e-01
1.8e+00
—
—
9.4e-01
5.5e-01
cases:0.73%
controls:0.44%
cases:0.12%
controls:0.07%
cases:0.04%
controls:0.01%
—
—
—
—
cases:0.17%
controls:0.07%
cases:0.47%
controls:0.27%
124
743
16925
169745
20
126
17029
170394
7
12
17041
170508
—
—
26
103
14865
151078
49
266
10420
98509
Monocytes [#/volume] in Blood
26484-6 [3001604]
-2.9e-02
-1.4e-02
3.6e-01
2.4e+00
5.5e-01
1.5e-01
2.4e-01
cases:19.73%
controls:20.20%
cases:10.89%
controls:11.03%
cases:2.97%
controls:2.08%
cases:0.90%
controls:0.08%
cases:3.44%
controls:2.01%
cases:12.24%
controls:10.67%
cases:26.37%
controls:21.99%
3364
34431
13685
136057
1857
18810
15192
151710
506
3547
16542
166973
153
135
16895
170385
580
3386
16277
165408
1822
16135
13069
135046
2761
21720
7708
77055
Tinea pedis
B35.3 [45581158]
3.4e-01
5.9e-01
1.0e+00
2.8e+00
5.5e-01
2.7e-01
1.6e-01
cases:0.89%
controls:0.63%
cases:0.39%
controls:0.22%
cases:0.08%
controls:0.03%
cases:0.06%
controls:0.00%
cases:0.05%
controls:0.03%
cases:0.26%
controls:0.20%
cases:0.88%
controls:0.75%
152
1082
16897
169406
66
367
16983
170153
13
47
17035
170473
10
6
17038
170514
9
52
16848
168742
39
303
14852
150878
92
743
10377
98032
Hand/finger symptom/complaint
L12 [2002000636]
1.5e-01
9.2e-02
3.4e-01
3.1e+00
9.1e-02
2.6e-01
2.7e-01
cases:3.57%
controls:3.07%
cases:1.24%
controls:1.14%
cases:0.18%
controls:0.13%
cases:0.09%
controls:0.00%
cases:0.12%
controls:0.11%
cases:1.44%
controls:1.11%
cases:4.90%
controls:3.80%
608
5242
16441
165246
212
1936
16837
168584
31
220
17017
170300
15
7
17033
170513
21
192
16836
168602
214
1683
14677
149498
513
3752
9956
95023
Basophils [#/volume] in Blood
26444-0 [3006315]
-3.2e-02
-1.4e-02
3.6e-01
2.4e+00
5.6e-01
1.6e-01
2.4e-01
cases:19.75%
controls:20.26%
cases:10.92%
controls:11.06%
cases:2.97%
controls:2.08%
cases:0.90%
controls:0.08%
cases:3.46%
controls:2.01%
cases:12.30%
controls:10.72%
cases:26.46%
controls:22.09%
3368
34546
13681
135942
1862
18860
15187
151660
506
3552
16542
166968
154
137
16894
170383
584
3396
16273
165398
1832
16205
13059
134976
2770
21824
7699
76951
European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
69927-2 [42868418]
7.9e-01
1.7e+00
—
1.0e+50
1.0e+50
2.3e+00
1.4e+00
cases:0.05%
controls:0.02%
cases:0.03%
controls:0.01%
—
—
cases:0.22%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.11%
controls:0.03%
9
41
17040
170447
5
9
17044
170511
—
37
0
17011
170520
17
0
16840
168794
10
10
14881
151171
11
25
10458
98750
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.7e-02
2.7e-01
1.5e+00
1.6e+00
1.2e+00
4.2e-01
4.0e-01
cases:5.04%
controls:4.96%
cases:1.82%
controls:1.39%
cases:0.66%
controls:0.15%
cases:0.04%
controls:0.01%
cases:0.44%
controls:0.14%
cases:1.96%
controls:1.30%
cases:6.03%
controls:4.13%
860
8459
16189
162029
310
2366
16739
168154
112
252
16936
170268
6
12
17042
170508
74
235
16783
168559
292
1960
14599
149221
631
4079
9838
94696
Fungus identified in Specimen by Culture
580-1 [3000494]
2.2e-02
7.6e-02
3.4e-01
3.2e+00
2.3e-01
2.8e-01
2.6e-01
cases:3.79%
controls:3.71%
cases:1.20%
controls:1.11%
cases:0.16%
controls:0.11%
cases:0.07%
controls:0.00%
cases:0.15%
controls:0.12%
cases:1.44%
controls:1.09%
cases:4.76%
controls:3.70%
646
6323
16403
164165
204
1892
16845
168628
27
193
17021
170327
12
5
17036
170515
25
199
16832
168595
214
1652
14677
149529
498
3651
9971
95124
Short blood count panel - Blood
55429-5 [40758558]
1.4e-01
8.6e-02
4.1e-01
2.2e+00
5.2e-01
1.7e-01
2.4e-01
cases:10.53%
controls:9.25%
cases:4.95%
controls:4.56%
cases:1.40%
controls:0.93%
cases:0.38%
controls:0.04%
cases:1.49%
controls:0.89%
cases:5.24%
controls:4.46%
cases:13.11%
controls:10.58%
1795
15772
15254
154716
844
7774
16205
162746
238
1588
16810
168932
64
69
16984
170451
251
1507
16606
167287
781
6745
14110
144436
1372
10452
9097
88323
Polyneuropathy, unspecified
G62.9 [45566898]
9.4e-02
4.9e-01
1.0e+00
—
8.7e-01
7.3e-01
6.2e-01
cases:0.49%
controls:0.45%
cases:0.39%
controls:0.24%
cases:0.15%
controls:0.05%
—
—
cases:0.12%
controls:0.05%
cases:0.47%
controls:0.23%
cases:0.97%
controls:0.53%
84
765
16965
169723
67
413
16982
170107
25
91
17023
170429
—
21
88
16836
168706
70
345
14821
150836
102
521
10367
98254
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-3.0e-02
-2.2e-02
3.5e-01
2.4e+00
5.5e-01
1.4e-01
2.2e-01
cases:20.41%
controls:20.90%
cases:11.06%
controls:11.28%
cases:2.99%
controls:2.12%
cases:0.92%
controls:0.08%
cases:3.48%
controls:2.05%
cases:12.38%
controls:10.94%
cases:26.68%
controls:22.55%
3479
35627
13570
134861
1886
19236
15163
151284
510
3611
16538
166909
156
139
16892
170381
587
3454
16270
165340
1843
16534
13048
134647
2793
22277
7676
76498
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
-1.6e-01
1.4e-02
3.8e-01
2.6e+00
7.5e-01
1.1e-01
2.9e-01
cases:1.71%
controls:1.99%
cases:0.69%
controls:0.68%
cases:0.13%
controls:0.09%
cases:0.04%
controls:0.00%
cases:0.17%
controls:0.08%
cases:0.69%
controls:0.62%
cases:2.31%
controls:1.74%
291
3400
16758
167088
117
1154
16932
169366
22
150
17026
170370
7
5
17041
170515
28
133
16829
168661
103
940
14788
150241
242
1717
10227
97058
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-2.9e-02
-1.0e-02
3.4e-01
2.4e+00
5.3e-01
1.5e-01
2.4e-01
cases:20.58%
controls:21.07%
cases:11.31%
controls:11.41%
cases:3.05%
controls:2.19%
cases:0.92%
controls:0.08%
cases:3.54%
controls:2.11%
cases:12.65%
controls:11.04%
cases:27.37%
controls:22.88%
3509
35918
13540
134570
1928
19459
15121
151061
520
3726
16528
166794
156
142
16892
170378
596
3557
16261
165237
1884
16685
13007
134496
2865
22603
7604
76172
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
-1.7e-01
-2.8e-01
9.5e-01
2.7e+00
-1.7e-01
-2.6e-01
7.3e-02
cases:2.12%
controls:2.49%
cases:0.56%
controls:0.74%
cases:0.41%
controls:0.16%
cases:0.53%
controls:0.04%
cases:0.15%
controls:0.18%
cases:0.57%
controls:0.74%
cases:2.63%
controls:2.45%
361
4250
16688
166238
96
1263
16953
169257
70
272
16978
170248
91
60
16957
170460
26
310
16831
168484
85
1121
14806
150060
275
2416
10194
96359
terbinafine; oral
D01BA02 [21601967]
2.3e-01
3.2e-01
7.1e-01
2.2e+00
1.3e-01
1.2e-01
2.2e-01
cases:4.16%
controls:3.34%
cases:1.23%
controls:0.89%
cases:0.23%
controls:0.11%
cases:0.05%
controls:0.01%
cases:0.14%
controls:0.12%
cases:0.97%
controls:0.87%
cases:3.64%
controls:2.95%
710
5698
16339
164790
209
1520
16840
169000
40
196
17008
170324
8
9
17040
170511
23
203
16834
168591
145
1310
14746
149871
381
2912
10088
95863
Erythrocyte sedimentation rate above reference range
165468009 [4013526]
-2.5e-01
2.4e-01
1.6e+00
—
2.1e+00
7.1e-01
1.8e-01
cases:0.15%
controls:0.19%
cases:0.09%
controls:0.07%
cases:0.05%
controls:0.01%
—
—
cases:0.04%
controls:0.01%
cases:0.11%
controls:0.05%
cases:0.21%
controls:0.18%
25
320
17024
170168
15
118
17034
170402
8
16
17040
170504
—
7
9
16850
168785
16
80
14875
151101
22
174
10447
98601
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
-6.1e-02
2.1e-01
9.9e-01
—
1.7e+00
5.2e-01
4.4e-01
cases:1.41%
controls:1.50%
cases:0.65%
controls:0.53%
cases:0.21%
controls:0.08%
—
—
cases:0.24%
controls:0.05%
cases:0.80%
controls:0.47%
cases:1.87%
controls:1.21%
241
2559
16808
167929
110
896
16939
169624
36
134
17012
170386
—
41
78
16816
168716
119
718
14772
150463
196
1196
10273
97579
C reactive protein [Mass/volume] in Body fluid
16503-5 [3035320]
7.7e-01
9.3e-01
1.4e+00
—
9.2e-01
7.4e-01
1.2e+00
cases:0.56%
controls:0.26%
cases:0.26%
controls:0.10%
cases:0.04%
controls:0.01%
—
—
cases:0.03%
controls:0.01%
cases:0.21%
controls:0.10%
cases:0.98%
controls:0.31%
95
440
16954
170048
45
177
17004
170343
7
18
17041
170502
—
5
20
16852
168774
31
151
14860
151030
103
303
10366
98472
Very extensive MRI examination of brain with 3 Tesla magnet
AA1DM [2001300121]
2.2e-01
—
—
1.0e+50
—
2.1e+00
1.5e+00
cases:0.05%
controls:0.04%
—
—
—
—
cases:0.03%
controls:0.00%
—
—
cases:0.05%
controls:0.01%
cases:0.11%
controls:0.03%
8
64
17041
170424
—
—
5
0
17043
170520
—
8
10
14883
151171
12
25
10457
98750
Other urticaria
L50.8 [45562540]
2.8e-01
6.1e-01
—
—
1.7e+00
1.0e+00
8.4e-01
cases:0.19%
controls:0.15%
cases:0.09%
controls:0.05%
—
—
—
—
cases:0.05%
controls:0.01%
cases:0.13%
controls:0.05%
cases:0.30%
controls:0.13%
33
250
17016
170238
16
87
17033
170433
—
—
9
16
16848
168778
19
70
14872
151111
31
126
10438
98649
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
2.4e-01
3.4e-01
2.7e-01
2.2e+00
1.6e-01
3.5e-01
4.2e-01
cases:8.37%
controls:6.69%
cases:4.27%
controls:3.08%
cases:0.46%
controls:0.35%
cases:0.08%
controls:0.01%
cases:0.39%
controls:0.33%
cases:4.16%
controls:2.96%
cases:10.82%
controls:7.41%
1427
11400
15622
159088
728
5255
16321
165265
78
595
16970
169925
14
15
17034
170505
66
565
16791
168229
620
4475
14271
146706
1133
7316
9336
91459
Other and unspecified abdominal pain
R10.4 [45568113]
7.3e-02
2.9e-01
5.3e-01
2.1e+00
2.2e-01
3.4e-01
3.5e-01
cases:7.65%
controls:7.15%
cases:2.90%
controls:2.20%
cases:0.43%
controls:0.26%
cases:0.08%
controls:0.01%
cases:0.31%
controls:0.25%
cases:3.05%
controls:2.20%
cases:9.31%
controls:6.72%
1304
12187
15745
158301
495
3750
16554
166770
74
436
16974
170084
14
18
17034
170502
53
427
16804
168367
454
3324
14437
147857
975
6641
9494
92134
naproxcinod
M01AE18 [40254094]
1.7e-01
1.9e-01
3.7e-01
2.4e+00
2.1e-01
1.9e-01
2.1e-01
cases:10.77%
controls:9.22%
cases:3.72%
controls:3.10%
cases:0.56%
controls:0.39%
cases:0.12%
controls:0.01%
cases:0.47%
controls:0.39%
cases:3.51%
controls:2.90%
cases:8.44%
controls:6.93%
1837
15713
15212
154775
634
5289
16415
165231
96
663
16952
169857
20
18
17028
170502
80
652
16777
168142
522
4389
14369
146792
884
6841
9585
91934
naproxen; oral, rectal
M01AE02 [21603968]
1.7e-01
1.9e-01
3.7e-01
2.4e+00
2.1e-01
1.9e-01
2.1e-01
cases:10.77%
controls:9.22%
cases:3.72%
controls:3.10%
cases:0.56%
controls:0.39%
cases:0.12%
controls:0.01%
cases:0.47%
controls:0.39%
cases:3.51%
controls:2.90%
cases:8.44%
controls:6.93%
1837
15713
15212
154775
634
5289
16415
165231
96
663
16952
169857
20
18
17028
170502
80
652
16777
168142
522
4389
14369
146792
884
6841
9585
91934
aciclovir; oral, parenteral
J05AB01 [21603131]
1.0e-01
2.4e-01
4.7e-01
2.6e+00
3.0e-02
2.1e-01
2.2e-01
cases:3.96%
controls:3.59%
cases:1.67%
controls:1.33%
cases:0.39%
controls:0.25%
cases:0.09%
controls:0.01%
cases:0.25%
controls:0.24%
cases:1.63%
controls:1.32%
cases:4.11%
controls:3.33%
675
6125
16374
164363
285
2260
16764
168260
67
421
16981
170099
15
11
17033
170509
42
408
16815
168386
242
1990
14649
149191
430
3288
10039
95487
Localized scleroderma [morphea]
L94.0 [45553008]
-3.6e-01
6.7e-01
—
—
2.0e+00
1.5e+00
7.7e-01
cases:0.04%
controls:0.05%
cases:0.05%
controls:0.03%
—
—
—
—
cases:0.04%
controls:0.00%
cases:0.10%
controls:0.02%
cases:0.08%
controls:0.04%
6
86
17043
170402
9
46
17040
170474
—
—
6
8
16851
168786
15
34
14876
151147
8
35
10461
98740
Hyperplasia of prostate
N40 [45563015]
1.3e-01
2.6e-01
-1.3e-02
2.4e+00
3.1e-01
3.4e-01
3.6e-01
cases:4.87%
controls:4.30%
cases:2.69%
controls:2.09%
cases:0.35%
controls:0.35%
cases:0.16%
controls:0.01%
cases:0.46%
controls:0.33%
cases:2.87%
controls:2.07%
cases:7.09%
controls:5.07%
831
7336
16218
163152
458
3564
16591
166956
59
598
16989
169922
27
24
17021
170496
77
564
16780
168230
428
3133
14463
148048
742
5012
9727
93763
fluvoxamine; oral
N06AB08 [21604716]
8.8e-01
1.3e+00
—
—
—
9.5e-01
1.3e+00
cases:0.15%
controls:0.06%
cases:0.10%
controls:0.03%
—
—
—
—
—
—
cases:0.08%
controls:0.03%
cases:0.16%
controls:0.04%
25
104
17024
170384
17
48
17032
170472
—
—
—
12
47
14879
151134
17
44
10452
98731
saccharomyces boulardii; oral
A07FA02 [21600670]
1.9e-01
1.9e-01
8.2e-01
—
2.4e+00
5.4e-01
4.6e-01
cases:1.38%
controls:1.14%
cases:0.39%
controls:0.33%
cases:0.08%
controls:0.04%
—
—
cases:0.44%
controls:0.04%
cases:0.58%
controls:0.34%
cases:1.74%
controls:1.10%
235
1941
16814
168547
67
556
16982
169964
14
62
17034
170458
—
75
66
16782
168728
86
512
14805
150669
182
1088
10287
97687
Result test/procedure
-60 [2002000131]
3.3e-01
7.9e-01
1.7e+00
—
1.2e+00
7.3e-01
9.1e-01
cases:0.48%
controls:0.34%
cases:0.18%
controls:0.08%
cases:0.05%
controls:0.01%
—
—
cases:0.04%
controls:0.01%
cases:0.15%
controls:0.07%
cases:0.32%
controls:0.13%
81
583
16968
169905
31
141
17018
170379
9
16
17039
170504
—
6
18
16851
168776
22
108
14869
151073
33
126
10436
98649
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
1.3e-01
4.4e-02
-1.4e-01
3.1e+00
-5.6e-02
1.2e-01
1.9e-01
cases:10.64%
controls:9.42%
cases:2.80%
controls:2.68%
cases:0.23%
controls:0.27%
cases:0.20%
controls:0.01%
cases:0.26%
controls:0.28%
cases:2.93%
controls:2.60%
cases:9.91%
controls:8.32%
1814
16067
15235
154421
477
4570
16572
165950
40
461
17008
170059
34
16
17014
170504
44
466
16813
168328
436
3924
14455
147257
1038
8219
9431
90556
Other skin changes
R23 [45568122]
5.3e-01
8.5e-01
2.5e+00
—
—
3.9e-01
9.0e-01
cases:0.22%
controls:0.13%
cases:0.10%
controls:0.04%
cases:0.04%
controls:0.00%
—
—
—
—
cases:0.07%
controls:0.05%
cases:0.32%
controls:0.13%
38
223
17011
170265
17
73
17032
170447
6
5
17042
170515
—
—
11
76
14880
151105
34
131
10435
98644
Demyelinating disease of central nervous system, unspecified
G37.9 [45571797]
7.1e-01
7.4e-01
—
1.0e+50
1.9e+00
1.1e+00
1.4e+00
cases:0.09%
controls:0.04%
cases:0.05%
controls:0.02%
—
—
cases:0.04%
controls:0.00%
cases:0.04%
controls:0.01%
cases:0.07%
controls:0.02%
cases:0.14%
controls:0.03%
15
74
17034
170414
8
38
17041
170482
—
6
0
17042
170520
7
10
16850
168784
10
34
14881
151147
15
34
10454
98741
Tinea corporis
B35.4 [45576265]
2.2e-02
9.3e-01
2.4e+00
1.0e+50
—
7.7e-01
3.3e-01
cases:0.13%
controls:0.13%
cases:0.12%
controls:0.05%
cases:0.05%
controls:0.00%
cases:0.03%
controls:0.00%
—
—
cases:0.11%
controls:0.05%
cases:0.25%
controls:0.18%
23
225
17026
170263
21
83
17028
170437
8
7
17040
170513
5
0
17043
170520
—
17
80
14874
151101
26
177
10443
98598
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69924-9 [42868415]
3.1e-01
6.9e-01
—
1.0e+50
—
2.0e+00
1.4e+00
cases:0.08%
controls:0.06%
cases:0.04%
controls:0.02%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.10%
controls:0.01%
cases:0.25%
controls:0.06%
13
95
17036
170393
6
30
17043
170490
—
72
0
16976
170520
—
15
21
14876
151160
26
62
10443
98713
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
1.9e-01
4.7e-01
1.6e+00
—
1.7e+00
6.5e-01
5.6e-01
cases:0.34%
controls:0.28%
cases:0.13%
controls:0.08%
cases:0.05%
controls:0.01%
—
—
cases:0.07%
controls:0.01%
cases:0.18%
controls:0.09%
cases:0.40%
controls:0.23%
58
481
16991
170007
23
144
17026
170376
8
16
17040
170504
—
12
21
16845
168773
27
143
14864
151038
42
227
10427
98548
Acute bronchitis, unspecified
J20.9 [45562445]
1.0e-01
5.4e-02
-6.4e-01
2.6e+00
-3.4e-01
3.8e-01
3.3e-01
cases:3.51%
controls:3.18%
cases:1.06%
controls:1.01%
cases:0.05%
controls:0.10%
cases:0.04%
controls:0.00%
cases:0.06%
controls:0.08%
cases:1.47%
controls:1.01%
cases:4.61%
controls:3.36%
598
5422
16451
165066
181
1716
16868
168804
9
170
17039
170350
7
5
17041
170515
10
141
16847
168653
219
1525
14672
149656
483
3314
9986
95461
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
5.4e-02
1.6e+00
—
1.0e+50
—
1.7e+00
8.4e-01
cases:0.12%
controls:0.12%
cases:0.08%
controls:0.02%
—
—
cases:0.03%
controls:0.00%
—
—
cases:0.09%
controls:0.02%
cases:0.16%
controls:0.07%
21
199
17028
170289
14
28
17035
170492
—
5
0
17043
170520
—
14
26
14877
151155
17
69
10452
98706
Polymyalgia rheumatica
M35.3 [45533830]
1.3e-01
3.0e-01
3.8e-01
2.4e+00
5.6e-01
4.7e-01
4.2e-01
cases:0.78%
controls:0.69%
cases:0.60%
controls:0.45%
cases:0.15%
controls:0.10%
cases:0.06%
controls:0.01%
cases:0.20%
controls:0.11%
cases:0.71%
controls:0.44%
cases:1.44%
controls:0.95%
133
1174
16916
169314
103
767
16946
169753
26
178
17022
170342
10
9
17038
170511
34
194
16823
168600
105
670
14786
150511
151
940
10318
97835
Trochanteric bursitis
M70.6 [45606304]
9.6e-02
1.3e-01
3.1e-01
2.7e+00
6.9e-02
3.0e-01
2.8e-01
cases:2.99%
controls:2.72%
cases:1.13%
controls:1.00%
cases:0.21%
controls:0.15%
cases:0.07%
controls:0.00%
cases:0.15%
controls:0.14%
cases:1.38%
controls:1.02%
cases:4.05%
controls:3.09%
509
4638
16540
165850
193
1702
16856
168818
35
256
17013
170264
12
8
17036
170512
26
243
16831
168551
205
1541
14686
149640
424
3051
10045
95724
Other specified disorders of external ear
H61.8 [45557489]
3.8e-01
1.7e-02
—
—
2.3e+00
5.6e-01
9.9e-01
cases:0.14%
controls:0.10%
cases:0.04%
controls:0.03%
—
—
—
—
cases:0.04%
controls:0.00%
cases:0.07%
controls:0.04%
cases:0.22%
controls:0.08%
24
164
17025
170324
6
59
17043
170461
—
—
6
6
16851
168788
10
58
14881
151123
23
81
10446
98694
Mononeuropathy, unspecified
G58.9 [45557250]
1.2e+00
2.1e+00
—
—
—
—
—
cases:0.07%
controls:0.02%
cases:0.04%
controls:0.01%
—
—
—
—
—
—
—
—
—
—
12
35
17037
170453
7
9
17042
170511
—
—
—
—
—
Headache
N01 [2002000720]
2.9e-02
3.8e-01
1.4e+00
—
1.2e+00
3.1e-01
2.6e-01
cases:1.82%
controls:1.77%
cases:0.79%
controls:0.54%
cases:0.19%
controls:0.05%
—
—
cases:0.20%
controls:0.06%
cases:0.69%
controls:0.51%
cases:2.26%
controls:1.76%
311
3023
16738
167465
134
919
16915
169601
33
82
17015
170438
—
34
98
16823
168696
103
770
14788
150411
237
1734
10232
97041
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
4.2e-01
5.0e-01
4.0e-01
8.8e-01
4.7e-01
6.3e-01
8.5e-01
cases:9.12%
controls:6.16%
cases:5.52%
controls:3.41%
cases:0.57%
controls:0.39%
cases:0.04%
controls:0.01%
cases:0.58%
controls:0.36%
cases:5.91%
controls:3.25%
cases:13.99%
controls:6.50%
1555
10498
15494
159990
941
5809
16108
164711
98
658
16950
169862
6
25
17042
170495
98
612
16759
168182
880
4917
14011
146264
1465
6423
9004
92352
Other local infections of skin and subcutaneous tissue
L08 [45596365]
4.2e-01
8.9e-01
2.4e+00
—
—
6.0e-01
5.3e-01
cases:0.33%
controls:0.22%
cases:0.16%
controls:0.07%
cases:0.08%
controls:0.01%
—
—
—
—
cases:0.11%
controls:0.06%
cases:0.36%
controls:0.21%
56
370
16993
170118
28
115
17021
170405
13
12
17035
170508
—
—
17
95
14874
151086
38
211
10431
98564
Disease/condition unspecnature/site
A99 [2002000232]
3.0e-02
9.1e-02
5.1e-01
3.3e+00
4.5e-01
1.6e-01
1.7e-01
cases:1.65%
controls:1.60%
cases:0.88%
controls:0.80%
cases:0.20%
controls:0.12%
cases:0.20%
controls:0.01%
cases:0.18%
controls:0.12%
cases:0.95%
controls:0.82%
cases:2.82%
controls:2.40%
281
2729
16768
167759
150
1371
16899
169149
34
205
17014
170315
34
13
17014
170507
31
199
16826
168595
142
1234
14749
149947
295
2370
10174
96405
Cerebrospinal fluid IgG ratio and IgG index
1324000 [4027681]
-1.6e-01
7.1e-01
3.3e+00
1.0e+50
—
9.5e-01
3.9e-01
cases:0.18%
controls:0.21%
cases:0.09%
controls:0.04%
cases:0.08%
controls:0.00%
cases:0.11%
controls:0.00%
—
—
cases:0.09%
controls:0.03%
cases:0.18%
controls:0.12%
31
365
17018
170123
15
74
17034
170446
13
5
17035
170515
19
0
17029
170520
—
13
51
14878
151130
19
121
10450
98654
Pain localized to upper abdomen
R10.1 [45568111]
1.1e-01
1.4e-01
1.4e-01
2.7e+00
4.6e-02
2.6e-01
2.8e-01
cases:3.86%
controls:3.48%
cases:1.25%
controls:1.08%
cases:0.14%
controls:0.12%
cases:0.05%
controls:0.00%
cases:0.14%
controls:0.13%
cases:1.42%
controls:1.10%
cases:4.58%
controls:3.50%
658
5929
16391
164559
213
1848
16836
168672
24
209
17024
170311
9
6
17039
170514
23
220
16834
168574
211
1665
14680
149516
479
3454
9990
95321
Gonarthrosis [arthrosis of knee]
M17 [45601350]
2.0e-01
1.8e-01
2.7e-01
2.2e+00
1.7e-01
4.5e-01
4.1e-01
cases:2.88%
controls:2.37%
cases:1.13%
controls:0.94%
cases:0.16%
controls:0.12%
cases:0.04%
controls:0.00%
cases:0.13%
controls:0.11%
cases:1.39%
controls:0.89%
cases:3.77%
controls:2.52%
491
4049
16558
166439
192
1600
16857
168920
27
207
17021
170313
7
8
17041
170512
22
185
16835
168609
207
1353
14684
149828
395
2493
10074
96282
Aldosterone [Moles/volume] in Serum or Plasma --upright
15012-8 [3003171]
-1.2e-01
1.6e+00
—
—
—
—
1.6e+00
cases:0.06%
controls:0.07%
cases:0.05%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.08%
controls:0.02%
11
124
17038
170364
8
16
17041
170504
—
—
—
—
8
15
10461
98760
Abdominal ultrasound examination
JN3AE [2001305555]
-3.5e-02
-8.4e-02
7.8e-01
2.9e+00
7.9e-01
2.0e-01
3.3e-01
cases:1.90%
controls:1.97%
cases:0.46%
controls:0.50%
cases:0.10%
controls:0.05%
cases:0.05%
controls:0.00%
cases:0.11%
controls:0.05%
cases:0.59%
controls:0.48%
cases:2.29%
controls:1.67%
324
3354
16725
167134
79
859
16970
169661
17
78
17031
170442
9
5
17039
170515
18
82
16839
168712
88
732
14803
150449
240
1646
10229
97129
hydroxyzine; oral, parenteral
N05BB01 [21604590]
-4.4e-02
7.3e-02
-5.6e-03
2.9e+00
2.3e-01
-1.6e-02
2.9e-01
cases:2.72%
controls:2.84%
cases:1.16%
controls:1.08%
cases:0.20%
controls:0.20%
cases:0.14%
controls:0.01%
cases:0.26%
controls:0.21%
cases:1.03%
controls:1.05%
cases:3.16%
controls:2.38%
464
4845
16585
165643
198
1842
16851
168678
34
342
17014
170178
24
13
17024
170507
44
350
16813
168444
154
1588
14737
149593
331
2355
10138
96420
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
-2.7e-01
4.7e-01
1.7e+00
—
1.5e+00
2.3e-01
3.0e-02
cases:0.45%
controls:0.59%
cases:0.23%
controls:0.14%
cases:0.06%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.16%
controls:0.13%
cases:0.50%
controls:0.48%
77
1006
16972
169482
39
243
17010
170277
10
18
17038
170502
—
10
23
16847
168771
24
193
14867
150988
52
476
10417
98299
Acute upper respiratory infection, unspecified
J06.9 [45562437]
2.1e-01
3.3e-01
1.9e-01
2.0e+00
1.2e-01
3.1e-01
3.6e-01
cases:16.72%
controls:14.05%
cases:8.58%
controls:6.32%
cases:0.88%
controls:0.73%
cases:0.22%
controls:0.03%
cases:0.81%
controls:0.71%
cases:8.34%
controls:6.28%
cases:20.47%
controls:15.25%
2850
23958
14199
146530
1462
10769
15587
159751
150
1238
16898
169282
37
51
17011
170469
136
1206
16721
167588
1242
9490
13649
141691
2143
15059
8326
83716
Radiculopathy
M54.1 [45577287]
2.5e-01
5.5e-01
1.4e+00
—
1.7e+00
4.5e-01
3.5e-01
cases:0.54%
controls:0.42%
cases:0.24%
controls:0.14%
cases:0.08%
controls:0.02%
—
—
cases:0.05%
controls:0.01%
cases:0.21%
controls:0.14%
cases:0.55%
controls:0.39%
92
715
16957
169773
41
237
17008
170283
13
31
17035
170489
—
8
14
16849
168780
32
207
14859
150974
58
387
10411
98388
Phadiatop IgE Ab [Units/volume] in Serum
7599-4 [3025443]
4.3e-01
1.4e+00
—
—
—
1.1e+00
1.7e+00
cases:0.25%
controls:0.16%
cases:0.08%
controls:0.02%
—
—
—
—
—
—
cases:0.05%
controls:0.02%
cases:0.28%
controls:0.05%
43
281
17006
170207
14
33
17035
170487
—
—
—
8
26
14883
151155
29
50
10440
98725
prednisolone
A07EA01 [21600653]
7.7e-02
1.2e-01
4.2e-01
1.8e+00
2.6e-01
1.9e-01
2.5e-01
cases:15.14%
controls:14.18%
cases:6.83%
controls:6.08%
cases:1.64%
controls:1.08%
cases:0.25%
controls:0.04%
cases:1.35%
controls:1.05%
cases:7.08%
controls:5.94%
cases:16.58%
controls:13.36%
2582
24174
14467
146314
1164
10367
15885
160153
279
1843
16769
168677
42
68
17006
170452
228
1771
16629
167023
1054
8985
13837
142196
1736
13200
8733
85575
prednisolone; oral, parenteral
H02AB06 [21602734]
7.8e-02
1.3e-01
4.2e-01
1.8e+00
2.6e-01
1.8e-01
2.5e-01
cases:15.08%
controls:14.11%
cases:6.80%
controls:6.05%
cases:1.63%
controls:1.08%
cases:0.25%
controls:0.04%
cases:1.35%
controls:1.05%
cases:7.02%
controls:5.92%
cases:16.46%
controls:13.28%
2571
24049
14478
146439
1160
10320
15889
160200
278
1836
16770
168684
42
68
17006
170452
228
1765
16629
167029
1046
8951
13845
142230
1723
13117
8746
85658
cetirizine; oral
R06AE07 [21603497]
9.9e-02
8.7e-02
1.8e-01
2.4e+00
3.8e-01
1.2e-01
2.5e-01
cases:9.98%
controls:9.13%
cases:4.96%
controls:4.57%
cases:1.06%
controls:0.88%
cases:0.42%
controls:0.04%
cases:1.16%
controls:0.80%
cases:5.10%
controls:4.55%
cases:10.28%
controls:8.17%
1702
15560
15347
154928
846
7785
16203
162735
180
1501
16868
169019
71
64
16977
170456
195
1344
16662
167450
760
6872
14131
144309
1076
8074
9393
90701
prednisone
A07EA03 [21600655]
4.3e-01
5.9e-01
3.6e-01
—
7.5e-01
6.8e-01
6.8e-01
cases:2.04%
controls:1.34%
cases:0.78%
controls:0.44%
cases:0.11%
controls:0.08%
—
—
cases:0.18%
controls:0.09%
cases:0.82%
controls:0.42%
cases:1.99%
controls:1.01%
348
2289
16701
168199
133
742
16916
169778
19
133
17029
170387
—
31
147
16826
168647
122
632
14769
150549
208
1000
10261
97775
prednisone; oral
H02AB07 [21602735]
4.3e-01
5.9e-01
3.6e-01
—
7.5e-01
6.8e-01
6.8e-01
cases:2.04%
controls:1.34%
cases:0.78%
controls:0.44%
cases:0.11%
controls:0.08%
—
—
cases:0.18%
controls:0.09%
cases:0.82%
controls:0.42%
cases:1.99%
controls:1.01%
348
2289
16701
168199
133
742
16916
169778
19
133
17029
170387
—
31
147
16826
168647
122
632
14769
150549
208
1000
10261
97775
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
8.1e-03
2.5e-01
1.1e+00
—
1.6e+00
3.3e-01
4.4e-01
cases:0.96%
controls:0.95%
cases:0.42%
controls:0.33%
cases:0.15%
controls:0.05%
—
—
cases:0.15%
controls:0.03%
cases:0.44%
controls:0.31%
cases:1.12%
controls:0.72%
163
1617
16886
168871
72
560
16977
169960
25
84
17023
170436
—
25
53
16832
168741
65
474
14826
150707
117
712
10352
98063
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-6.4e-03
-3.0e-02
2.1e-01
2.1e+00
3.6e-01
1.6e-01
2.5e-01
cases:23.88%
controls:23.99%
cases:12.85%
controls:13.19%
cases:3.74%
controls:3.05%
cases:1.04%
controls:0.13%
cases:4.16%
controls:2.94%
cases:14.51%
controls:12.59%
cases:29.79%
controls:24.83%
4071
40907
12978
129581
2190
22484
14859
148036
638
5206
16410
165314
177
220
16871
170300
702
4960
16155
163834
2161
19028
12730
132153
3119
24521
7350
74254
Titanium [Mass/volume] in Blood
59753-4 [40762814]
8.0e-01
1.2e+00
—
—
—
7.8e-01
1.1e+00
cases:0.18%
controls:0.08%
cases:0.08%
controls:0.03%
—
—
—
—
—
—
cases:0.06%
controls:0.03%
cases:0.24%
controls:0.08%
31
139
17018
170349
14
44
17035
170476
—
—
—
9
42
14882
151139
25
79
10444
98696
Standard cardiac ultrasound examination
FM1AE [2001303278]
3.1e-02
-1.8e-02
1.9e-01
2.7e+00
2.9e-01
2.4e-01
3.9e-01
cases:3.68%
controls:3.57%
cases:1.26%
controls:1.28%
cases:0.17%
controls:0.14%
cases:0.06%
controls:0.00%
cases:0.16%
controls:0.12%
cases:1.46%
controls:1.15%
cases:4.74%
controls:3.26%
627
6088
16422
164400
214
2178
16835
168342
29
239
17019
170281
10
7
17038
170513
27
203
16830
168591
217
1741
14674
149440
496
3217
9973
95558
Laboratory test
15220000 [4034850]
1.6e-01
6.9e-02
4.9e-01
2.2e+00
3.8e-01
1.9e-01
1.2e-02
cases:4.83%
controls:4.16%
cases:2.14%
controls:2.00%
cases:0.48%
controls:0.30%
cases:0.11%
controls:0.01%
cases:0.41%
controls:0.28%
cases:2.56%
controls:2.13%
cases:6.71%
controls:6.63%
823
7090
16226
163398
365
3411
16684
167109
82
505
16966
170015
19
21
17029
170499
69
472
16788
168322
381
3214
14510
147967
702
6549
9767
92226
other preparations, combinations; ointment
C05AX03 [21601631]
7.5e-02
6.6e-02
1.0e-01
3.0e+00
1.7e-01
3.1e-03
1.0e-01
cases:3.03%
controls:2.82%
cases:1.01%
controls:0.95%
cases:0.15%
controls:0.13%
cases:0.08%
controls:0.00%
cases:0.14%
controls:0.11%
cases:0.94%
controls:0.94%
cases:2.78%
controls:2.51%
517
4805
16532
165683
173
1621
16876
168899
25
226
17023
170294
14
7
17034
170513
23
194
16834
168600
140
1417
14751
149764
291
2480
10178
96295
Laboratory Visit
OMOP4822461 [32036]
2.0e-02
6.8e-02
2.1e-01
2.3e+00
2.1e-01
1.0e-01
1.4e-01
cases:72.62%
controls:72.23%
cases:65.43%
controls:63.88%
cases:22.67%
controls:19.21%
cases:9.30%
controls:1.06%
cases:22.33%
controls:18.87%
cases:66.12%
controls:63.76%
cases:85.13%
controls:83.26%
12381
123144
4668
47344
11155
108924
5894
61596
3865
32759
13183
137761
1585
1801
15463
168719
3765
31857
13092
136937
9846
96391
5045
54790
8912
82237
1557
16538
dexrabeprazole
A02BC07 [45893509]
2.3e-01
2.0e-01
5.7e-02
2.4e+00
-2.8e-01
1.6e-01
3.4e-01
cases:1.94%
controls:1.54%
cases:0.90%
controls:0.74%
cases:0.17%
controls:0.16%
cases:0.05%
controls:0.00%
cases:0.12%
controls:0.16%
cases:0.84%
controls:0.72%
cases:1.91%
controls:1.37%
331
2631
16718
167857
153
1259
16896
169261
29
274
17019
170246
9
8
17039
170512
21
278
16836
168516
125
1088
14766
150093
200
1351
10269
97424
rabeprazole; oral
A02BC04 [21600099]
2.3e-01
2.0e-01
5.7e-02
2.4e+00
-2.8e-01
1.6e-01
3.4e-01
cases:1.94%
controls:1.54%
cases:0.90%
controls:0.74%
cases:0.17%
controls:0.16%
cases:0.05%
controls:0.00%
cases:0.12%
controls:0.16%
cases:0.84%
controls:0.72%
cases:1.91%
controls:1.37%
331
2631
16718
167857
153
1259
16896
169261
29
274
17019
170246
9
8
17039
170512
21
278
16836
168516
125
1088
14766
150093
200
1351
10269
97424
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 [3019539]
-1.5e-02
2.9e-01
1.4e+00
1.0e+50
1.8e+00
6.7e-01
5.4e-01
cases:0.42%
controls:0.42%
cases:0.18%
controls:0.13%
cases:0.05%
controls:0.01%
cases:0.03%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.21%
controls:0.11%
cases:0.52%
controls:0.30%
71
721
16978
169767
30
224
17019
170296
9
22
17039
170498
5
0
17043
170520
13
22
16844
168772
32
166
14859
151015
54
297
10415
98478
cefuroxime; oral, parenteral
J01DC02 [21602884]
2.4e-01
2.6e-01
—
1.0e+50
2.4e+00
3.1e-01
5.6e-01
cases:0.65%
controls:0.51%
cases:0.11%
controls:0.09%
—
—
cases:0.05%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.11%
controls:0.08%
cases:0.50%
controls:0.28%
111
874
16938
169614
19
146
17030
170374
—
8
0
17040
170520
17
15
16840
168779
17
126
14874
151055
52
281
10417
98494
Asthma
J45 [45596282]
1.5e-01
3.4e-01
7.8e-02
1.9e+00
-9.8e-02
3.0e-01
2.7e-01
cases:3.85%
controls:3.34%
cases:1.69%
controls:1.21%
cases:0.14%
controls:0.13%
cases:0.05%
controls:0.01%
cases:0.13%
controls:0.14%
cases:1.50%
controls:1.11%
cases:3.92%
controls:3.02%
657
5700
16392
164788
288
2069
16761
168451
24
222
17024
170298
9
13
17039
170507
22
243
16835
168551
223
1683
14668
149498
410
2981
10059
95794
Dentistry
C5 [903277]
1.0e-01
-1.6e-01
-2.6e-02
2.8e+00
2.4e-01
3.0e-02
2.1e-01
cases:2.93%
controls:2.65%
cases:0.82%
controls:0.96%
cases:0.13%
controls:0.14%
cases:0.09%
controls:0.01%
cases:0.18%
controls:0.15%
cases:0.87%
controls:0.84%
cases:2.93%
controls:2.39%
500
4520
16549
165968
139
1632
16910
168888
23
236
17025
170284
16
10
17032
170510
31
245
16826
168549
129
1271
14762
149910
307
2357
10162
96418
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
-2.8e-01
5.0e-01
1.6e+00
—
1.4e+00
2.3e-01
4.7e-02
cases:0.44%
controls:0.58%
cases:0.23%
controls:0.14%
cases:0.05%
controls:0.01%
—
—
cases:0.06%
controls:0.01%
cases:0.16%
controls:0.13%
cases:0.51%
controls:0.48%
75
992
16974
169496
40
242
17009
170278
9
19
17039
170501
—
10
24
16847
168770
24
194
14867
150987
53
477
10416
98298
tadalafil; oral
G04BE08 [21602653]
2.4e-01
3.3e-01
2.2e-01
2.1e+00
2.0e-01
2.1e-01
3.2e-01
cases:2.01%
controls:1.59%
cases:1.50%
controls:1.08%
cases:0.33%
controls:0.27%
cases:0.10%
controls:0.01%
cases:0.33%
controls:0.27%
cases:1.34%
controls:1.09%
cases:2.60%
controls:1.90%
343
2703
16706
167785
255
1841
16794
168679
57
457
16991
170063
17
21
17031
170499
55
452
16802
168342
200
1644
14691
149537
272
1878
10197
96897
alfuzosin; oral
G04CA01 [21602668]
2.6e-01
1.9e-01
-2.6e-02
2.1e+00
1.6e-01
3.1e-01
3.6e-01
cases:2.62%
controls:2.03%
cases:1.60%
controls:1.32%
cases:0.35%
controls:0.36%
cases:0.08%
controls:0.01%
cases:0.43%
controls:0.37%
cases:1.76%
controls:1.30%
cases:3.03%
controls:2.13%
446
3462
16603
167026
273
2258
16776
168262
60
616
16988
169904
14
18
17034
170502
73
624
16784
168170
262
1966
14629
149215
317
2102
10152
96673
Urticaria, unspecified
L50.9 [45562541]
2.0e-01
3.0e-01
1.1e+00
—
2.3e+00
3.2e-01
6.3e-01
cases:0.52%
controls:0.43%
cases:0.18%
controls:0.13%
cases:0.06%
controls:0.02%
—
—
cases:0.15%
controls:0.01%
cases:0.19%
controls:0.14%
cases:0.84%
controls:0.45%
89
727
16960
169761
30
223
17019
170297
11
35
17037
170485
—
26
25
16831
168769
29
213
14862
150968
88
445
10381
98330
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
7.5e-02
5.1e-01
7.3e-01
—
1.2e+00
6.7e-01
5.6e-01
cases:0.84%
controls:0.78%
cases:0.42%
controls:0.25%
cases:0.07%
controls:0.03%
—
—
cases:0.10%
controls:0.03%
cases:0.54%
controls:0.28%
cases:1.42%
controls:0.81%
144
1337
16905
169151
71
429
16978
170091
12
58
17036
170462
—
17
50
16840
168744
80
416
14811
150765
149
805
10320
97970
naproxen and esomeprazole; oral
M01AE52 [40254096]
1.7e-01
1.9e-01
4.3e-02
2.2e+00
-3.6e-01
2.8e-01
3.5e-01
cases:3.89%
controls:3.32%
cases:1.21%
controls:1.00%
cases:0.14%
controls:0.13%
cases:0.04%
controls:0.00%
cases:0.09%
controls:0.14%
cases:1.28%
controls:0.97%
cases:3.98%
controls:2.84%
664
5652
16385
164836
206
1708
16843
168812
24
230
17024
170290
7
8
17041
170512
16
229
16841
168565
190
1466
14701
149715
417
2808
10052
95967
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
4.2e-02
2.6e-01
1.5e+00
—
1.0e+00
3.7e-01
4.8e-01
cases:1.40%
controls:1.34%
cases:0.46%
controls:0.36%
cases:0.16%
controls:0.04%
—
—
cases:0.11%
controls:0.04%
cases:0.48%
controls:0.34%
cases:1.57%
controls:0.97%
238
2284
16811
168204
79
608
16970
169912
28
65
17020
170455
—
18
66
16839
168728
72
508
14819
150673
164
961
10305
97814
Tension-type headache
G44.2 [45581495]
1.6e-01
4.9e-01
8.3e-01
—
8.5e-01
4.7e-01
2.9e-01
cases:2.53%
controls:2.17%
cases:1.04%
controls:0.64%
cases:0.17%
controls:0.07%
—
—
cases:0.17%
controls:0.07%
cases:0.97%
controls:0.61%
cases:2.63%
controls:1.99%
432
3702
16617
166786
178
1093
16871
169427
29
127
17019
170393
—
29
124
16828
168670
145
923
14746
150258
275
1961
10194
96814
Foot/toe symptom/complaint
L17 [2002000641]
7.9e-02
1.5e-01
3.3e-01
2.7e+00
-3.7e-02
1.1e-01
2.0e-01
cases:7.48%
controls:6.95%
cases:3.26%
controls:2.82%
cases:0.52%
controls:0.37%
cases:0.26%
controls:0.02%
cases:0.35%
controls:0.36%
cases:3.14%
controls:2.81%
cases:10.77%
controls:8.95%
1276
11857
15773
158631
555
4816
16494
165704
88
636
16960
169884
44
29
17004
170491
59
613
16798
168181
468
4252
14423
146929
1127
8845
9342
89930
Skin infection other
S76 [2002001040]
-3.3e-02
2.6e-01
1.5e+00
—
1.4e+00
-3.8e-02
8.6e-02
cases:0.72%
controls:0.75%
cases:0.28%
controls:0.22%
cases:0.18%
controls:0.04%
—
—
cases:0.12%
controls:0.03%
cases:0.24%
controls:0.24%
cases:0.88%
controls:0.81%
123
1271
16926
169217
48
369
17001
170151
31
70
17017
170450
—
21
51
16836
168743
35
369
14856
150812
92
797
10377
97978
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
5.2e-02
1.4e-01
7.4e-01
2.0e+00
4.1e-01
7.7e-02
1.7e-01
cases:7.74%
controls:7.37%
cases:2.56%
controls:2.23%
cases:0.46%
controls:0.22%
cases:0.08%
controls:0.01%
cases:0.32%
controls:0.21%
cases:2.30%
controls:2.14%
cases:8.29%
controls:7.12%
1319
12569
15730
157919
436
3804
16613
166716
78
372
16970
170148
14
19
17034
170501
54
361
16803
168433
343
3229
14548
147952
868
7028
9601
91747
Predominantly allergic asthma
J45.0 [45557624]
1.4e-01
2.9e-02
2.2e-01
2.9e+00
-3.0e-01
1.2e-01
2.1e-01
cases:1.56%
controls:1.36%
cases:0.63%
controls:0.62%
cases:0.16%
controls:0.13%
cases:0.05%
controls:0.00%
cases:0.09%
controls:0.13%
cases:0.66%
controls:0.59%
cases:1.53%
controls:1.25%
266
2311
16783
168177
108
1049
16941
169471
27
217
17021
170303
9
5
17039
170515
16
217
16841
168577
98
887
14793
150294
160
1233
10309
97542
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
2.4e-01
4.3e-01
5.0e-01
2.5e+00
4.1e-01
3.6e-01
3.8e-01
cases:0.61%
controls:0.48%
cases:0.48%
controls:0.31%
cases:0.12%
controls:0.07%
cases:0.04%
controls:0.00%
cases:0.11%
controls:0.07%
cases:0.44%
controls:0.31%
cases:0.62%
controls:0.43%
104
823
16945
169665
82
534
16967
169986
21
127
17027
170393
7
6
17041
170514
18
120
16839
168674
65
463
14826
150718
65
422
10404
98353
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
1.1e-01
4.6e-01
8.4e-01
—
1.1e+00
7.7e-01
5.5e-01
cases:0.94%
controls:0.84%
cases:0.40%
controls:0.26%
cases:0.08%
controls:0.03%
—
—
cases:0.09%
controls:0.03%
cases:0.58%
controls:0.27%
cases:1.40%
controls:0.81%
160
1434
16889
169054
69
436
16980
170084
13
56
17035
170464
—
15
50
16842
168744
87
409
14804
150772
147
804
10322
97971
Polyarthrosis, unspecified
M15.9 [45543481]
7.7e-02
-4.6e-02
8.6e-03
2.5e+00
7.6e-01
3.9e-01
1.7e-01
cases:1.11%
controls:1.03%
cases:0.42%
controls:0.44%
cases:0.07%
controls:0.07%
cases:0.08%
controls:0.01%
cases:0.14%
controls:0.06%
cases:0.67%
controls:0.45%
cases:1.61%
controls:1.37%
189
1751
16860
168737
72
754
16977
169766
12
119
17036
170401
13
11
17035
170509
23
108
16834
168686
100
686
14791
150495
169
1351
10300
97424
Ankle symptom/complaint
L16 [2002000640]
-1.0e-01
1.0e-01
3.6e-01
2.6e+00
-1.6e-01
2.2e-01
2.7e-01
cases:1.87%
controls:2.06%
cases:0.77%
controls:0.70%
cases:0.13%
controls:0.09%
cases:0.05%
controls:0.00%
cases:0.08%
controls:0.09%
cases:0.85%
controls:0.69%
cases:3.00%
controls:2.31%
319
3519
16730
166969
132
1191
16917
169329
23
160
17025
170360
8
6
17040
170514
13
153
16844
168641
127
1037
14764
150144
314
2281
10155
96494
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
303 [2001600260]
6.3e-03
—
—
—
—
1.6e+00
1.2e+00
cases:0.09%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.07%
controls:0.01%
cases:0.12%
controls:0.04%
16
159
17033
170329
—
—
—
—
11
22
14880
151159
13
36
10456
98739
Nuclear Ab [Presence] in Serum
8061-4 [3004616]
3.1e-01
1.0e+00
1.2e+00
—
1.3e+00
1.1e+00
7.5e-01
cases:0.60%
controls:0.44%
cases:0.31%
controls:0.11%
cases:0.05%
controls:0.01%
—
—
cases:0.05%
controls:0.01%
cases:0.34%
controls:0.12%
cases:0.74%
controls:0.35%
103
753
16946
169735
53
196
16996
170324
8
23
17040
170497
—
8
21
16849
168773
51
175
14840
151006
77
343
10392
98432
Cellulitis of other parts of limb
L03.1 [45586760]
-6.0e-02
6.0e-01
2.4e+00
—
1.1e+00
2.6e-01
4.5e-01
cases:0.31%
controls:0.32%
cases:0.21%
controls:0.12%
cases:0.16%
controls:0.02%
—
—
cases:0.04%
controls:0.01%
cases:0.15%
controls:0.11%
cases:0.63%
controls:0.40%
52
552
16997
169936
36
197
17013
170323
28
26
17020
170494
—
7
23
16850
168771
22
172
14869
151009
66
397
10403
98378
Other reactive arthropathies
M02.8 [45596422]
4.8e-01
7.3e-01
—
—
2.0e+00
1.6e+00
1.2e+00
cases:0.06%
controls:0.04%
cases:0.04%
controls:0.02%
—
—
—
—
cases:0.03%
controls:0.00%
cases:0.09%
controls:0.02%
cases:0.13%
controls:0.04%
10
62
17039
170426
6
29
17043
170491
—
—
5
7
16852
168787
13
26
14878
151155
14
40
10455
98735
Fibromyalgia
M79.7 [45553272]
-6.7e-02
2.4e-02
8.6e-03
2.4e+00
4.4e-01
1.4e-01
3.9e-01
cases:0.70%
controls:0.75%
cases:0.38%
controls:0.37%
cases:0.07%
controls:0.07%
cases:0.05%
controls:0.00%
cases:0.11%
controls:0.07%
cases:0.44%
controls:0.38%
cases:1.11%
controls:0.75%
120
1283
16929
169205
65
635
16984
169885
12
119
17036
170401
9
8
17039
170512
19
122
16838
168672
65
575
14826
150606
116
744
10353
98031
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
2.0e-01
2.1e-01
1.3e-01
1.8e+00
1.1e-01
2.2e-01
2.2e-01
cases:25.59%
controls:21.92%
cases:19.26%
controls:16.18%
cases:4.66%
controls:4.11%
cases:0.94%
controls:0.15%
cases:4.58%
controls:4.13%
cases:19.64%
controls:16.44%
cases:27.28%
controls:23.12%
4362
37364
12687
133124
3284
27584
13765
142936
795
7012
16253
163508
160
260
16888
170260
772
6973
16085
161821
2925
24847
11966
126334
2856
22833
7613
75942
Health maint/preventive medicine
A98 [2002000231]
1.9e-01
2.9e-01
8.0e-02
1.4e+00
1.6e-01
3.7e-01
3.6e-01
cases:68.39%
controls:64.19%
cases:54.44%
controls:47.21%
cases:8.51%
controls:7.91%
cases:1.75%
controls:0.42%
cases:9.28%
controls:8.00%
cases:56.40%
controls:47.13%
cases:78.78%
controls:72.19%
11659
109440
5390
61048
9282
80505
7767
90015
1451
13485
15597
157035
299
718
16749
169802
1564
13511
15293
155283
8399
71250
6492
79931
8248
71309
2221
27466
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
-1.8e-01
-2.5e-01
-3.4e-01
3.7e+00
-2.2e-01
-2.1e-01
-2.7e-01
cases:6.38%
controls:7.53%
cases:1.81%
controls:2.33%
cases:0.38%
controls:0.54%
cases:1.14%
controls:0.03%
cases:0.41%
controls:0.51%
cases:1.86%
controls:2.29%
cases:4.76%
controls:6.16%
1088
12845
15961
157643
309
3966
16740
166554
65
915
16983
169605
194
48
16854
170472
69
862
16788
167932
277
3461
14614
147720
498
6088
9971
92687
Arthritis, unspecified
M13.9 [45567463]
-7.3e-02
2.8e-01
1.0e+00
—
8.2e-01
5.8e-01
3.4e-01
cases:1.12%
controls:1.20%
cases:0.66%
controls:0.50%
cases:0.24%
controls:0.08%
—
—
cases:0.18%
controls:0.08%
cases:0.81%
controls:0.45%
cases:1.54%
controls:1.10%
191
2052
16858
168436
112
847
16937
169673
41
144
17007
170376
—
31
137
16826
168657
120
686
14771
150495
161
1082
10308
97693
cefalexin; oral
J01DB01 [21602870]
9.7e-02
1.5e-01
6.5e-01
1.7e+00
-3.0e-01
9.2e-02
2.1e-01
cases:31.20%
controls:29.15%
cases:9.94%
controls:8.67%
cases:1.84%
controls:0.97%
cases:0.17%
controls:0.03%
cases:0.66%
controls:0.89%
cases:9.21%
controls:8.47%
cases:28.61%
controls:24.48%
5319
49705
11730
120783
1695
14790
15354
155730
314
1661
16734
168859
29
55
17019
170465
111
1502
16746
167292
1371
12805
13520
138376
2995
24183
7474
74592
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
8.0e-02
1.5e-01
3.8e-01
2.1e+00
3.4e-01
3.1e-01
3.2e-01
cases:7.24%
controls:6.72%
cases:2.23%
controls:1.92%
cases:0.31%
controls:0.21%
cases:0.06%
controls:0.01%
cases:0.25%
controls:0.18%
cases:2.40%
controls:1.77%
cases:8.24%
controls:6.12%
1234
11458
15815
159030
381
3281
16668
167239
52
356
16996
170164
11
13
17037
170507
42
299
16815
168495
358
2683
14533
148498
863
6046
9606
92729
etoricoxib; oral
M01AH05 [21603996]
1.3e-01
1.8e-01
1.8e-01
2.0e+00
7.8e-02
1.8e-01
2.5e-01
cases:24.06%
controls:21.72%
cases:10.22%
controls:8.64%
cases:1.48%
controls:1.24%
cases:0.30%
controls:0.04%
cases:1.35%
controls:1.25%
cases:9.98%
controls:8.46%
cases:23.86%
controls:19.67%
4102
37029
12947
133459
1742
14735
15307
155785
253
2118
16795
168402
51
68
16997
170452
227
2104
16630
166690
1486
12788
13405
138393
2498
19431
7971
79344
Foot and toes X-ray examination
NH3AA [2001308267]
9.5e-02
2.1e-01
1.3e-02
2.3e+00
3.9e-01
3.2e-01
4.6e-01
cases:1.55%
controls:1.41%
cases:0.49%
controls:0.40%
cases:0.05%
controls:0.05%
cases:0.04%
controls:0.00%
cases:0.05%
controls:0.04%
cases:0.52%
controls:0.38%
cases:1.96%
controls:1.25%
264
2403
16785
168085
84
684
16965
169836
8
79
17040
170441
6
6
17042
170514
9
61
16848
168733
78
576
14813
150605
205
1230
10264
97545
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
5.5e-02
1.0e-01
4.6e-01
2.1e+00
-7.9e-02
3.4e-01
2.7e-01
cases:2.22%
controls:2.10%
cases:0.77%
controls:0.70%
cases:0.18%
controls:0.11%
cases:0.04%
controls:0.00%
cases:0.11%
controls:0.12%
cases:0.91%
controls:0.65%
cases:2.28%
controls:1.75%
378
3581
16671
166907
132
1192
16917
169328
30
189
17018
170331
6
7
17042
170513
18
195
16839
168599
136
989
14755
150192
239
1732
10230
97043
chloramphenicol
S03AA08 [21605197]
2.1e-01
2.1e-01
2.3e-01
2.1e+00
-3.0e-01
1.3e-01
2.4e-01
cases:14.99%
controls:12.51%
cases:5.07%
controls:4.14%
cases:0.56%
controls:0.45%
cases:0.12%
controls:0.01%
cases:0.34%
controls:0.46%
cases:4.76%
controls:4.22%
cases:16.52%
controls:13.42%
2556
21336
14493
149152
865
7066
16184
163454
96
761
16952
169759
20
25
17028
170495
57
773
16800
168021
709
6380
14182
144801
1730
13256
8739
85519
chloramphenicol
S01AA01 [21603554]
2.1e-01
2.1e-01
2.3e-01
2.1e+00
-3.0e-01
1.3e-01
2.4e-01
cases:14.99%
controls:12.51%
cases:5.07%
controls:4.14%
cases:0.56%
controls:0.45%
cases:0.12%
controls:0.01%
cases:0.34%
controls:0.46%
cases:4.76%
controls:4.22%
cases:16.52%
controls:13.42%
2556
21336
14493
149152
865
7066
16184
163454
96
761
16952
169759
20
25
17028
170495
57
773
16800
168021
709
6380
14182
144801
1730
13256
8739
85519

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
3967
9812
4.96
307.65
1.7
1.2
62.66
43.75
au/ml
8.34
787
413
4417
10536
5.30
307.65
3.2
2.3
29.11
18.90
au/ml
13.68
971
981
419
545
7.86
301.58
1.1
1.1
986.20
307.72
ng/l
1.16
126
140
3111
18685
1.81
175.35
5.1
5.0
32.97
32.36
%
2.12
1812
12740
548
1613
3.48
153.09
1.1
1.1
31.99
4.70
au/ml
—
16
6
464
12858
0.34
119.78
4.1
4.1
—
—
—
0
0
861
4063
2.18
94.82
1.2
1.4
569.15
530.66
mg/l
1.37
837
3880
581
12976
0.43
89.91
2.7
3.9
1.23
1.23
mmol/l
1.23
517
11219
2255
14861
1.60
83.78
3.6
4.3
7.37
7.36
ph
0.58
1377
10781
755
3590
2.15
81.38
1.2
1.3
3.52
3.76
mmol/l
11.11
711
3404
16887
163836
3.40
78.16
22.2
24.8
136.40
135.28
g/l
25.61
16708
162400
16879
163748
3.32
77.46
22.0
24.7
248.62
254.24
e9/l
28.52
16514
160686
16882
163808
3.34
77.17
22.0
24.6
4.52
4.49
e12/l
9.46
16426
160250
16880
163789
3.32
76.93
21.9
24.5
30.39
30.31
pg
9.50
16699
162328
16880
163794
3.31
76.83
22.0
24.6
91.19
91.07
fl
3.29
16697
162335
16880
163802
3.31
76.66
22.4
25.1
41.00
40.87
%
0.18
16695
162286
16880
163828
3.30
76.13
22.0
24.7
6.36
6.69
e9/l
52.46
16464
160221
16522
159324
2.08
66.76
12.3
12.6
25.68
26.37
u/l
5.87
15999
155275
333
1238
2.72
62.00
1.2
1.2
53.61
39.78
mg/l
2.99
317
1029
878
15145
0.56
61.23
4.3
4.5
0.88
0.95
%
0.26
292
4536
390
1592
2.48
60.02
1.3
1.6
—
—
—
0
0
322
1207
2.70
59.01
1.1
1.1
318.99
255.71
mg/l
4.16
308
1057
847
14500
0.56
57.22
4.3
4.6
0.09
0.12
%
0.47
263
3907
15923
152492
1.64
56.97
6.0
5.9
2.79
2.74
mmol/l
11.52
14722
142994
849
14456
0.57
56.17
4.2
4.4
0.70
0.72
%
0.10
309
4323
866
14658
0.57
56.05
4.5
4.8
0.05
0.36
%
4.60
252
3735
160
5177
0.30
54.71
3.0
3.6
7.41
7.41
ph
0.08
160
5117
15680
149820
1.56
54.27
5.3
5.1
1.53
1.48
mmol/l
49.26
14490
140218
16527
160137
1.95
54.14
18.3
20.8
74.05
75.81
umol/l
20.42
16292
158568
4817
39115
1.32
54.10
2.2
2.4
—
—
—
0
0
142
4859
0.29
53.88
3.3
5.9
1.23
1.30
mmol/l
0.62
131
4296
3626
45580
0.74
53.14
2.7
3.4
0.93
0.24
estimate
0.71
691
14159
15739
150633
1.56
52.64
5.2
5.2
4.76
4.68
mmol/l
20.54
14617
141766
3738
46724
0.74
52.57
3.8
4.2
0.00
0.00
estimate
4.59
838
16454
313
7218
0.42
51.34
3.2
5.1
1.47
1.63
%
2.42
302
6834
268
6574
0.40
51.08
3.5
5.4
0.84
0.88
%
0.68
260
6209
2484
32892
0.71
50.22
1.5
1.7
28571871.47
32863076.26
pmol/l
0.16
2051
27548
309
1241
2.52
49.28
1.2
1.3
1.92
2.14
mmol/l
3.46
281
1159
3556
27967
1.34
48.91
2.9
3.0
0.83
1.23
e6/l
2.86
1812
14797
4691
38551
1.30
46.76
3.5
3.8
0.29
0.31
—
7
360
530
9815
0.53
46.43
6.6
7.2
24.72
24.59
mmol/l
0.51
521
9398
12549
116400
1.29
45.41
4.7
4.5
10.09
11.97
mm/h
60.14
11686
109474
4923
40873
1.29
44.96
3.6
4.2
92.41
91.11
%
3.53
4820
39954
3194
24999
1.34
44.83
3.5
3.2
0.72
0.76
ug/l
1.42
2049
16330
14998
142936
1.40
43.63
4.4
4.4
1.22
1.30
mmol/l
39.19
13679
132551
289
1214
2.40
41.88
3.0
2.7
24.87
27.83
mg/l
0.72
207
880
85
3338
0.25
41.05
3.4
3.9
8.82
8.70
kpa
0.31
85
3269
87
3349
0.26
40.61
3.9
7.0
104.93
105.10
mmol/l
0.19
80
3012
87
3348
0.26
40.59
3.9
7.0
11.25
11.19
mmol/l
0.07
80
3010
85
3315
0.25
40.57
3.4
3.9
5.03
5.00
kpa
0.15
85
3247
85
3313
0.25
40.53
3.3
3.9
1.92
2.48
mmol/l
2.17
62
2262
384
1841
2.11
40.48
1.8
2.1
20.56
25.70
mg/l
1.16
93
722
1131
7469
1.55
40.15
1.2
1.2
—
—
—
0
0
15005
143396
1.38
39.52
5.9
6.4
37.85
39.16
mmol/mol
103.16
13801
135009
635
3641
1.77
39.20
1.3
1.5
254.86
2609.96
e6/l
1.56
461
2870
15658
150812
1.45
38.78
14.1
16.2
22.41
23.66
mg/l
4.64
12444
124354
3570
28888
1.30
38.67
1.4
1.3
11.57
11.80
u/ml
0.06
1180
11407
5335
45490
1.25
37.32
2.8
2.9
0.00
0.07
8.28
38
983
2233
17043
1.36
36.21
2.0
2.0
3.36
3.47
ratio
3.56
1739
13142
3798
31253
1.28
35.59
1.4
1.3
34.24
33.28
iu/ml
0.11
1055
9594
5522
63543
0.81
35.57
3.3
3.9
2.18
0.45
estimate
0.78
697
14491
615
3593
1.74
35.56
1.3
1.4
36.54
39.25
e6/l
0.09
424
2646
180
651
2.78
35.52
4.1
3.1
—
—
—
0
0
706
4286
1.68
35.45
1.2
1.2
3.92
3.82
0.10
80
591
7812
69661
1.22
35.24
2.2
2.1
100.92
97.19
pmol/l
8.36
3755
36839
120
3591
0.33
35.17
3.1
3.8
—
—
—
0
0
2958
23773
1.30
33.05
1.4
1.4
482.09
525.27
titre
0.67
632
5112
3133
25481
1.28
31.73
3.0
3.1
2.33
2.87
e6/l
2.00
1379
12265
14837
142344
1.32
31.58
5.7
5.6
1.89
1.89
mu/l
0.22
13534
132767
184
716
2.59
31.50
4.0
3.0
—
—
—
0
0
3932
32968
1.25
30.65
1.5
1.5
2.31
2.41
g/l
2.34
2136
20497
79
186
4.26
30.56
1.2
1.3
78.51
50.99
%
6.09
43
80
756
4853
1.58
30.29
1.3
1.3
3.31
8.09
u/ml
5.36
87
720
756
4859
1.58
30.13
1.3
1.3
2.16
5.90
u/ml
2.00
51
474
1673
12581
1.37
29.46
1.7
1.7
3.49
3.49
mmol/l
0.03
1169
8634
393
2153
1.84
28.28
1.4
1.3
—
—
—
0
0
53
95
5.59
28.24
1.1
1.2
7.33
26.05
%
1.79
21
20
15149
146127
1.32
28.18
5.3
5.2
5.75
5.92
mmol/l
84.81
13802
135490
791
5226
1.54
27.89
1.3
1.3
38.72
39.89
u/ml
0.03
33
284
8319
75655
1.19
27.62
6.7
6.7
55.64
57.09
%
26.61
7790
72459
110
3035
0.36
27.28
3.7
3.4
3.74
4.05
e9/l
1.21
110
3030
1742
13344
1.34
27.07
1.2
1.2
—
—
—
0
0
2448
30080
0.78
26.40
2.5
3.0
548.55
526.87
mosm/kgh2o
5.16
2027
26448
640
4112
1.58
25.55
1.2
1.3
1.16
4.23
u/ml
2.92
32
271
1005
7096
1.44
25.48
1.7
1.8
8.43
7.17
iu/ml
0.50
203
1716
658
4280
1.56
24.90
1.3
1.3
14.26
14.23
u/ml
—
5
45
325
1763
1.86
24.20
1.2
1.2
30.94
46.24
u/ml
0.35
12
100
4684
53329
0.83
23.86
3.7
4.2
6.13
8.40
mg/mmol
1.51
2589
32682
11314
106380
1.19
23.58
4.5
4.6
1.68
2.39
0.90
24
163
1964
15579
1.29
23.56
2.3
2.6
37.23
49.45
u/l
1.36
1667
13232
2623
21590
1.25
23.21
2.3
2.4
110.69
133.22
ug/g
2.98
2005
17219
427
6936
0.61
22.83
2.6
3.5
25.30
25.29
mmol/l
0.05
421
6713
15812
154065
1.35
22.66
15.9
18.9
3.95
3.96
mmol/l
7.54
15428
151086
9826
91446
1.18
22.62
9.1
10.2
3.73
4.09
e9/l
44.10
8303
79527
5780
51525
1.18
22.51
2.2
2.5
—
—
—
0
0
453
2760
1.66
22.51
1.1
1.1
18.03
14.32
au/ml
0.35
106
669
15782
153746
1.34
22.50
15.7
18.7
139.92
139.71
mmol/l
24.65
15436
151009
8895
82155
1.17
22.40
6.7
6.6
0.04
0.04
e9/l
1.65
7452
70794
8041
73690
1.17
22.27
2.4
2.5
79.28
1294.78
nmol/l
0.50
7081
67366
402
2380
1.71
22.26
1.2
1.2
2.59
12.82
u/ml
3.14
14
103
9135
84600
1.17
22.09
6.8
6.8
0.19
0.19
e9/l
3.13
7818
74094
8867
81937
1.17
22.01
6.7
6.6
0.55
0.58
e9/l
40.17
7435
70627
8187
75195
1.17
21.89
6.8
6.8
2.92
2.85
%
2.25
7588
70684
8205
75390
1.17
21.79
6.9
6.9
8.83
8.79
%
0.69
7612
70933
11263
106155
1.18
21.67
3.3
3.4
40.72
47.88
u/l
19.19
10528
100126
264
1389
1.91
21.65
1.2
1.2
—
—
—
0
0
77
2228
0.34
21.21
2.2
2.1
0.94
0.92
%
0.14
53
1489
247
1286
1.93
20.92
1.2
1.2
—
—
—
0
0
9019
83673
1.16
20.65
6.7
6.6
1.93
1.93
e9/l
0.03
7745
73831
8167
75197
1.16
20.64
6.9
6.9
0.73
0.69
%
8.76
7565
70645
55
1861
0.29
20.59
1.8
1.8
91.18
89.91
%
0.89
55
1834
1473
18650
0.77
19.58
7.0
8.0
13.51
12.55
kpa
7.60
1436
17994
1460
18503
0.77
19.55
7.0
8.0
0.49
0.94
mmol/l
5.62
1286
15402
2320
19173
1.24
19.51
1.4
1.4
—
—
—
0
0
1475
18657
0.77
19.45
7.0
8.1
5.09
5.10
kpa
0.13
1436
18008
75
2103
0.35
19.38
2.3
2.1
33.33
32.63
pg
1.01
75
2088
1476
18656
0.77
19.35
7.0
8.1
7.43
7.42
ph
3.00
591
10151
8336
77106
1.16
19.24
6.7
6.8
29.53
28.07
%
30.47
7841
73251
667
4600
1.47
19.14
1.5
1.5
23.97
16.25
iu/ml
0.44
19
103
888
12024
0.72
18.85
2.2
2.9
136.51
174.30
ng/l
4.70
802
10991
1207
15595
0.76
18.64
7.9
8.9
122.69
121.08
g/l
2.31
1199
15237
1301
16615
0.77
18.41
7.4
8.4
95.87
95.69
%
0.40
1285
16059
4739
42095
1.17
18.32
6.1
5.5
2.30
3.04
ug/l
3.30
4245
38336
1586
12635
1.28
18.17
2.4
2.6
6.00
6.06
ph
2.02
877
8444
288
1662
1.75
17.59
1.2
1.1
—
—
—
0
0
1522
12132
1.28
17.33
2.3
2.3
13.73
13.01
nmol/l
2.81
1360
10984
182
3451
0.52
17.14
4.0
4.1
—
—
—
0
0
36
1378
0.26
16.90
3.3
3.0
77.75
49.11
mg/l
0.20
24
989
4712
52509
0.86
16.84
3.3
3.5
34.64
46.04
mg/l
1.80
2672
32879
1761
21444
0.80
16.68
4.4
6.2
1.02
1.04
mmol/l
2.23
1603
20060
3831
33665
1.18
16.60
4.5
4.5
21.71
21.88
%
0.28
1834
16374
44
107
4.12
16.47
1.3
1.4
—
—
—
0
0
13204
127013
1.17
16.35
18.7
20.6
332.49
332.20
g/l
3.62
13155
126412
1120
14353
0.76
16.18
5.2
7.9
8.02
9.56
mmol/l
14.99
1068
13784
563
3887
1.46
16.11
1.2
1.3
44.64
44.99
u/ml
0.01
38
366
4015
35490
1.17
16.10
1.7
1.8
1.03
1.18
mg/l
1.80
2987
27603
6624
71854
0.87
15.96
12.9
13.9
1.22
1.22
inr
0.00
4988
59831
7325
67678
1.14
15.94
1.8
1.9
1.27
1.37
mmol/l
26.12
6157
56936
684
9399
0.72
15.86
8.6
10.2
16.24
16.03
%
1.32
677
9074
7745
71896
1.14
15.57
5.5
6.8
1.22
1.21
mmol/l
18.44
7028
66840
224
3887
0.57
15.57
1.7
2.3
131.19
129.68
g/l
0.35
116
2964
849
6333
1.36
15.57
1.6
1.6
12.98
17.28
u/ml
1.28
160
1464
10722
101715
1.15
15.53
4.5
4.7
5102.92
1644.25
e6/l
0.68
38
1363
3785
42620
0.86
15.11
3.7
4.4
—
—
—
0
0
5105
56210
0.87
14.97
3.2
3.5
7.64
7.49
mmol/l
1.51
4147
47799
819
6116
1.36
14.92
2.6
2.4
2.82
2.88
g/l
1.13
734
5587
12539
120399
1.16
14.84
8.0
8.6
75.39
79.02
u/l
15.86
11799
114818
5367
48722
1.15
14.77
6.7
6.6
—
—
—
0
0
2541
21747
1.20
14.74
1.3
1.3
—
—
—
0
0
6586
71215
0.88
14.62
9.1
11.8
0.00
0.00
e9/l
3.77
4959
58244
76
1857
0.41
14.52
2.1
2.5
—
—
—
0
0
598
4266
1.42
14.38
1.1
1.2
—
—
—
0
0
1012
7864
1.30
14.00
1.7
1.7
—
—
—
0
0
161
835
1.94
13.97
1.1
1.1
—
—
—
0
0
4989
54729
0.88
13.43
3.0
3.4
31.38
34.02
u/l
3.17
4700
51699
77
1794
0.43
13.14
1.6
10.1
6.92
7.53
mmol/l
0.73
55
1511
4222
37946
1.15
13.07
1.3
1.3
1.68
1.71
u/ml
0.03
870
10457
843
6464
1.32
12.86
2.5
2.4
4.17
4.25
g/l
1.56
759
5939
843
6471
1.32
12.76
2.5
2.4
7.06
7.39
g/l
7.02
757
5939
992
7787
1.29
12.72
1.1
1.1
—
—
—
0
0
142
732
1.95
12.60
1.1
1.1
5.63
7.52
u/ml
0.47
27
123
170
933
1.83
12.45
1.5
1.5
6.09
8.12
ug/l
2.48
163
846
838
6452
1.31
12.42
2.5
2.4
3.56
3.70
g/l
1.94
752
5925
4930
44912
1.14
12.35
1.6
1.7
21.64
20.29
nmol/l
8.69
3953
38308
441
6255
0.70
12.34
1.9
2.0
1.49
2.13
ug/l
1.02
394
5621
214
3531
0.60
12.32
2.2
2.4
100.22
107.84
ug/min
0.10
119
2126
5660
61352
0.88
12.31
2.7
3.2
—
—
—
0
0
193
1107
1.75
12.20
1.1
1.1
25.64
19.12
u/ml
0.85
75
447
1854
15705
1.20
11.88
2.2
2.1
0.00
0.02
estimate
6.85
210
3282
4651
42341
1.14
11.63
2.5
2.7
328.02
337.52
umol/l
10.06
4034
37539
212
1276
1.67
11.29
1.3
1.2
35.81
54.27
u/ml
0.70
12
81
94
1917
0.49
11.25
1.5
1.5
57.99
59.71
ug/l
0.14
94
1917
1341
16113
0.82
10.92
3.0
4.1
7.38
7.38
ph
1.18
628
9219
191
3141
0.60
10.90
3.3
3.5
31.23
26.22
mg/l
0.59
91
2163
400
2796
1.44
10.86
1.5
1.5
1.17
1.15
ratio
0.18
231
1697
122
633
1.93
10.70
2.0
2.1
40.84
40.23
g/l
0.45
122
633
718
5528
1.31
10.68
2.5
2.4
9.98
10.11
g/l
0.37
624
4946
1322
15858
0.82
10.57
2.9
4.1
5.81
5.82
kpa
0.18
1295
15479
1534
12918
1.21
10.43
2.8
2.9
10.41
10.50
g/l
0.37
1439
11976
1031
8336
1.25
10.38
1.1
1.1
16.98
7.80
u/ml
—
6
99
2428
27580
0.86
10.27
2.8
3.6
0.83
0.82
mmol/l
9.95
2248
26055
45
1170
0.38
10.10
2.7
2.3
631.20
663.46
ml
0.27
35
824
88
415
2.13
10.06
1.1
1.1
—
—
—
0
0
12595
121934
1.12
10.02
4.5
4.6
14.62
14.75
pmol/l
8.33
11410
112818
1293
15452
0.82
9.93
2.9
4.1
1.60
1.83
mmol/l
1.76
1174
13619
12331
127179
0.89
9.90
17.4
19.8
13.42
13.61
%
65.84
12211
125609
686
5307
1.30
9.88
1.1
1.1
0.60
0.62
ratio
0.33
91
715
771
9733
0.78
9.83
2.2
3.5
133.86
129.27
g/l
8.33
752
9456
545
4088
1.34
9.75
1.6
1.6
10413.99
13541.63
e6/l
1.42
384
2877
2290
20079
1.16
9.64
1.4
1.5
—
—
—
0
0
198
1224
1.62
9.58
1.1
1.1
8.41
8.46
iu/ml
0.01
59
308
412
2967
1.40
9.52
1.6
1.5
67.08
60.19
ug/l
0.79
333
2444
4615
42414
1.12
9.47
3.2
3.2
0.35
274.41
estimate
0.86
15
164
164
970
1.70
9.41
1.2
1.2
0.59
0.68
ratio
0.55
107
552
34
968
0.35
9.35
21.8
20.3
1306.76
2414.97
nmol/l
0.58
34
931
707
5536
1.29
9.31
1.1
1.1
—
—
—
0
0
1368
11533
1.20
9.19
1.3
1.3
—
—
—
0
0
3072
27589
1.14
9.16
1.9
1.9
—
—
—
0
0
10472
108797
0.90
9.14
3.7
4.0
0.18
3425.02
1.18
11
223
276
1861
1.49
9.10
1.5
1.8
11226.67
1471.11
titre
—
6
72
4779
51655
0.90
9.09
2.5
2.7
62.53
64.97
u/l
0.37
4323
47947
164
982
1.68
9.01
1.1
1.1
4.59
7.92
nmol/l
0.60
40
182
56
232
2.42
8.74
2.7
2.5
2.97
3.78
ug/l
1.17
24
83
83
1613
0.51
8.70
1.9
2.3
4.03
4.03
mmol/l
0.03
83
1597
83
1612
0.51
8.68
1.9
2.3
105.98
105.47
mmol/l
0.46
83
1596
3370
37071
0.89
8.63
3.6
4.1
1.02
1.14
kg/l
1.09
2075
24583
6287
59027
1.10
8.38
4.0
4.0
52.15
94.73
e6/l
10.91
3946
41436
668
5270
1.28
8.33
1.8
1.8
1.18
1.20
g/l
0.63
633
5043
247
1663
1.49
8.25
2.8
2.7
—
—
—
0
0
182
1147
1.59
8.21
1.3
1.2
—
—
—
0
0
83
1581
0.52
8.19
1.9
2.3
1.20
1.20
mmol/l
0.31
83
1565
123
2082
0.59
8.01
1.4
1.5
33.44
33.63
g/l
0.06
112
1902
647
5118
1.27
7.91
1.8
1.8
0.23
0.24
g/l
1.02
608
4878
3246
35628
0.89
7.91
2.5
2.8
4.75
5.76
e6/l
3.58
2878
32497
375
5051
0.74
7.78
2.9
3.5
1.28
1.52
mg/l
10.23
348
4629
692
5531
1.26
7.77
2.7
2.6
—
—
—
0
0
77
385
2.00
7.64
1.6
2.1
—
—
—
0
0
243
3502
0.69
7.59
3.1
2.8
31.99
34.04
umol/l
0.72
217
3171
7915
75354
1.09
7.58
3.1
3.2
109.66
124.76
ug/l
7.36
7329
70622
589
4633
1.28
7.55
1.9
1.9
44.88
41.67
nmol/l
2.61
573
4509
35
883
0.40
7.47
1.4
1.3
—
—
—
0
0
303
2169
1.40
7.36
1.1
1.1
3.70
3.66
eliau/ml
0.01
119
1022
34
863
0.39
7.36
1.5
2.1
7.36
8.09
mmol/l
0.78
34
863
11
508
0.22
7.31
7.0
6.5
26.61
25.07
mmol/l
1.27
11
464
696
5610
1.25
7.29
3.1
4.0
24.93
24.87
mmol/l
0.30
645
5195
315
2282
1.39
7.15
1.5
1.5
1.28
1.25
mm
0.35
225
1642
320
2325
1.38
7.14
1.5
1.5
—
—
—
0
0
327
2388
1.38
7.08
1.6
1.6
—
—
—
0
0
129
2086
0.62
7.04
2.8
2.7
—
—
—
0
0
134
2143
0.62
6.98
2.5
2.6
—
—
—
0
0
62
1227
0.50
6.98
1.1
1.1
—
—
—
0
0
148
2312
0.64
6.95
4.8
6.5
10.81
11.84
mg/l
2.29
137
2145
340
2507
1.36
6.94
1.7
1.8
—
—
—
0
0
36
867
0.41
6.91
2.1
2.3
16.24
15.94
%
0.24
36
867
7105
67498
1.09
6.90
3.2
3.5
6.20
6.22
ph
0.55
3443
37719
164
1057
1.56
6.80
1.1
1.1
—
0.33
—
0
7
1520
13265
1.16
6.76
1.7
1.8
—
—
—
0
0
1333
11524
1.17
6.71
3.3
3.5
—
0.83
—
0
6
228
3244
0.70
6.68
1.8
2.0
0.86
0.85
nmol/l
0.05
190
2757
130
2069
0.63
6.65
1.3
1.3
7.14
7.33
mmol/l
0.24
109
1832
254
3540
0.71
6.60
2.8
3.7
410.08
859.91
u/ml
0.65
226
3221
1136
13204
0.85
6.36
2.0
2.5
0.38
0.40
e6/l
0.17
1052
12609
375
2856
1.32
6.21
1.1
1.1
—
—
—
0
0
163
1073
1.52
6.19
2.4
2.7
0.69
0.69
e9/l
0.02
158
1018
1626
14369
1.15
6.08
1.4
1.4
—
—
—
0
0
86
1477
0.58
6.04
1.5
1.6
35.65
31.57
%
0.52
62
868
149
2249
0.66
6.01
4.7
5.5
365.73
364.52
umol/l
0.03
117
1974
373
2854
1.31
5.99
1.1
1.1
—
—
—
0
0
2529
23012
1.12
5.88
1.3
1.3
—
—
—
0
0
69
366
1.89
5.87
1.1
1.2
—
836.36
—
0
22
10
420
0.24
5.80
1.3
1.4
1.50
2.48
%
—
10
364
8353
80252
1.08
5.75
5.8
7.5
1.22
1.21
mmol/l
18.68
7407
69485
34
774
0.44
5.75
1.1
1.3
7.43
7.41
ph
0.51
17
539
564
4580
1.24
5.61
1.1
1.1
—
—
—
0
0
153
1017
1.51
5.60
1.3
1.3
156.73
175.91
pmol/l
0.86
153
1017
430
3385
1.28
5.59
2.0
1.8
—
—
—
0
0
564
4594
1.24
5.47
2.1
2.1
12.36
11.43
mg/l
1.40
523
4313
710
5944
1.20
5.25
1.3
1.3
—
—
—
0
0
2111
19142
1.12
5.21
2.7
2.8
7.04
8.45
umol/l
2.91
1874
16701
34
144
2.36
5.20
1.0
1.1
0.08
0.03
u/ml
0.52
34
144
431
3429
1.26
5.17
1.1
1.1
2.27
1.86
u/ml
0.32
233
1839
2554
27786
0.90
5.05
2.3
2.7
14.29
13.19
umol/l
11.62
2410
25946
323
2486
1.31
5.04
1.2
1.2
3.26
3.84
u/ml
0.54
158
1151
4731
44626
1.08
5.04
3.3
3.3
0.29
0.40
e6/l
3.95
3156
32601
70
393
1.78
5.04
1.5
1.5
0.56
0.51
e9/l
1.11
70
393
84
1380
0.61
5.04
1.8
1.4
1.01
1.26
promille
0.86
70
1072
82
482
1.70
5.03
1.1
1.1
—
—
—
0
0
147
994
1.48
5.00
1.4
1.5
5.64
6.00
u/l
0.42
125
862
10
377
0.26
4.90
1.3
1.4
34.58
21.71
%
—
10
342
936
8076
1.17
4.89
2.2
2.2
0.00
0.24
estimate
1.08
164
2598
123
1839
0.67
4.83
1.4
1.5
2934.40
3158.93
e6/l
0.06
70
1285
1158
13149
0.87
4.77
2.4
3.5
4.57
4.56
kpa
0.06
1134
12804
17
52
3.27
4.74
1.0
1.1
0.04
0.04
u/ml
0.10
17
52
1726
19107
0.89
4.73
1.6
1.8
—
—
—
0
0
819
7017
1.18
4.69
1.5
1.6
12.43
15.13
iu/ml
0.24
19
187
287
2198
1.31
4.68
1.8
2.1
4.00
8.08
titre
—
7
48
3388
31622
1.09
4.61
2.8
3.1
2.44
2.45
mmol/l
5.98
2990
28505
406
5034
0.80
4.60
2.4
2.2
5517.91
5063.67
u/l
0.12
154
1921
60
332
1.81
4.57
1.1
1.1
30.68
31.70
iu/ml
0.05
60
332
45
849
0.53
4.52
1.3
1.3
5.67
5.80
mmol/l
0.50
45
798
24
562
0.43
4.46
2.8
1.6
0.13
0.04
estimate
0.31
24
562
492
4046
1.22
4.43
1.1
1.1
—
—
—
0
0
269
2059
1.31
4.43
1.1
1.1
0.74
0.49
u/ml
0.27
79
685
5177
49206
1.07
4.41
2.1
2.2
154.85
202.25
u/l
8.89
4899
46536
35
162
2.16
4.41
1.3
1.2
—
—
—
0
0
370
2953
1.26
4.39
1.1
1.1
3.87
4.69
u/ml
0.69
201
1547
26
106
2.46
4.36
1.5
1.4
11.70
35.71
%
3.24
20
66
110
724
1.52
4.32
1.6
1.7
29.79
29.29
umol/l
0.21
104
683
433
3537
1.23
4.19
1.9
1.9
204.47
199.37
pmol/l
0.50
407
3352
9
286
0.31
4.18
1.1
1.7
—
—
—
0
0
293
2288
1.29
4.18
1.1
1.1
3.86
4.83
u/ml
0.50
125
1015
31
642
0.48
4.17
1.8
2.0
833.40
2978.15
e6/l
0.80
20
428
486
4020
1.22
4.16
1.2
1.2
—
—
—
0
0
25
558
0.45
4.14
3.6
4.9
—
—
—
0
0
19
472
0.40
4.11
3.2
3.7
41.34
52.91
%
1.32
19
458
38
728
0.52
4.06
27.2
29.7
116.06
114.94
ug/l
0.04
33
590
25
552
0.45
4.03
1.8
1.9
2681.62
13432.61
e6/l
1.62
13
277
24
98
2.45
4.03
1.0
1.3
0.17
0.16
umol/l
0.16
24
98
307
2425
1.27
4.01
1.1
1.1
3.68
4.03
u/ml
0.13
138
1195
2109
22910
0.91
4.01
1.7
2.1
—
—
—
0
0
157
1126
1.40
3.99
2.4
2.7
226.31
235.72
e6/l
0.28
137
963
100
1489
0.67
3.93
1.5
1.5
—
—
—
0
0
12
359
0.33
3.91
1.1
1.1
—
39.21
u/ml
—
0
14
247
1909
1.30
3.85
2.0
2.3
0.62
0.58
mmol/l
0.07
241
1843
2398
25845
0.92
3.83
2.2
2.6
2.37
2.35
g/l
1.18
2221
23950
112
1619
0.69
3.78
1.4
1.5
36031.73
56421.67
e6/l
0.88
45
892
58
338
1.72
3.77
1.2
1.2
339.28
323.24
pmol/l
0.06
32
250
230
2972
0.77
3.76
1.4
1.4
59.22
62.72
mmol/l
0.72
181
2374
110
749
1.47
3.73
1.6
1.8
2.01
1.96
umol/l
0.27
98
691
117
1672
0.70
3.72
1.0
1.2
—
33.88
—
0
6
7
236
0.30
3.70
3.0
6.1
6.97
8.42
mmol/l
—
7
236
7
234
0.30
3.56
9.9
11.0
5.09
5.31
mmol/l
—
7
234
181
1360
1.33
3.49
1.2
1.2
—
—
—
0
0
350
2857
1.23
3.48
1.1
1.1
0.60
1.04
u/ml
2.10
156
1268
340
2767
1.23
3.48
1.1
1.1
1.40
1.62
u/ml
0.21
168
1412
161
1191
1.36
3.45
1.4
1.4
10.49
12.54
umol/l
6.01
151
1122
9
258
0.35
3.40
1.0
1.3
—
—
—
0
0
110
1560
0.70
3.39
1.5
1.6
—
—
—
0
0
15
376
0.40
3.38
3.1
2.4
6.60
102.33
ug/l
0.68
15
376
19
76
2.50
3.37
1.1
1.8
1.51
1.58
mpas
—
10
40
19
427
0.44
3.28
5.9
7.5
6.15
5.96
kpa
0.51
19
383
39
212
1.84
3.24
1.7
1.6
—
—
—
0
0
109
764
1.43
3.23
1.1
1.1
3.83
3.77
iu/ml
—
6
47
2221
23840
0.92
3.22
2.3
2.7
24.03
22.62
%
5.56
2097
22190
97
1392
0.70
3.21
1.3
1.3
9.74
8.75
mmol/l
1.16
82
1313
69
441
1.57
3.19
1.4
1.3
17.48
16.72
umol/l
0.66
64
382
272
2185
1.25
3.17
1.2
1.3
76.97
62.15
u/ml
—
8
139
123
1689
0.73
3.15
1.4
1.3
1.38
1.49
nmol/l
0.39
102
1522
177
1350
1.31
3.12
1.1
1.1
296.86
291.14
mg/l
0.41
159
1225
147
1091
1.35
3.12
2.2
2.5
460.69
526.04
e6/l
1.21
124
879
5786
55693
1.06
3.11
3.3
3.6
2.37
2.36
mmol/l
7.98
5012
50883
199
2545
0.78
3.08
1.1
1.1
78.98
5219.91
iu/ml
0.66
37
533
192
1484
1.30
3.08
1.4
1.4
42407.72
129891.84
e6/l
2.74
127
989
1462
15940
0.91
3.03
2.4
2.3
378.66
376.53
nmol/l
0.15
1351
14820
5
177
0.28
2.95
1.6
1.2
5.24
5.96
mmol/l
—
5
177
80
1167
0.68
2.93
1.6
1.9
1.00
1.80
u/field
1.45
31
644
4668
48685
0.94
2.91
3.7
4.4
7.40
7.40
ph
1.54
2986
34813
10
278
0.36
2.89
6.6
2.0
1.17
1.18
mmol/l
—
10
263
19
402
0.47
2.84
1.1
1.3
53.09
40.46
%
0.60
11
269
50
797
0.63
2.82
1.3
1.9
162.85
129.41
umol/l
0.23
26
400
62
942
0.66
2.81
1.8
1.5
1.27
1.24
nmol/l
0.06
36
721
121
888
1.37
2.80
1.1
1.1
1570.24
1541.62
miu/ml
0.10
121
888
29
151
1.92
2.78
1.0
1.1
169.80
370.85
u/ml
—
5
33
508
4388
1.16
2.78
2.7
3.2
3.24
2.30
index
0.45
238
2229
57
362
1.58
2.76
1.2
1.5
0.27
0.31
mmol/l
0.10
15
63
1214
11074
1.10
2.76
1.3
1.3
184.72
244.99
u/ml
1.44
1143
10292
30
540
0.55
2.73
1.8
1.9
—
—
—
0
0
1354
12425
1.10
2.72
1.4
1.5
—
—
—
0
0
29
526
0.55
2.71
1.0
1.0
—
—
—
0
0
167
2142
0.78
2.70
1.4
1.5
—
—
—
0
0
167
2142
0.78
2.70
1.4
1.5
—
—
—
0
0
167
2142
0.78
2.70
1.4
1.5
—
—
—
0
0
167
2142
0.78
2.70
1.4
1.5
—
—
—
0
0
62
932
0.66
2.69
11.2
13.7
0.60
0.63
mmol/l
0.56
55
849
80
552
1.45
2.65
1.6
2.1
9.45
9.13
mg/l
0.19
68
461
17
73
2.33
2.64
1.0
1.4
—
—
—
0
0
1259
11534
1.10
2.63
1.2
1.2
161.23
138.71
u/ml
1.01
429
4453
222
1792
1.24
2.56
1.1
1.1
98.94
96.81
%
0.64
204
1688
11
274
0.40
2.53
4.1
2.1
1.19
1.19
mmol/l
0.05
11
263
170
1333
1.28
2.51
1.1
1.2
183.93
201.88
titre
0.11
28
224
212
1708
1.24
2.50
1.7
1.8
306.53
358.37
mu/l
2.79
172
1346
19
382
0.50
2.50
5.9
7.3
5.04
5.45
kpa
0.83
19
382
23
116
1.98
2.44
1.7
1.2
—
—
—
0
0
119
893
1.33
2.44
2.4
2.2
5.46
3.59
ug/l
0.93
109
831
570
5019
1.14
2.43
1.2
1.3
—
—
—
0
0
1733
16158
1.08
2.43
1.5
1.5
—
20.46
—
0
5
215
1742
1.24
2.42
3.7
3.5
54.62
57.25
%
1.06
191
1513
6
173
0.35
2.39
2.0
2.5
0.50
0.61
u/field
—
6
173
9035
92320
0.95
2.39
4.2
5.2
6.40
6.67
mmol/l
43.03
8565
87670
334
2832
1.18
2.36
1.1
1.1
—
—
—
0
0
30
515
0.58
2.35
1.1
1.1
—
—
—
0
0
48
306
1.57
2.34
1.0
1.1
1.04
1.79
u/ml
0.28
35
261
24
435
0.55
2.29
1.3
1.2
4.15
11.78
pmol/l
—
5
161
115
868
1.33
2.29
2.3
2.2
3.33
2.37
ug/l
0.94
93
723
961
10533
0.91
2.28
3.2
3.8
5.09
5.15
kpa
1.97
905
10097
13
288
0.45
2.27
2.8
2.9
11.56
40.50
mg/l
—
8
67
22
113
1.95
2.24
1.0
1.2
0.49
0.67
iu/ml
0.41
13
59
280
2350
1.19
2.24
1.2
1.2
—
—
—
0
0
280
2351
1.19
2.23
1.1
1.1
121.83
117.60
%
1.35
248
2132
126
968
1.30
2.22
3.6
3.3
21.97
26.54
mu/l
0.98
117
918
68
474
1.44
2.19
1.1
1.3
149.03
129.33
nmol/l
0.57
44
348
21
389
0.54
2.18
1.1
1.4
29.18
25.17
g/l
0.55
16
299
73
517
1.41
2.17
1.1
1.0
5.73
10.94
u/ml
2.38
43
326
7
19
3.69
2.15
1.0
1.2
—
—
—
0
0
342
2939
1.17
2.09
1.6
1.6
0.74
0.75
g/l
0.06
287
2273
11
43
2.56
2.07
1.0
1.1
0.19
0.22
g/l
0.89
11
33
11
43
2.56
2.07
1.0
1.1
—
—
—
0
0
9
31
2.90
2.07
1.4
2.7
—
—
—
0
0
171
1379
1.24
2.06
1.9
2.3
42.03
39.21
%
1.69
166
1351
60
414
1.45
2.06
1.4
1.7
49.58
137.15
au/ml
—
6
58
747
6761
1.11
2.06
1.3
1.3
0.41
1.08
u/ml
2.30
64
553
218
1805
1.21
2.05
2.3
2.3
—
—
—
0
0
479
4227
1.14
2.03
1.3
1.3
—
—
—
0
0
82
601
1.37
2.02
1.1
1.2
—
—
—
0
0
57
392
1.46
2.00
2.1
2.0
—
2.00
—
0
8
14
63
2.22
2.00
1.1
1.1
—
—
—
0
0
14
63
2.22
2.00
1.5
1.3
436.29
963.62
nmol/l
1.26
14
58
290
2471
1.18
1.99
1.4
1.4
28.75
31.38
u/l
0.61
230
2010
228
2722
0.84
1.98
3.6
3.2
0.73
0.81
nmol/l
2.72
176
2183
230
2741
0.84
1.96
1.5
1.3
32.95
30.65
u/l
0.13
199
2369
196
2369
0.83
1.95
1.3
1.3
294.78
372.75
pmol/l
0.86
178
2022
130
1023
1.27
1.95
1.2
1.3
74.29
61.08
titre
—
7
74
122
1552
0.78
1.95
1.8
2.0
—
0.86
—
0
7
24
134
1.79
1.94
1.1
1.3
19.96
14.82
nmol/l
—
5
33
41
265
1.55
1.94
1.1
1.1
1.65
9.35
u/ml
1.41
26
175
121
945
1.28
1.93
1.0
1.1
2.18
6.25
u/ml
0.46
31
236
70
504
1.39
1.93
1.1
1.2
1100.00
980.77
titre
0.38
18
104
15
71
2.11
1.91
1.1
1.2
—
—
—
0
0
161
1980
0.81
1.91
1.9
2.5
1.07
1.22
g/24h
0.23
81
1180
5815
56561
1.04
1.85
3.3
3.5
1.23
2.06
e6/l
—
7
27
17
86
1.98
1.84
1.1
1.0
2.06
0.27
u/ml
—
10
58
194
1613
1.21
1.79
3.8
3.7
—
—
—
0
0
45
303
1.49
1.79
1.1
1.1
—
—
—
0
0
25
413
0.60
1.76
1.1
1.3
2.27
271.00
ug/l
2.54
14
224
144
1771
0.81
1.74
1.8
1.4
278.97
278.67
mosm/kgh2o
0.06
96
1350
27
436
0.62
1.74
1.2
1.3
2.99
3.47
mmol/l
0.61
27
400
472
4213
1.12
1.72
1.1
1.1
4.15
7.44
eliau/ml
1.26
65
524
131
1051
1.25
1.71
1.2
1.3
20.00
530.69
titre
—
5
72
320
2787
1.15
1.70
1.3
1.2
—
—
—
0
0
947
10227
0.92
1.69
3.2
3.8
7.42
7.42
ph
4.34
739
8538
66
483
1.37
1.69
1.3
1.3
38.41
39.81
g/l
0.29
21
253
0
49
0.00
1.68
0.0
2.2
—
4.40
—
0
49
178
1479
1.21
1.68
1.2
1.2
—
—
—
0
0
2503
23934
1.05
1.65
1.6
1.7
—
—
—
0
0
21
119
1.77
1.65
1.1
1.2
—
—
—
0
0
805
7404
1.09
1.65
1.9
1.9
—
—
—
0
0
121
967
1.25
1.65
1.0
1.1
0.96
1.84
u/ml
0.60
37
316
109
861
1.27
1.64
1.0
1.1
0.30
1.66
u/ml
1.05
24
214
48
679
0.71
1.64
3.0
4.9
4821.60
598.93
mg/l
0.42
35
489
1526
14392
1.07
1.62
6.1
8.1
1.28
1.33
mmol/l
0.86
1484
14137
672
6143
1.10
1.59
1.9
2.1
20.49
21.07
s
1.93
593
5407
49
685
0.71
1.57
1.3
1.7
—
—
—
0
0
24
144
1.67
1.57
1.0
1.1
2.07
1.66
iu/ml
0.56
16
76
18
99
1.82
1.56
1.2
1.5
350.83
306.79
umol/24h
0.57
18
99
62
833
0.74
1.55
1.5
1.7
3.97
7.28
nmol/l
0.41
53
685
305
2670
1.14
1.54
1.2
1.2
—
—
—
0
0
47
659
0.71
1.54
1.6
2.5
—
—
—
0
0
768
8328
0.92
1.54
2.1
3.2
1.14
1.26
%
3.49
762
8288
110
1370
0.80
1.54
1.9
2.6
763.66
1073.90
mg
1.74
110
1358
7
159
0.44
1.53
1.1
1.2
—
0.45
—
0
36
0
43
0.00
1.52
0.0
1.3
—
132.75
—
0
32
95
747
1.27
1.51
1.2
1.2
10.05
10.25
mm/h
0.06
95
747
28
177
1.58
1.51
2.1
2.3
—
—
—
0
0
46
644
0.71
1.50
3.4
1.7
7889.40
359.32
pmol/l
0.46
11
106
44
308
1.43
1.48
1.3
1.3
93.41
94.13
mu/l
0.00
25
231
17
94
1.81
1.46
1.6
1.2
69.53
80.89
umol/l
0.89
17
87
207
2415
0.86
1.46
1.3
1.3
—
—
—
0
0
2322
24231
0.95
1.45
2.0
2.2
29.31
29.55
s
1.27
2281
23598
22
132
1.67
1.45
1.2
1.2
—
—
—
0
0
252
2190
1.15
1.44
1.2
1.1
—
—
—
0
0
6
22
2.73
1.43
1.2
1.2
—
—
—
0
0
130
1070
1.22
1.40
1.4
1.8
6.28
6.73
mmol/l
2.05
109
744
6
139
0.43
1.38
1.5
1.3
21.23
21.12
mmol/l
—
6
107
3130
30228
1.04
1.38
3.6
3.9
319.62
434.56
ng/l
1.12
2377
23039
213
1836
1.16
1.37
1.3
1.3
—
—
—
0
0
8
161
0.50
1.35
1.6
1.5
—
—
—
0
0
8
162
0.49
1.35
2.0
1.6
—
—
—
0
0
0
37
0.00
1.34
0.0
8.6
—
51.69
—
0
16
161
1364
1.18
1.30
1.1
1.1
—
—
—
0
0
137
1144
1.20
1.30
1.2
1.1
384.42
366.40
nmol/l
0.47
128
984
61
464
1.32
1.28
2.0
2.2
0.18
0.50
e9/l
1.00
35
220
33
226
1.46
1.28
1.1
1.0
12.35
8.07
u/ml
0.25
33
226
6
131
0.46
1.28
1.0
1.1
—
18.30
—
0
47
182
1561
1.17
1.27
2.2
2.4
1204.30
1201.02
e6/l
0.02
161
1377
41
565
0.73
1.26
2.7
3.2
28.33
28.26
umol/l
0.01
34
426
21
130
1.62
1.26
1.0
1.1
—
—
—
0
0
356
3199
1.12
1.24
1.9
1.9
5.29
5.09
mmol/24h
0.57
310
2862
4393
45081
0.97
1.24
1.4
1.4
—
—
—
0
0
165
1408
1.17
1.23
1.2
1.2
122.49
109.20
pmol/l
1.04
165
1408
1183
12503
0.94
1.22
2.1
2.3
7.79
7.64
ug/l
0.07
1005
11108
150
1272
1.18
1.21
1.7
1.6
2040.13
1972.03
ml
0.47
150
1240
5
19
2.63
1.21
1.2
1.0
4500.00
2913.68
titre
—
5
19
520
4777
1.09
1.18
7.8
9.9
—
—
—
0
0
47
349
1.35
1.18
1.1
1.1
—
21.20
—
0
5
16
94
1.70
1.17
3.6
3.8
—
0.00
estimate
—
0
14
62
793
0.78
1.16
1.8
2.2
42.77
37.81
umol/l
—
6
79
5272
51572
1.03
1.16
3.3
3.4
61.84
75.69
e6/l
0.23
3723
39306
13
223
0.58
1.15
1.2
2.2
0.51
1.11
mmol/l
—
8
152
1403
13361
1.05
1.14
2.6
2.7
66.87
66.43
g/l
1.64
1263
12326
21
134
1.57
1.14
1.2
1.2
—
—
—
0
0
149
1739
0.86
1.13
1.2
1.2
—
—
—
0
0
76
944
0.80
1.12
1.1
1.1
1.04
1.06
ratio
1.75
59
782
41
302
1.36
1.10
1.8
1.8
—
—
—
0
0
171
1968
0.87
1.08
1.5
1.6
46.30
57.04
%
3.07
121
1208
226
2552
0.88
1.08
1.5
1.5
64.94
63.15
mu/l
0.05
200
2289
556
5999
0.92
1.07
3.5
3.7
433.92
1736.67
u/ml
1.72
481
5179
1921
18470
1.05
1.07
1.5
1.6
—
—
—
0
0
670
7177
0.93
1.07
1.7
1.7
1.35
1.56
g/l
8.69
564
6209
38
278
1.37
1.07
1.0
1.1
—
—
—
0
0
38
279
1.36
1.05
1.0
1.1
—
—
—
0
0
38
279
1.36
1.05
1.0
1.1
—
—
—
0
0
203
2301
0.88
1.04
2.9
2.7
4.97
834.02
u/ml
1.29
203
2279
24
162
1.48
1.03
1.0
1.0
0.00
2.84
u/ml
0.55
11
74
5
22
2.27
1.03
2.0
2.0
—
—
—
0
0
11
60
1.83
1.02
1.2
1.2
—
—
—
0
0
365
3330
1.10
1.01
1.2
1.4
9.01
25.51
u/ml
—
5
66
9
48
1.88
1.00
1.2
1.1
28.09
62.57
umol/24h
—
9
48
832
7844
1.06
0.99
1.1
1.1
148.24
207.38
titre
0.52
17
223
813
7664
1.06
0.98
2.9
3.3
1.02
1.02
ratio
2.29
701
6912
320
2907
1.10
0.97
3.4
3.8
31.05
35.87
u/ml
0.24
310
2814
9
50
1.80
0.96
1.0
1.0
—
—
—
0
0
0
31
0.00
0.96
0.0
1.5
—
437.55
—
0
31
63
505
1.25
0.95
1.2
1.2
—
—
—
0
0
0
32
0.00
0.95
0.0
1.6
—
1714.25
—
0
8
64
791
0.81
0.94
1.1
1.3
94.08
63.80
%
6.67
13
93
613
5734
1.07
0.94
1.8
2.3
170.94
586.24
ug/l
10.09
563
5432
65
524
1.24
0.94
1.1
1.3
3.90
26.38
%
5.75
20
74
41
312
1.31
0.92
1.3
1.3
—
—
—
0
0
7076
71816
0.97
0.92
4.2
5.2
36.92
35.83
g/l
62.85
6620
67594
238
2645
0.90
0.91
1.5
1.6
—
—
—
0
0
23
159
1.45
0.90
1.0
1.0
0.01
0.46
u/ml
—
10
77
16
102
1.57
0.90
1.1
1.2
—
—
—
0
0
111
1296
0.86
0.90
2.1
2.3
19.09
18.10
nmol/l
0.57
106
1223
143
1638
0.87
0.90
2.0
2.1
—
—
—
0
0
78
646
1.21
0.89
1.7
1.4
37.95
34.18
nmol/l
0.46
72
576
8374
84781
0.98
0.88
3.5
3.9
10.34
3.33
estimate
0.98
886
18065
73
601
1.22
0.88
1.2
1.2
0.09
0.22
g/l
—
5
38
68
556
1.22
0.88
3.5
3.7
8.64
8.65
mg/l
0.00
59
447
924
8780
1.06
0.87
1.2
1.3
—
—
—
0
0
170
1502
1.13
0.87
1.1
1.1
—
—
—
0
0
555
5192
1.07
0.87
1.4
1.4
283.71
275.14
ug/g
0.45
300
3021
2454
25270
0.97
0.87
1.6
1.7
1047.04
1163.30
nmol/l
8.30
1695
19339
191
1702
1.12
0.86
2.1
2.1
5.34
8.42
umol/l
3.02
138
1245
62
504
1.23
0.85
2.5
2.7
38.84
145.29
au/ml
—
5
78
2155
20884
1.04
0.85
3.0
3.2
4.25
4.42
e9/l
0.41
1618
18248
364
3355
1.09
0.84
1.2
1.4
—
—
—
0
0
5782
58769
0.98
0.83
3.3
3.7
33.57
63.32
ng/l
2.30
3783
39877
245
2701
0.91
0.83
3.7
3.5
1.69
1.58
%
0.15
222
2450
74
616
1.20
0.82
2.5
2.9
—
—
—
0
0
11
177
0.62
0.81
1.2
2.5
—
—
—
0
0
203
1825
1.11
0.80
1.4
1.4
6.41
6.79
g/l
0.96
167
1309
46
575
0.80
0.79
1.4
1.4
14.59
15.33
pmol/l
0.53
41
475
431
4015
1.08
0.78
1.9
3.5
60.54
62.00
%
0.70
422
3885
21
148
1.42
0.77
1.0
1.0
0.10
0.60
u/ml
—
10
72
202
1823
1.11
0.75
1.4
1.4
0.35
0.41
g/l
2.05
167
1306
59
714
0.83
0.75
1.9
2.1
24.94
136.78
ug/min
2.28
17
161
203
2245
0.90
0.75
1.5
1.5
24.64
29.78
ng/l
1.75
203
2238
92
1069
0.86
0.74
1.2
1.2
41.04
34.49
mmol/l
1.41
78
937
31
403
0.77
0.74
1.1
1.2
—
—
—
0
0
31
237
1.31
0.72
1.0
1.0
78.20
78.86
ug/l
0.03
23
187
201
1824
1.10
0.69
1.4
1.4
2.85
2.91
g/l
0.24
167
1310
91
786
1.16
0.69
1.6
1.7
—
—
—
0
0
1507
14578
1.04
0.69
1.4
1.4
—
—
—
0
0
40
319
1.25
0.68
1.5
1.9
3.70
3.04
ug/l
0.15
21
188
48
392
1.23
0.67
1.0
1.0
—
—
—
0
0
468
4404
1.06
0.67
1.4
1.4
10.78
11.11
u/l
0.19
370
3510
7
43
1.63
0.66
1.1
1.0
—
—
—
0
0
5
29
1.72
0.64
1.0
1.0
0.03
0.05
u/ml
—
5
20
6
101
0.59
0.62
1.7
1.2
27.00
1044.14
u/l
—
6
92
653
6847
0.95
0.61
1.7
1.7
0.28
0.31
mg/l
0.81
278
3251
196
1792
1.09
0.61
1.4
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
2.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
97.47
—
0
15
0
20
0.00
0.60
0.0
1.2
—
0.53
—
0
20
9
140
0.64
0.60
1.3
2.6
527.22
391.75
umol/l
—
9
134
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
863
8287
1.04
0.60
1.4
1.4
30.97
29.83
iu/l
0.44
736
7081
111
986
1.13
0.59
1.4
1.5
29.86
23.45
umol/l
1.11
100
914
26
333
0.78
0.59
6.5
4.7
58.31
57.19
u/l
0.02
26
326
1058
10208
1.04
0.58
1.8
1.9
1.36
1.30
g/l
0.41
964
9431
16
114
1.40
0.58
1.0
1.1
0.02
0.21
u/ml
1.83
16
114
0
23
0.00
0.58
0.0
1.1
—
0.56
—
0
12
53
446
1.19
0.58
1.3
1.5
—
—
—
0
0
307
3284
0.93
0.57
1.9
1.7
—
—
—
0
0
192
1764
1.09
0.55
2.4
2.4
36.24
26.27
iu/ml
0.38
28
194
21
159
1.32
0.55
1.0
1.1
5.33
5.27
u/ml
0.00
14
125
14
99
1.41
0.54
1.1
1.1
—
—
—
0
0
40
331
1.21
0.53
1.2
1.1
2.61
0.66
umol/24h
0.47
16
153
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
55
470
1.17
0.52
1.1
1.1
—
—
—
0
0
55
470
1.17
0.52
1.1
1.1
—
—
—
0
0
55
470
1.17
0.52
1.1
1.1
—
—
—
0
0
1748
17914
0.97
0.51
2.3
2.6
1.66
1.79
%
7.70
1533
16088
6
100
0.60
0.51
2.2
2.2
0.60
0.61
ug/l
—
6
100
87
978
0.89
0.50
3.0
2.8
41.06
38.84
%
0.44
47
547
91
1020
0.89
0.49
6.9
7.1
45.87
96.93
ug/l
0.47
56
658
179
1653
1.08
0.48
1.7
1.4
3.46
3.90
ug/l
0.37
155
1391
475
4979
0.95
0.48
1.3
1.3
217.71
221.83
miu/ml
0.10
234
2235
11
76
1.45
0.48
1.0
1.0
0.02
0.07
u/ml
—
5
30
268
2516
1.07
0.47
1.5
1.4
0.32
0.36
nmol/l
0.79
204
1850
1652
16907
0.97
0.45
3.9
4.4
12.23
24.98
ug/l
1.30
1266
13743
339
3215
1.06
0.44
1.2
1.3
253.60
267.85
u/ml
0.40
220
2009
94
847
1.11
0.44
1.3
1.2
304.48
383.41
u/l
0.39
89
776
442
4622
0.96
0.42
1.7
2.1
—
—
—
0
0
124
1136
1.09
0.42
1.0
1.0
772.98
740.45
ng/l
0.30
87
802
52
595
0.87
0.41
2.7
2.7
0.60
0.61
mmol/l
0.28
52
595
0
16
0.00
0.41
0.0
2.5
—
8.68
—
0
11
0
16
0.00
0.41
0.0
1.2
—
36.42
—
0
16
0
18
0.00
0.40
0.0
1.2
—
69.04
—
0
18
320
3044
1.05
0.39
1.2
1.5
146.73
151.14
au/ml
0.31
120
845
264
2499
1.06
0.39
1.3
1.3
0.58
2.45
nmol/l
1.30
250
2412
70
781
0.90
0.39
1.5
1.8
0.87
2.90
u/field
4.84
32
560
123
1133
1.09
0.38
1.0
1.0
285.15
329.43
ng/l
1.52
87
831
312
2971
1.05
0.37
1.2
1.2
497.67
302.12
titre
0.40
15
233
67
746
0.90
0.36
1.1
1.1
8.90
12.35
u/ml
—
10
78
36
418
0.86
0.36
1.1
1.1
0.90
12.17
u/ml
0.78
23
233
1361
13902
0.98
0.35
2.3
2.6
66.68
70.28
e9/l
3.63
945
10240
164
1536
1.07
0.35
4.7
5.4
39.04
102.20
u/ml
3.35
61
501
15
189
0.79
0.34
1.9
1.8
1.68
1.72
mg/l
0.04
15
161
29
340
0.85
0.33
3.1
2.2
—
—
—
0
0
28
329
0.85
0.33
2.5
2.9
—
—
—
0
0
14
109
1.28
0.33
1.0
1.1
7.79
11.13
u/l
0.66
14
109
128
1193
1.07
0.32
1.4
1.5
21.57
23.67
u/ml
0.17
14
218
129
1203
1.07
0.32
1.1
1.1
—
—
—
0
0
229
2178
1.05
0.31
1.3
1.3
0.27
0.20
nmol/l
0.35
176
1692
4058
40973
0.99
0.29
2.3
2.4
2.59
2.78
mg/l
6.10
3338
35591
464
4789
0.97
0.28
3.5
3.3
3.40
3.53
ratio
0.03
252
2743
14
112
1.25
0.28
1.1
1.0
0.07
0.58
u/ml
—
8
65
9
117
0.77
0.27
1.6
1.6
—
—
—
0
0
127
1194
1.06
0.27
3.9
3.6
103.10
163.20
nmol/l
1.74
127
1182
1567
15917
0.98
0.26
2.4
2.3
0.23
0.21
g/l
12.40
1459
14912
1107
10864
1.02
0.26
3.2
3.5
4.52
4.47
pmol/l
1.03
960
9794
406
3933
1.03
0.26
1.4
1.5
107.45
154.64
pmol/l
1.71
397
3835
80
742
1.08
0.25
1.1
1.1
168.23
187.07
iu/ml
0.17
80
733
74
799
0.93
0.25
1.9
1.7
—
—
—
0
0
14
170
0.82
0.25
2.1
3.3
0.71
1.09
mg/l
—
8
121
129
1364
0.95
0.24
1.5
1.8
3.24
3.85
mg/l
2.04
123
1313
57
522
1.09
0.24
1.1
1.2
27.21
28.31
s
1.11
57
522
188
1966
0.96
0.24
1.1
1.1
—
—
—
0
0
6
85
0.71
0.24
1.2
1.1
35.57
36.59
s
—
6
75
12
97
1.24
0.22
1.2
1.1
38.60
25.02
u/ml
—
5
27
12
97
1.24
0.22
1.2
1.1
26.20
23.16
u/ml
—
5
19
75
805
0.93
0.22
1.3
1.2
145.03
161.24
mmol/24h
1.30
75
805
18
153
1.18
0.22
1.0
1.0
0.03
0.10
u/ml
0.96
12
101
18
153
1.18
0.22
1.0
1.1
0.02
1.83
u/ml
1.97
11
123
17
144
1.18
0.22
1.0
1.1
105.41
94.22
titre
0.15
17
144
0
11
0.00
0.21
0.0
1.0
—
17.36
—
0
11
0
11
0.00
0.21
0.0
1.0
—
196.73
—
0
11
8
104
0.77
0.21
1.0
1.0
—
—
—
0
0
69
643
1.07
0.21
1.8
2.1
31.67
31.24
%
0.09
69
643
12
145
0.83
0.21
1.7
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
7.5
—
91.50
—
0
8
10
80
1.25
0.20
1.1
1.1
—
22.15
—
0
13
193
1856
1.04
0.20
1.2
1.2
52.55
63.29
u/l
3.91
173
1618
0
14
0.00
0.20
0.0
1.1
—
82.71
—
0
9
33
365
0.90
0.19
1.3
1.4
—
—
—
0
0
64
685
0.93
0.19
1.7
1.6
3993.85
3316.70
titre
0.29
13
109
59
549
1.07
0.19
1.1
1.1
—
—
—
0
0
8348
83795
0.99
0.19
3.5
3.9
0.00
0.00
estimate
0.06
858
17658
11
132
0.83
0.18
2.3
1.3
0.22
0.16
umol/l
—
5
45
8567
85374
1.01
0.17
3.6
4.0
0.00
0.29
estimate
1.86
847
17113
20
176
1.14
0.17
1.1
1.5
6.34
7.05
mmol/l
—
7
51
1269
12535
1.01
0.17
3.0
4.0
72.63
88.75
ng/l
15.35
1108
10883
1046
10602
0.99
0.17
8.4
10.1
1.20
1.33
%
4.13
1041
10538
1414
13980
1.01
0.17
7.1
9.4
—
—
—
0
0
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
122
1273
0.96
0.16
1.5
1.4
—
—
—
0
0
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
263
2558
1.03
0.16
1.3
1.3
0.14
0.23
nmol/l
1.50
14
175
18
158
1.14
0.16
1.1
1.3
—
—
—
0
0
4585
45606
1.01
0.16
2.8
3.1
748.41
1179.76
ng/l
28.09
3753
39286
16
183
0.87
0.16
1.4
1.2
69.81
68.60
ug/l
0.02
16
183
11
92
1.20
0.16
1.1
1.1
—
—
—
0
0
65
689
0.94
0.16
2.7
2.4
51.17
51.99
umol/l
0.08
55
602
248
2413
1.03
0.15
1.1
1.1
1.47
1.51
g/l
0.80
224
2203
10
83
1.20
0.15
1.3
2.0
14.26
18.22
mmol/l
—
10
69
57
606
0.94
0.15
1.4
1.4
85.29
222.84
nmol/24h
1.72
57
606
9
80
1.13
0.15
1.0
1.5
—
—
—
0
0
978
9659
1.01
0.15
8.1
10.0
24.39
24.28
mmol/l
0.59
951
9496
9
83
1.08
0.14
1.2
1.6
—
—
—
0
0
7
88
0.80
0.14
1.3
1.5
816.27
478.55
nmol/l
—
7
88
17
150
1.13
0.14
1.0
1.0
0.19
0.68
u/ml
—
5
73
30
326
0.92
0.14
2.1
2.1
18.13
16.50
umol/l
0.51
30
326
22
243
0.91
0.13
1.2
1.2
102.77
120.03
ng/l
0.13
11
158
15
170
0.88
0.13
1.4
1.5
260.27
166.85
mmol/l
1.43
15
151
605
5960
1.02
0.13
1.6
1.9
—
—
—
0
0
27
293
0.92
0.12
3.8
3.1
50.52
43.60
%
1.01
27
293
27
292
0.92
0.11
7.6
6.2
7.22
8.64
%
0.63
27
292
472
4787
0.99
0.10
1.8
2.0
4.07
12.14
iu/l
1.09
153
1985
85
820
1.04
0.10
1.1
1.1
—
—
—
0
0
275
2798
0.98
0.09
1.1
1.1
—
—
—
0
0
599
5926
1.01
0.09
1.6
2.0
—
—
—
0
0
20
184
1.09
0.09
1.5
1.2
4.83
6.42
mmol/l
—
6
91
942
9344
1.01
0.09
3.2
3.8
52.53
59.86
u/ml
0.20
913
9038
604
5978
1.01
0.08
1.6
2.0
—
—
—
0
0
542
5361
1.01
0.08
2.8
3.4
642.65
426.52
mg/l
0.26
212
2403
133
1298
1.02
0.08
1.2
1.3
1.15
1.81
u/ml
0.80
97
753
533
5275
1.01
0.08
1.6
1.6
938.64
1006.12
mu/l
1.26
431
4392
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
7
67
1.04
0.08
2.7
10.6
98.57
104.99
g/l
—
7
67
51
490
1.04
0.07
1.1
1.1
—
—
—
0
0
9
86
1.05
0.07
1.1
1.0
—
—
—
0
0
195
1920
1.02
0.06
3.4
3.6
4.39
12.50
nmol/l
1.26
185
1857
15
138
1.09
0.06
1.3
1.2
103.57
111.81
ug/l
—
7
85
520
5243
0.99
0.06
1.6
1.7
267.58
300.98
mu/l
2.80
479
4757
943
9375
1.01
0.06
2.9
4.3
24.37
24.25
mmol/l
0.80
931
9272
535
5383
0.99
0.04
3.5
3.4
34.28
43.77
mg/l
0.97
486
4556
22
231
0.95
0.04
1.4
1.6
108.07
114.04
ug/l
0.08
15
196
12
111
1.08
0.04
1.0
1.0
0.18
0.27
u/ml
—
5
70
498
4952
1.01
0.04
2.2
2.6
3.51
3.59
g/l
0.65
469
4737
159
1574
1.01
0.03
2.7
3.3
24.62
13.81
index
0.52
76
901
37
360
1.03
0.03
4.4
3.1
103.94
113.73
ng/l
0.10
17
155
494
4919
1.00
0.02
1.3
1.2
750.00
968.05
titre
—
10
154
586
5882
1.00
0.02
1.6
2.0
—
—
—
0
0
7421
74259
1.00
0.02
2.5
2.8
—
—
estimate
—
0
0
15
158
0.95
0.02
1.0
1.1
—
—
—
0
0
8414
84186
1.00
0.02
6.1
6.8
11.27
11.26
umol/l
0.02
7945
80379
256
2545
1.01
0.02
2.1
2.7
—
—
—
0
0
552
5535
1.00
0.01
1.7
2.1
—
—
—
0
0
67
678
0.99
0.01
1.7
1.7
0.85
2.45
u/ml
1.82
26
181
497
4980
1.00
0.01
1.3
1.2
178.18
126.72
titre
0.26
33
476
13
124
1.05
0.00
1.0
1.1
—
0.23
—
0
6
18
186
0.97
0.00
1.1
1.5
4.12
4.76
nmol/l
0.33
18
178
538
5388
1.00
0.00
3.5
3.4
36.89
60.35
mg/l
1.60
483
4566
14
138
1.01
0.00
1.1
1.0
—
7.13
—
0
15
11
110
1.00
0.00
1.0
1.0
—
—
—
0
0
43
429
1.00
0.00
1.1
1.3
—
—
—
0
0
22
225
0.98
0.00
1.0
1.1
—
—
—
0
0
74
743
1.00
0.00
1.8
1.8
—
—
—
0
0
24
239
1.00
0.00
1.1
1.2
72.08
62.16
ug/l
1.10
24
239
16
155
1.03
0.00
1.1
1.1
2.27
1.67
umol/24h
0.34
16
155
47
467
1.01
0.00
1.7
1.7
9.93
9.07
ug/l
0.65
47
467
13
133
0.98
0.00
2.2
1.7
39.62
45.56
umol/l
0.43
13
133
6
67
0.90
0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
6
67
0.90
0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
44.57
—
0
7
6
67
0.90
0.00
1.0
1.0
—
—
—
0
0
8
85
0.94
-0.00
1.0
1.9
2.02
3.70
nmol/l
—
8
80
6
66
0.91
-0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
19.77
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
1.82
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
0.05
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.0
—
137.17
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SPIROCHAETAL – Other spirochaetal diseases

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).